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Résumé 
L’athérosclérose est une maladie qui cause, par l’accumulation de plaques 
lipidiques, le durcissement de la paroi des artères et le rétrécissement de la lumière. Ces 
lésions sont généralement localisées sur les segments artériels coronariens, carotidiens, 
aortiques, rénaux, digestifs et périphériques. En ce qui concerne l’atteinte périphérique, 
celle des membres inférieurs est particulièrement fréquente. En effet, la sévérité de ces 
lésions artérielles est souvent évaluée par le degré d’une sténose (réduction >50 % du 
diamètre de la lumière) en angiographie, imagerie par résonnance magnétique (IRM), 
tomodensitométrie ou échographie. Cependant, pour planifier une intervention chirurgicale, 
une représentation géométrique artérielle 3D est notamment préférable. Les méthodes 
d’imagerie par coupe (IRM et tomodensitométrie) sont très performantes pour générer une 
imagerie tridimensionnelle de bonne qualité mais leurs utilisations sont dispendieuses et 
invasives pour les patients.  
L’échographie 3D peut constituer une avenue très prometteuse en imagerie pour la 
localisation et la quantification des sténoses. Cette modalité d’imagerie offre des avantages 
distincts tels la commodité, des coûts peu élevés pour un diagnostic non invasif (sans 
irradiation ni agent de contraste néphrotoxique) et aussi l’option d’analyse en Doppler pour 
quantifier le flux sanguin. Étant donné que les robots médicaux ont déjà été utilisés avec 
succès en chirurgie et en orthopédie, notre équipe a conçu un nouveau système robotique 
d’échographie 3D pour détecter et quantifier les sténoses des membres inférieurs. Avec 
cette nouvelle technologie, un radiologue fait l’apprentissage manuel au robot d’un 
balayage échographique du vaisseau concerné. Par la suite, le robot répète à très haute 
précision la trajectoire apprise, contrôle simultanément le processus d’acquisition d’images 
échographiques à un pas d’échantillonnage constant et conserve de façon sécuritaire la 
force appliquée par la sonde sur la peau du patient. Par conséquent, la reconstruction d’une 
géométrie artérielle 3D des membres inférieurs à partir de ce système pourrait permettre 
une localisation et une quantification des sténoses à très grande fiabilité. L’objectif de ce 
projet de recherche consistait donc à valider et optimiser ce système robotisé d’imagerie 
échographique 3D. 
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La fiabilité d’une géométrie reconstruite en 3D à partir d’un système référentiel 
robotique dépend beaucoup de la précision du positionnement et de la procédure de 
calibration. De ce fait, la précision pour le positionnement du bras robotique fut évaluée à 
travers son espace de travail avec un fantôme spécialement conçu pour simuler la 
configuration des artères des membres inférieurs (article 1 - chapitre 3). De plus, un 
fantôme de fils croisés en forme de Z a été conçu pour assurer une calibration précise du 
système robotique (article 2 - chapitre 4). Ces méthodes optimales ont été utilisées pour 
valider le système pour l’application clinique et trouver la transformation qui convertit les 
coordonnées de l’image échographique 2D dans le référentiel cartésien du bras robotisé. À 
partir de ces résultats, tout objet balayé par le système robotique peut être caractérisé pour 
une reconstruction 3D adéquate. 
Des fantômes vasculaires compatibles avec plusieurs modalités d’imagerie ont été 
utilisés pour simuler différentes représentations artérielles des membres inférieurs (article 2 
- chapitre 4, article 3 - chapitre 5). La validation des géométries reconstruites a été 
effectuée à l`aide d`analyses comparatives. La précision pour localiser et quantifier les 
sténoses avec ce système robotisé d’imagerie échographique 3D a aussi été déterminée. Ces 
évaluations ont été réalisées in vivo pour percevoir le potentiel de l’utilisation d’un tel 
système en clinique (article 3- chapitre 5). 
 
Mots-clés : Système d’échographie 3D, sténoses, calibration, robotique médicale, fantôme 
de calibration, maladies artérielles périphériques, fantômes vasculaires, athérosclérose 
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Abstract 
Atherosclerosis is a disease caused by the accumulation of lipid deposits inducing 
the remodeling and hardening of the vessel wall, which leads to a progressive narrowing of 
arteries. These lesions are generally located on the coronary, carotid, aortic, renal, digestive 
and peripheral arteries. With regards to peripheral vessels, lower limb arteries are 
frequently affected. The severity of arterial lesions are evaluated by the stenosis degree 
(reduction > 50.0 % of the lumen diameter) using angiography, magnetic resonance 
angiography (MRA), computed tomography (CT) and ultrasound (US). However, to plan a 
surgical therapeutic intervention, a 3D arterial geometric representation is notably 
preferable. Imaging methods such as MRA and CT are very efficient to generate a three-
dimensional imaging of good quality even though their use is expensive and invasive for 
patients.  
3D-ultrasound can be perceived as a promising avenue in imaging for the location 
and the quantification of stenoses. This non invasive, non allergic (i.e, nephrotoxic contrast 
agent) and non-radioactive imaging modality offers distinct advantages in convenience, low 
cost and also multiple diagnostic options to quantify blood flow in Doppler. Since medical 
robots already have been used with success in surgery and orthopedics, our team has 
conceived a new medical 3D-US robotic imaging system to localize and quantify arterial 
stenoses in lower limb vessels. With this new technology, a clinician manually teaches the 
robotic arm the scanning path. Then, the robotic arm repeats with high precision the taught 
trajectory and controls simultaneously the ultrasound image acquisition process at even 
sampling and preserves safely the force applied by the US probe. Consequently, the 
reconstruction of a lower limb arterial geometry in 3D with this system could allow the 
location and quantification of stenoses with high accuracy. The objective of this research 
project consisted in validating and optimizing this 3D-ultrasound imaging robotic system. 
The reliability of a 3D reconstructed geometry obtained with 2D-US images 
captured with a robotic system depends considerably on the positioning accuracy and the 
calibration procedure. Thus, the positioning accuracy of the robotic arm was evaluated in 
the workspace with a lower limb-mimicking phantom design (article 1 - chapter 3). In 
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addition, a Z-phantom was designed to assure a precise calibration of the robotic system. 
These optimal methods were used to validate the system for the clinical application and to 
find the transformation which converts image coordinates of a 2D-ultrasound image into 
the robotic arm referential. From these results, all objects scanned by the robotic system can 
be adequately reconstructed in 3D. 
Multimodal imaging vascular phantoms of lower limb arteries were used to evaluate 
the accuracy of the 3D representations (article 2 - chapter 4, article 3 - chapter 5). The 
validation of the reconstructed geometry with this system was performed by comparing 
surface points with the manufacturing vascular phantom file surface points. The accuracy to 
localize and quantify stenoses with the 3D-ultrasound robotic imaging system was also 
determined. These same evaluations were analyzed in vivo to perceive the feasibility of the 
study. 
 
Keywords: 3D-US system, stenoses, calibration, medical robotics, calibration phantom, 
peripheral arterial diseases, vascular phantom, atherosclerosis 
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Chapter 1 
Atherosclerosis 
Problems are not stop signs, they are guidelines. 
 
Robert H. Schuller 
This chapter presents the clinical context behind this thesis. Atherosclerosis disease 
and its progression into stenotic lesions are first described, while the manifestation of this 
pathology in lower limb arteries follows. Various diagnostic methods of peripheral arterial 
disease and common therapies are also discussed. The chapter ends with a short summary. 
1.1 Introduction 
Cardiovascular diseases are one of the leading causes of death in developed 
countries and that affect particularly the elderly [1]. These pathologies rank high in terms of 
cost in health care [2] (both direct and indirect) to the nation’s economy as their prevalence 
is expected to increase with the aging population. 
Atherosclerosis is a cardiovascular disease that leads to the hardening and 
remodelling of the arterial walls due to fatty cells deposition. This process can 
progressively narrow the lumen and affect the arteries supplying blood to the heart (causing 
coronary artery disease or CAD), the brain (causing cerebrovascular disease or CVD) 
and/or the legs (causing peripheral arterial disease or PAD) [3-5]. This pathology is a 
complex process that involves endothelial dysfunction, lipid metabolic disturbances, 
platelet activation, thrombosis, oxidative stress production, vascular smooth muscle 
activation, altered matrix metabolism, remodelling, genetic factors and inflammation [6]. 
1.2 Pathogenesis of atherosclerosis 
Narrowing of arteries caused by atherosclerosis is usually initiated when the intimal 
endothelium becomes dysfunctional (see Fig. 1.1) [7]. This inner membrane of arteries is 
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significantly responsible for the vascular equilibrium (i.e., homeostasis). In normal 
function, the endothelium provides a permeability barrier for nutrient delivery and waste 
removal, reduces clotting (i.e., coagulation or thrombosis formation) in inflammation (i.e., 
injury or infection) and finally regulates the vascular tone. 
 
Figure 1.1: Atherosclerosis plaque progression.1 
Endothelial dysfunction develops frequently in arterial bifurcations and branch 
locations [6], where disturbed blood flow occurs [7]. Low-density lipoproteins (LDL) (i.e., 
cholesterol) circulating in the blood stream can easily deposit in the arterial wall or be 
trapped in the sub endothelial space [4]. When free radicals oxidize cholesterol, the 
endothelial cells become intoxicated. Cigarette smoking, hypertension, diabetes mellitus 
and obesity are all, factors that create these toxins [7]. After damages of endothelial cells, 
atheroprotective mechanisms are triggered and inflammation is signalled [4]. Hence, white 
blood cell recruitment (i.e., monocytes, macrophages and leukocytes etc.) for massive 
accumulation of cholesterol are initiated, which starts the process of atherosclerosis at these 
sites (see Fig. 1.1). 
                                               
1
 Source: http://s3.images.com/huge.96.481111.JPG (Accessed: 12/06/2009). 
Fibrous cap 
Lipids, calcium, 
cellular debris 
Macrophages 
transformed 
into foam cells 
Smooth 
muscle cells 
Damaged 
endothelium 
 3 
 
   (a)     (b) 
Figure 1.2: (a) Histology of initial smooth muscle cells trapped into the lipid core of a type IV lesion and 
macrophage foam cells (fo) overlying the core on the side towards the arterial lumen.2 (b) Atherosclerosis 
pathogenesis.3 
When the white blood cells are ingested with cholesterol, they have a foamy 
cytoplasm. From that point, they are called foam cells, where they accumulate in the sub 
endothelial tissue to form an inflammatory lesion referred to as the fatty streak [6, 7]. Foam 
cells generate growth factors and cytokines that make them become necrotic over time [7, 
8]. Cholesterol, foam cells and debris continue to adhere to the necrotic tissue in addition to 
a large number of smooth muscle cells filled with lipids that multiply and form an 
extracellular matrix. This is when the fatty streak becomes a highly cellular advanced lesion 
called the fibroproliferative atheroma (i.e., atheroma plaque). This lesion illustrated in                
Fig. 1.2a contains a lipid core covered by a fibrous cap that is growing in size [6, 8]. The 
complete structural disorganization and thickening of the vessel wall is showed on 
histology hallmarks. Important characteristics of atherosclerosis histological compositions 
[9] are classified in lesion types I-VIII (see Fig. 1.3). 
                                               
2
 Source: [8] H. C. Stary "Atlas of Atherosclerosis Progression and Regression," Second ed, T. P. P. 
Group, Ed. London: Richmond House, 2004. 
3
 Source : http://www.arnoldehret.org/images/cutsectionofartery.gif (Accessed: 10/05/2010). 
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Figure 1.3: Pathways of atherosclerosis progression and regression. The order in which distinct lesion 
types usually develop is designated with the numerals I to VIII. The diagram lists the main histological 
characteristics of each sequential step (lesion type). Thick or thin arrows differentiate between the relative 
ease with which lesions develop in specific locations, or they indicate the relative frequency and importance 
of a specific pathway section.4  
 
 
 
Initially, arteries will compensate for atherosclerosis growth by remodelling. 
Consequently, blood vessels increase in size in order to improve the vascular flow. 
Nevertheless, the arterial wall hardens and can no longer compensate for atherosclerosis 
development, thus in advanced lesions, the arterial lumen is often invaded, which narrows 
and decreases the arterial blood flow. These particular lesions can become more complex 
and calcification can occur to the atherosclerosis plaque (see Fig. 1.4). 
 
 
                                               
4
 Source : [8] H. C. Stary "Atlas of Atherosclerosis Progression and Regression," Second ed, T. P. P. 
Group, Ed. London: Richmond House, 2004. 
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Figure 1.4: Atherosclerosis plaque progression5 
Severe arterial events can occur if the plaque fibrous cap is disrupted [6] or 
obstructs the arterial wall (see Fig. 1.4). Plaque rupture can take place through different 
mechanisms that include inflammation [7, 8]. Exposed necrotic lipid core and 
subendothelial tissue lead to platelet aggregation. Subsequently, thrombus formation and 
flow occlusion arise. At this advanced stage, the pathology can cause a stroke or a 
myocardial infarction and/or limb ischemia. 
1.3 Stenotic lesion characterization 
Occlusions in arteries are called stenotic lesions (or stenoses). A severe stenosis is 
defined by clinicians as more than 50.0 % reduction of the arterial diameter. Generally, 
NASCET (North American Symptomatic Carotid Endarterectomy Trial) and ECST 
(European Carotid Surgery Trial) guidelines are used by clinicians to quantify carotid 
stenosis with percentage ratio on angiograms (i.e., images of the lumen artery); this method 
is also applicable to other arteries and imaging modalities [10-12]. 
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Figure 1.5: In the guidelines to evaluate the severity of stenosis, NASCET and ECST measurement 
methods are used.6 
 
Usually, the numerator is the narrowest diameter difference (i.e., stenosis) for both 
methods. The denominator is either the distal artery (for NASCET) or the estimated 
diameter of unseen stenosis outer walls (for ECST) (Fig. 1.5). While both methods are used 
for different diagnostic imaging technologies, each present their own set of errors. 
NASCET, the most commonly used technique, is more representative of the luminal 
narrowing but can underestimate the lesion in case of near occlusions or diffuse 
atheromatous infiltration [10, 11]. Likewise, ECST has the subjective bias of measuring an 
unseen artery [10]. Regardless of the method, the degree of stenosis correlates with blood 
flow velocity and symptoms that can be used to identify the severity of impaired arterial 
lesions [6, 13]. 
1.4 Lower limb peripheral arterial diseases 
Atherosclerosis is a systematic disease that progresses in most medium-size vessels 
of the lower extremity, such as the aorto-iliac and infrainguinal system [9, 16-18]. This 
disease is more prevalent in the femoral and popliteal arteries (80 % - 90 % of symptomatic 
patients), tibial and peroneal arteries (40 % - 50 % of symptomatic patients), in the aorta 
and iliac artery (30% of symptomatic patients) [8, 14]. Atherosclerosis mainly develops in 
                                                                                                                                               
5
 Source: http://multivu.prnewswire.com/mnr/uaa/37598/images/37598-hi-Athero_Progression.jpg (Accessed: 
10/05/2010) 
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the arterial system compared to the veins because more oxygen is available in arteries to 
oxidized cholesterol (see lower limb vessel anatomy in Fig. 1.6). When a cardiovascular 
event (i.e., myocardial infarction, stroke) occurs in other vascular regions (i.e., coronary 
and carotid arteries), PAD is often present symptomatically or asymptomatically [3, 7, 15, 
16]. 
Occlusions in lower limb peripheral arteries contribute to diminished blood supply, 
causing decreased oxygen and nutrient supply in distal tissues and muscles. If occlusions 
further progress and/or perpetuate, cell injury can cause severe tissue ischemia or 
furthermore, tissue breakdown which can lead to a cardiovascular event, amputation and 
even death. 
 
Figure 1.6: Complete anterior view of lower limb peripheral arteries and veins.7 
1.4.1. Symptoms 
Most PAD are diagnosed when severe symptoms are present because in early stages 
of the disease, they are usually silent [17]. When stenotic lesions are severe, intermittent 
claudication symptoms may appear in hips, buttocks, calves and arch of the foot and even 
                                                                                                                                               
6
 Source: http://www.tidsskriftet.no/index.php?seks_id=1181296&a=fig&art_id=1181232 (Accessed: 
22/07/2009). 
7
 Source: http://www.vascular.westcountysurgical.com/images/pad_1.jpg (Accessed: 11/06/2009). 
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sometimes produce erectile dysfunction in males [7, 18, 19]. Intermittent claudication, the 
primary perceptible PAD symptom, is defined by leg muscle pain, cramping and fatigue 
brought on by ambulation or exercise, relieved at rest [8]. The location of the pain is 
determined by the anatomical level of the disease. A blood flow velocity increase is 
observed inside the stenotic lesion with flow velocity and blood pressure drops downstream 
of the lesion. This phenomena is amplified during exertion because of the increase of 
oxygen consumption requiring more blood inflow. More complex symptoms are involved 
in case of critical limb ischemia where ischemic symptoms are present at rest. Rest pain, 
minor and major tissue losses (ulceration) can be observed. In this case, the limb can be 
mummified with dry black toes or devitalized soft tissues covered by crust (gangrene). 
Moreover, metabolic abnormalities in the skeletal muscles of the lower extremity can occur 
[17]. However, in case of chronic disease, an extensive collateralization (i.e., microvascular 
growth) occurs in the lower limb arteries increasing blood downstream of the lesion. This 
phenomenon can alleviate the symptoms and is promoted by exercise. With disease 
progression, obstructions at different levels are observed with a cumulative effect on flow 
impairment. Thus, symptoms usually surface when one or more vessels have been severely 
narrowed. To rate the symptom severity, two classification systems are commonly used 
[20, 21]. In the Rutherford system, mild, moderate and severe claudications are categorized 
from 1-3 and asymptomatic patient as 0, while categories 4-6 encompass ischemic rest 
pain, minor to major tissue losses and critical limb ischemia (see Table 1). In the Fontaine 
system of classification, only 4 grades (0-III) associated with asymptomatic, moderate 
claudication, ischemic rest pain and critical ischemia (see Table 1) are used. It is important 
to note that Rutherford’s classification is the clinical standard for describing clinical 
assessment and progress. 
 
 
                                                                                                                                               
 
 9 
Table 1: Classifications of peripheral arterial diseases according to Rutherford categories 
and Fontaine’s grades [21]. 
Clinical description Fontaine’s 
grades 
Rutherford’s 
categories 
Asymptomatic 0 0 
Mild claudication I 1 
Moderate claudication I 2 
Severe claudication I 3 
Ischemic rest pain II 4 
Minor tissue loss III 5 
Major tissue loss III 6 
 
1.4.2. Risk Factors 
PAD traditional risk factors are the same as those associated with atherosclerosis in 
the carotid, coronary and other vascular beds. They specifically include: advanced age, 
diabetes mellitus, smoking, hyperlipidemia and hypertension. Generally, subjects of 65 
years of age or older have higher risk for PAD development [6]. This risk increases 
approximately 4 times more if subjects smoke cigarettes [6, 7, 22]. In addition, PAD risk is 
apparently directly proportional to the dose of smoking (i.e., number of packs per year). 
This association is twice as strong as with coronary artery disease. Certainly, this is the 
single most important modifiable risk factor for PAD development. Moreover, if subjects 
have diabetes mellitus, they are 1.5 to 4 times more likely to develop symptomatic or 
asymptomatic PAD. In addition, they have an associated increase risk of cardiovascular 
events and premature death [6, 22]. Similarly, an elevated total cholesterol level (i.e., 
hyperlipidemia) increases 2 times more PAD symptoms. In fact, the prevalence of 
symptoms was found to be 77 % in patients with known PAD [6]. Finally, hypertension has 
been linked to 50 % – 92 % of patients with PAD [6]. In this case, an increase risk of stroke 
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and myocardial infarction independent of other factors exist with these patients [22]. 
Clearly, all these traditional risk factors can be modified to reduce PAD progression [23]. 
Non traditional risk factors also have shown to predict the prevalence of PAD. 
These risks include: race and ethnicity, inflammation, chronic kidney disease, genetics, 
hypercoagulable states and abnormal waist to hip ratio. However, not much study has been 
established to clearly outline their specific relationship to PAD. Black and Hispanic 
populations have shown to be disproportionately prevalent to PAD even after adjustments 
to traditional risk factors [6, 22, 23]. In addition, elevated levels of inflammatory markers 
(e.g., leukocytes) have already been observed in patients with atherosclerosis in other 
arterial systems. However, several studies suggest that high level of inflammatory markers 
are more specifically associated to PAD in lower limbs [6]. Furthermore, an unknown 
association of PAD with chronic kidney and severe renal diseases appears to exist 
independently of the traditional risk factors [6]. For example, PAD patients with chronic 
kidney disease are at increased risk for critical limb ischemia, while those with severe renal 
disease are at increase risk for amputation. 
Yet, recently, several studies suggested an independent association between PAD 
and hypercoagulable states or thrombophilia (i.e., increase tendency to develop blood clot 
due to an abnormality) [6]. In some cases, hemostatic factors seem to be associated with 
premature atherosclerosis more prominently in PAD progression than for carotid artery 
disease. Moreover, ongoing reports of genetic predisposition to PAD also seem to suggest 
increased rates of CVD at an earlier age (i.e., less than 55 years) [6]. Lastly, new reports 
have found an association between PAD and abdominal obesity. Apparently, an increased 
waist to hip ratio (more than 0.966) can be associated with a 1.7 time increase risk of PAD 
[6]. 
In final analysis, PAD is a systematic atherosclerotic process that is associated with 
high morbidity and mortality, and significant impairment on the quality of life. However, 
with all well known traditional and associated risk factors, it remains underdiagnosed and 
undertreated [24, 25]. Moreover, most previous studies that screened PAD in the primary 
care settings with risk factors include patients that are already known to have PAD or 
another associated CVD [25]. Thus, significant benefits could be achieved in detecting 
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PAD patients with risk factor awareness and enhanced screening. However, a collaborative 
effort between patients and clinicians is necessary to recognize lower limb symptoms and 
diagnose PAD appropriately. 
1.5 Diagnostic methods 
Patients with PAD are principally diagnosed when they report lower limb pain to 
their clinician. Clinicians first employ questionnaires to assist them in identifying PAD 
symptoms where the walking distance and the lower extremity pain are evaluated [7]. It is 
to note that PAD also exists in patients with no evident symptoms. Thus, the first line of 
investigation with a clinician is usually subjective. 
If PAD is suspected after the first consultation, specialized radiologists and/or 
vascular surgeons are normally referred to examine arterial lesions more specifically. Then, 
diagnostic approaches able to detect, locate and quantify stenoses in an objective manner 
are used. Non-invasive screening techniques such as ankle brachial index, tests & exercises 
and ultrasound (US) imaging are employed to assess PAD severity. To map the entire lower 
limb vascular tree, common invasive imaging technologies such as digital subtraction 
angiography (DSA), computed tomography angiography (CTA) and magnetic resonance 
angiography (MRA) are used [26]. 
1.5.1 Non-invasive screening methods 
1.5.1.1 Ankle brachial index 
The ankle brachial index (ABI) is the oldest non-invasive method that can 
accurately detect the presence and severity of PAD in primary care clinical setting [7, 8, 23, 
25-27]. This technique, illustrated in Fig 1.7, is described as the ratio of systolic blood 
pressures measured at the ankles to the one of arms with a cuff and manometer. A threshold 
value less than 0.90 is an indicator for PAD. 
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Figure 1.7: Screening of PAD with the ankle-brachial index (ABI) test.                                                    
(DP = dorsalis pedis, PT = posterior tibial).8 
 
ABI is a commonly accepted reference standard for PAD pre-diagnostic because it 
is sensitive and specific [13]. However, this technique presents limitations to detect PAD 
when peripheral arteries are heavily calcified. A falsely abnormal or high ABI can occur 
from arteries that consequently become rigid and non-compressible [7, 23]. ABI cannot 
diagnose PAD also in aorto-iliac disease, collateralized disease and occlusions for the same 
reason [28]. 
1.5.1.2 Tests and exercises 
Usually, if the ABI is conclusive, further investigations are performed to localize 
lesions with either segmental pressure evaluations, pulse volume recordings or treadmill 
exercise training [7, 8]. For segmental pressures, lower limbs are separated in sections, and 
then at each level, pressure measurements are assessed (see Fig. 1.8). This approach similar 
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to the ABI requires a continuous-wave Doppler probe (explained later in section 1.5.1.3) 
that is placed on the different vessel segments. Stenoses are detected when a decrease of 
pressure occurs between two consecutive levels or when a discrepancy arises between 
pressure measurements at the same level of both limbs. 
To perform pulse-volume recordings (PVR) at different levels, the same pressure 
measurement equipment is used and the record of plethysmographic tracing is also 
performed. Changes in the volume of blood flow are detected in these tracings and severe 
stenoses are identified when the normal peak velocity ratio (PVR) waveform becomes 
attenuated. Fig. 1.8 demonstrates PVR test in a patient with a symptomatic PAD on the left 
side with normal PVR in the right leg and decreased values in the left leg. 
PAD diagnosis is also confirmed by demonstrating objectively the functional 
limitation of lower limbs [26]. If patients have a normal resting study and exertion 
symptoms, a treadmill exercise training test can be performed. During the procedure, the 
subject walks on a treadmill at a constant speed with a fix setting or a variable incline. This 
method is used as well in therapy to monitor effects on initial and absolute claudication 
distances. 
 
                                                                                                                                               
8
 Source: http://www.mdconsult.com/das/book/body/148479302-3/0/1492/f4-u1.0-B978-1-4160-2805-
550084-7gr1.jpg (Accessed: 08/07/2009). 
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Figure 1.8: Pulse volume recordings of a patient presenting a PAD in its left leg9. 
Altogether, these tests and exercises are available options that are inexpensive and 
painless to provide a useful non-invasive method that can evaluate patients suspected with 
PAD when they present limb discomfort. However, all of the above vascular physical 
examinations have been severely criticized by physicians because they only quantify flow 
limitation but do not image the occlusive disease itself and its extension. Moreover, the 
reliability of screening is poorly reproducible, unreliable and difficult to interpret [29]. 
Thus, other non-invasive testing should be prompt to localize lesions more specifically. 
1.5.1.3 Duplex ultrasound (US) 
Medical diagnostic ultrasound is a modality that uses the ultrasound energy and the 
human tissue acoustic properties to produce an image (for further information relative to 
US see Appendix I). US images are produced from a ‘pulse echo’ technique that 
synthesizes a gray-scale 2D tomographic image of tissues based on the mechanical 
                                               
9
 Source : [26] D. Chan, M. E. Anderson, and B. L. Dolmatch, “Imaging evaluation of lower extremity 
infrainguinal disease: role of the noninvasive vascular laboratory, computed tomography angiography, and 
magnetic resonance angiography,” Tech Vasc Interv Radiol, vol. 13, no. 1, pp. 11-22, Mar, 2010. 
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interaction of short pulses of high-frequency sound waves and their returning echoes [30]. 
The whole image data acquisition process is performed from a US system that offers 
convenient real-time imaging with a transducer in contact with the human body (see Fig. 
1.9). 
 
 
 
 
 
 
 
Figure 1.9: (a) Diagnostic US imaging system. (b) US probe scanning the lower limb (leg). (c) Color 
Doppler superimposed on a B-mode arterial image in cross-sectional view.10 
 
This non-invasive, non-ionizing and low-cost US technology provides physicians 
with valuable information on vascular stenosis detection for both diagnosis and follow-up 
purposes. PAD severity could be analysed in multiple modes with options in B-mode, color 
and power Doppler that facilitate accurate blood flow quantification and localization. B-
mode presents the morphology on the atherosclerotic plaque in gray scale imaging [31], and 
Doppler US estimates the velocity and the direction of moving blood cells based on the 
frequency shift principle of an US wave [30]. The US imaging system extracts Doppler 
information in the form of pulsed and continuous wave Doppler to output into a spectral 
Doppler waveform, color flow and power maps [30]. 
                                               
10
 Source: (a) http://www.csd-ultrasound.com/mindray/DP-9900.htm (Accessed: 18/06/2009),                                       
(b) http://www.cardiosmart.org/HeartDisease/CTT.aspx?id=140 (Accessed: 09/07/2009),                                           
(c) http://www.kvu.com.au/Doctor-Information/image012.jpg (Accessed: 29/07/2009). 
(a) (b) 
(c) 
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To identify a stenosis, the spectral Doppler US waveform is often used.  This US 
imaging mode displays the spectrum of flow velocities over time. The normal spectral 
density waveform is "triphasic" (see Fig. 1.10b). Turbulent flow patterns that depend on the 
vessel wall characteristics, size and shape of the vessel, and the flow rate are used to detect 
stenosis [30]. To visualize the vessel anatomy and analyze the blood flow, color flow 
imaging is often used [30]. This US imaging mode is a form of pulsed wave Doppler, 
where returning echoes are assigned a color coding representing their flow velocity and 
direction. This color mapping is superimposed on B-mode images (i.e., Duplex scanning). 
In this form, semi quantitative assessment of blood flow velocity is provided (see             
Fig. 1.10a). By convention, shades of red represent flow towards the transducer, and blue 
away from it. Finally, to detect and interpret subtle and slow blood flow, power Doppler 
imaging is used. This form of imaging relies on the total strength (amplitude) of the 
Doppler signal energy and ignores its direction. Thus, this imaging mode is the most 
sensitive to motion of the blood flow. 
 
 
Figure 1.10 : Duplex scanning: a) longitudinal view of the common femoral artery in pulsed wave 
Doppler US. b) Corresponding spectral density waveform.11 
                                                                                                                                               
 
11
 Source: http://www.terarecon.com/gallery/images/us_5cfa_color_dopp.jpg  (Accessed: 16/06/2009). 
(a) (b) 
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However, all these analyses have limited accuracy in tortuous and densely calcified 
arterial segments. Furthermore, it is not easy to visualize the entire lower limb vascular tree 
within an acceptable time frame using color-flow or power Doppler US. Moreover, 
assessment of atherosclerotic disease with conventional B-mode 2D-US images is highly 
operator dependant because of the high variability encountered with 2D freehand US 
methods when imaging a 3D anatomy [32]. A complete 3D representation of lower limb 
vessels over long segments, usually starting from the abdominal aorta within the abdomen, 
following with iliac, femoral, and then with popliteal arteries to end in the tibial vessels of 
the calf, is required for comprehensive therapeutic planning (i.e., specific diameter and 
length of angioplasty balloons or stents). 
1.5.2 Invasive diagnostic methods 
1.5.2.1 Digital subtraction angiography (DSA) 
Digital subtraction angiography is a fluoroscopy technique that allows real-time x-
ray imaging of blood vessels with high temporal resolution [30]. Basically, the x-ray tube, 
filters and collimation are the components that altogether create a beam of x-ray photons of 
well-defined intensity; penetrability and spatial distribution that include an image 
intensifier and computer technology (see Fig. 1.11a). To visualize the lumen of blood 
vessels, this technique uses radio-opaque contrast agent injected into the blood with a guide 
wire and catheter inserted through the femoral artery. Then, radiologists can evaluate the 
anatomy of blood vessels by subtracting bones and other organs from previously acquired 
frames in order to view only the vessels filled with contrast agent. Patients have to remain 
motionless during the entire procedure. 
DSA is the standard of reference for evaluating lower limb arterial diseases [12]. 
Angiograms provide the best image quality that outlines the entire lower limb vessel 
anatomy in 2D projections and identifies areas of narrowing (see Fig. 1.11b). Stenosis 
quantification is performed on diameter reduction ratios only [33]. Angiography is also 
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primarily used during therapeutic interventions (e.g., arterial angioplasty) as it offers real-
time imaging. 
 
 
 
Figure 1.11: DSA diagnosis: (a) the fluroscopic equipment and (b) an angiogram of lower limb arteries 
with a stenosis on the right leg.12 
 
Nevertheless, DSA is an invasive ionizing procedure of substantial costs associated 
with potential morbidity [15]. The main complications of DSA examinations are 
thromboembolic events, bleeding from the puncture site, vascular injury, and exposure to 
radiation and toxicity related to iodinated contrast dyes [34]. Bed rest of 1 day is usually 
required after the procedure is completed to avoid putting stress on the arterial puncture. 
Furthermore, information on the morphology of the atherosclerotic plaque with this method 
is incomplete since DSA images only the lumen of the vessel and is usually two 
dimensional. This method is also known to often overestimate the length of lesions and to 
not always show all patent lower limb vessels (below-knee vessels may be difficult to 
identify, especially if the injection is not made selectively) [19, 29]. 
                                               
12
 Source: (a) http://en.wikipedia.org/wiki/X-ray_image_intensifier (Accessed: 16/06/2009),                                  
(b) http://www.rjmatthewsmd.com/Definitions/peripheral_vascular_disease.htm (Accessed: 09/07/2009). 
 
(a) (b) 
stenosis 
R L 
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1.5.2.2 Computed tomography angiography (CTA) 
Computed tomography angiography is a medical imaging technique used to 
visualize arterial and venous vessels. Its principle is based on computed tomography, which 
combines x-rays with computerized analysis for imaging [30]. Basically, x-ray beams are 
passed from a single rotational axis into the targeted area of the body at several different 
angles to obtain projection images that are after assembled by a computer into 3D memory 
matrix. Fig. 1.12a shows the CT scan equipment. CTA necessitates the injection of iodine 
contrast agent that is inserted with a needle into a peripheral vein. The computer software 
permits 3D imaging performed by multiplanar reconstruction (MPR) in stacking axial slices 
or alternatively by maximum intensity projection (MIP), surface or volume rendering 
techniques based on the threshold value of radiodensity chosen by the operator. 
                      
 
Figure 1.12: (a) A CTA medical imaging equipment. (b) A 3D surface rendered view of lower limb 
arteries with CTA.13 
CTA replaces conventional angiography in many PAD imaging studies [22]. In the 
assessment of symptomatic lower extremity arterial disease, the diagnostic performances of 
CTA and DSA are quite similar [12]. In fact, CTA involves minimal risk compared to DSA 
since it is less invasive (i.e., exposes the patient to less ionizing radiations and do not 
                                               
13
 Source : (a) http://www.mckweb.com/Services/Pages/Diagnostic%20Imaging%20Services.aspx (Accessed 
03/07/2009), 
(b)  http://www.maconcvi.org/pad.html (Accessed: 03/07/2009). 
(a) (b) 
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require arterial puncture) [26]. Furthermore, CTA has a lower cost than DSA for diagnosis, 
improvement in quality of images and acquires volumetric images. Thus, 3D visualization 
of the arteries is possible from multiple angles and planes from a simple acquisition [26] 
(see Fig. 1.12b). Moreover, compared to DSA, CTA takes less time (a few seconds) to 
acquire images and it is less expensive [15, 16]. 
In addition, current high-speed, multidetector CTA techniques allow for direct 
evaluation and measurement of lumen diameters. Thus, stenoses can be quantified in 
millimetres and further derived in ratio percentages [33]. CTA also has a limited scan 
coverage and a good resolution [10, 12, 27]. Furthermore, it has the capability to visualize 
calcification and metallic implants such as endovascular stents or stent grafts [35]. 
Likewise, disagreements between conventional DSA and CTA results often occur in 
smaller arteries, particularly below the knee [12]. Moreover, several studies report 
decreased accuracy in severely calcified arteries and the use of a relatively large amount of 
intravenous contrast is a real concern for patients with reduced renal function [12, 26]. 
Thus, CTA might be insufficient to image accurately the entire vascular tree. Henceforth, 
DSA examination can be necessary to complement suboptimal CTA examinations for 
appropriate treatment planning. 
1.5.2.3 Magnetic resonance angiography (MRA) 
Magnetic resonance angiography [36] is a technique to image blood vessels based 
on magnetic resonance imaging (MRI). MRI generally provides the ability to manipulate 
and adjust tissue contrast with increasingly complex pulse sequences [30]. Moreover, it has 
the capability to accurately determine the position from the nuclear magnetic resonance 
signal and thus create an image. Fig. 1.13 shows an MRI system and an example of a lower 
limb image from this system. 
Gadolinium contrast-enhanced magnetic resonance angiography is a non-invasive, 
non-ionizing, three-dimensional technique that has emerged as a front-line imaging 
approach for comprehensive evaluation of PAD [26, 37, 38]. The contrast medium is 
normally injected into a vein and images are acquired through the arteries within a 15-25 
seconds apnea (breath-hold). Thus, if the patient remains perfectly still, high quality images 
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are acquired with a stack of slices that represents the 3D volume of the entire body; where 
slices of the vessels of interest can be selected. Display of this 3D representation is 
performed with a rendering method, i.e. a maximum intensity projection (MIP) that 
computes pixels at the highest value for display on screen. The resulting images are 
comparable with conventional angiography [22, 38] (see Fig.1.13b). Furthermore, MRA 
provides precise measurements of arterial stenoses and occlusions that are required for the 
planning of therapeutic interventions [26, 37, 38]. Thus, in the clinical setting, MRA can be 
extremely helpful in diagnosis as well as subsequent management of patients with PAD. 
However, artefacts present challenges in MRA for diagnostic accuracy due to signal loss 
from in-plane saturation and turbulent flow. Artefacts are also caused by metallic clips and 
stents [26]. In addition, compared to CTA, MRA seems poorer in resolution, is far more 
expensive and the technology is often less available for scanning PAD [35]. Moreover, 
MRA images mainly the vessel lumen and tends to overestimate the degree of stenosis [23, 
35]. Other limiting factors with this modality in patients are claustrophobia, the rare 
occurrence of systemic nephrogenic fibrosis in case of renal failure and contradictions 
related to metal implants or pacemakers. 
    
 
Figure 1.13: (a) MRI system. (b) MRA combined views of different portions of the lower limb anatomy 
presented into one simple view.14 
                                               
14
 Source: (a) www.mri-equipment.com/MRI.cfm (Accessed: 17/06/2009),                                                                    
(b) http://www.freepatentsonline.com/6564085.html (Accessed: 16/06/2009). 
(a) (b) 
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1.5.2.4 Other technologies 
Diagnosis procedures at the cellular level are also emerging. They regard not only 
the symptomatic, but focus on the early asymptomatic phase of the disease as well [39]. For 
example, research on the vascular inflammation process is of interest because its 
importance in atherosclerosis is well established. However, limited data exist on the 
relationship between vascular inflammation and the severity of PAD despite several 
findings [40]. Thus, this might be of importance in future diagnosis and treatment of the 
disease. 
Other alternatives are intravascular ultrasonography (IVUS) and angioscopy which 
are both invasive techniques that can visualize the vessel wall from inside the lumen [27]. 
The IVUS technique allows a visualization of the atherosclerotic plaque with a high spatial 
resolution important to identify arterial lesions and its relation with vessel wall that cannot 
be depicted on DSA. It can also be beneficial to plan an appropriate therapy. Indeed, this 
technology has shown promise particularly for the monitoring of endovascular 
interventions (e.g., angioplasty or stent deployment). Nevertheless, segmenting IVUS 
images is challenging because the data is quite large and the IVUS is susceptible to 
artefacts especially in calcified arteries [41]. 
Finally, physicians largely rely on the clinical examination to identify patients 
needing further testing to diagnose PAD. They depend on imaging technologies to assess 
quantitatively, the location and severity of the lesion. Thus, based on the diagnosis, proper 
therapeutic planning can be achieved. 
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1.6 Therapeutic interventions 
Therapeutic goals in PAD are basically to preserve or restore a distal circulation 
allowing daily activities in claudicant patients and prevent limb loss in critical limb 
ischemia. The treatment also aims to improve the patient’s quality of life by reducing or 
eliminating symptoms and pain when legs are exerted [7, 19]. Early treatment of PAD is 
critical because benefits are then optimized [42]. At first, when PAD is suspected or 
diagnosed and risk factors are assessed, primary PAD management focuses on the 
reduction of the risk of cardiovascular events by modifying risk factors aggressively (i.e., 
diabetes mellitus, smoking, hyperlipidemia and hypertension), as suggested by the 
American Heart Association for CAD [43, 44]. This includes smoking cessation, exercise 
therapy, antiplatelet therapy as well as adequate blood pressure (i.e., hypertension), glucose 
and lipid control (i.e., dyslipidemia with statin drugs) [7, 42-44]. However, because this 
disease is mainly asymptomatic, in most cases, diagnosis is completed at an advanced stage 
when stenoses are severe. As a result, frequent invasive therapeutic interventions need to be 
planned and achieved in order to relieve PAD symptoms with balloon angioplasty, stents 
and surgical revascularization [18]. Specific details on all these treatments follow. 
1.6.1 Medical treatment 
The amount and the duration of tobacco use correlate directly with PAD 
development and progression [22, 45]. Thus, smoking cessation is the most important 
modifiable risk factor that can increase long-term survival in patients with PAD, reduce the 
severity of claudication and relieve associated pain [46]. Many clinicians advice patients to 
quit smoking and make use of nicotine replacement therapy combined with antidepressants 
(e.g., bupropion) to prolong the cessation rate [22, 36, 45]. Of course, this treatment option 
consists of modifying behaviour by counselling and by a short-term tobacco dependence 
pharmacotherapy. However, smoking cessation is a short term therapy that remains difficult 
to maintain long-term [46]. Thus, alternative methods should be considered. 
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Clinicians also advise exercise trainings to improve limb function. Exercise therapy 
programs can significantly improve the walking time and ability of patients affected with 
intermittent claudication [45]. The programs involve the combination of walking, stair 
climbing, cycling and dynamic & static leg exercises to near-maximal pain with 2-3 
sessions of 30 minutes per week over a period of 6 months [46-48]. By the end of the 
program (after no more exercises are performed), walking distances are doubled and this 
improvement can last for up to 15 months [27]. Because unsupervised exercises have rarely 
shown to offer meaningful clinical benefits [46], a financial support for a PAD 
rehabilitation program must be available with trained personnel for this method to be 
successful. Accordingly, supervised exercises can produce significant results that are 
equivalent to invasive surgical treatments [36, 44]. However, the patient needs to be 
motivated. 
At last, the most common and straightforward therapy are pharmaceuticals. 
Antiplatelet therapy is the cornerstone strategy for pharmacological intervention in PAD 
(with the exception of patients who suffer bleeding disorders) [45]. These drugs prevent 
ischemic events in lower limbs and like most PAD drugs, they also prevent secondary 
vascular events to occur (e.g., cardiovascular morbidity and mortality) [8, 49]. Also these 
drugs can modify the platelet activity which causes thrombus formation that can result in 
cardiovascular events. Aspirin is the most popular affordable antiplatelet agent prescribed 
by clinicians. The benefits associated to this drug are: delayed progression rate, reduce 
surgical need for an intervention and prolonged effectiveness of an invasive treatment (e.g., 
revascularization procedures with graft) [24, 36]. 
Also, patients with PAD normally have CAD and CVD that are associated to 
diabetes mellitus, hypertension and hyperlipidemia [36, 44]. To prevent atherosclerosis 
systematic complications (e.g., stroke, heart attack or death), therapies target on the control 
of risk factors such as blood pressure reduction (i.e., with β-blockers, angiotensin-
converting enzyme inhibitors (ACE)), aggressive LDL cholesterol lowering (e.g., with 
statins) and glycemic control. Other pharmacologic treatments are also available to 
potentially relieve symptoms and improve walking distance (e.g., cilostazol, etc...) [7, 8, 
25]. Also, it is known that a dysfunctional endothelium plays a crucial role in all stages of 
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atherosclerosis. As a result, many PAD upcoming therapeutic interventions are focusing on 
endothelial dysfunction prevention and healing [24]. 
In final analysis, PAD patients should be approached like coronary and carotid 
diseases with the above non-invasive treatments. Nonetheless, many patients with PAD are 
not receiving optimal medical management because the perceptions and knowledge of risk-
reduction pharmacotherapy are poor among vascular surgeons [27, 36, 42, 50]. 
1.6.2 Invasive treatment 
Invasive therapy provides the most immediate benefit to symptomatic patients with 
severe PAD. Common endovascular interventions are percutaneous balloon angioplasty and 
stenting whereas surgical management includes bypass revascularization and lastly, 
amputation [22]. Since they are less invasive, catheter-based methods are more frequently 
used [17] (see Fig. 1.14) and require appropriate imaging to plan the intervention [33]. 
These invasive procedures are indicated for advanced PAD limiting patient life style that 
had an inadequate response to non-invasive therapy or patient presenting a risk of limb loss. 
Percutaneous transluminal angioplasty (PTA) is the preferred initial treatment for 
patients with disabling claudication since it is the least invasive procedure [51]. Benefits 
associated with this method over other surgical interventions are lower initial morbidity and 
mortality, shorter hospital length stay and decreased trauma [7]. It is performed on vessel 
lesion segments of less than 10 cm in length mostly on femoropopliteal stenotic lesions [48, 
51]. To have a favourable outcome with this procedure, the stenotic lesion needs to be 
proximal with a good distal run-off. Initial success rate of PTA are > 90 %, however, 
subsequent failure rates remain high because platelet thrombus formation produces 
restenosis (40 to 60 % in the femoropopliteal segment after 2 years) and reocclusion [8, 
52]. Besides, PTA success rates are highly operator-dependant. Thus, this technique is 
usually used aggressively in clinical centers that manage a large volume of patients [51]. In 
addition, this approach offers short term (6 months) benefits compared to exercise therapy, 
but have similar long-term (24 months) advantages than the latter [27]. 
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Figure 1.14: Invasive therapeutic interventions: balloon angioplasty and stenting.15 
 
Intravascular stents were developed to provide a long-term radial force to support 
the vessel after angioplasty and to prevent elastic recoil with improved patency [22, 53]. 
Metallic stents can be placed at many different arterial sites (e.g., coronary, iliac and 
femoral arteries) to prevent restenosis. In addition, a significant improvement in patients 
with claudication symptoms can be seen after iliac-artery stenting where a 4 year patency 
rate increase of 12 % for stenoses and 7 % for occlusions, respectively, were reported 
compared to angioplasty alone [27]. Moreover, a 39% failure risk reduction was shown 
[27]. However, this method is limited because in-stent restenosis still represents a major 
limitation [54, 55]. Restenosis occurs as a vascular reaction to catheter-induced vessel 
injury that stimulates vessel wall proliferation more prominent in smaller vessels. To 
control this problem, it is necessary to avoid over sized stents, since the rate of restenosis is 
directly correlated with the arterial lumen obtained immediately after angioplasty. Other 
alternatives include fabricating pharmacologic therapeutic stents, where the vessel 
proliferation is inhibited locally [55]. Nevertheless, this type of stent is restricted to large 
vessels (i.e., 3.0-3.5 mm diameters). 
Surgical revascularization is reserved for patients with critical limb ischemia (i.e., 
limb-threatening) [17, 22]. This treatment is highly recommended to heal ischemic ulcers 
                                               
15
 Source: www.strokeupdate.co.uk/news.htm (Accessed: 16/06/2009). 
 27 
and prevent limb loss. Most of ischemic limbs can be revascularized with bypass surgery 
for patients with long aortoiliac or superficial femoral artery occlusions that are unsuitable 
for angioplasty and stenting [27]. Five year patency rates of 80.0 % – 90.0 % and 70.0 % 
are reported for the aortobifemoral and femoropopliteal bypasses, respectively [27]. Even 
so, the limited length of the aortoiliac or the superficial femoral artery, the unavailability of 
autogenous (self-generating) veins or the irreversible gangrene may limit this procedure 
and if graft occlusion occurs; lower-limb ischemia may become a worse threat to the limb 
[22]. 
Immediate and long-term survival rates are higher in patients having 
revascularization rather than amputation for limb threatening ischemia. At this advanced 
stage of the pathology, the infection can threaten the patient’s life [22]. Amputation is the 
last recourse when tissue loss can no longer be saved. In this case, the surgery is graded too 
risky, life expectancy is very low and/or there is functional limitation in the leg [22, 48]. 
Most medical and surgical interventions present programs that can prevent amputation, 
however, it remains an acceptable option for patients facing a prolonged course of 
treatment and a poor prognosis for a successful outcome. 
In conclusion, surgical interventions directed toward PAD require additional 
imaging modalities that can clearly locate the lesions with accurate stenosis quantification 
and occlusion detection in order to define the target vessel for bypass surgery [33]. 
Furthermore, pharmaceuticals can be combined with these interventions, in order to 
minimize symptoms and disability, slow down local disease progression, reduce systematic 
cardiovascular morbidity/mortality and improve the durability of the surgical intervention 
[18]. 
1.7 Summary 
At an early stage, before symptoms become apparent, the potential to treat 
atherosclerosis is high. In fact, significant disease progression can frequently be turned into 
disease regression [56]. To achieve this goal, it is critical to first screen PAD on 
symptomatic patients with precise information on the location and on the morphology of 
stenotic lesions using a standard method. Intermittent claudication symptoms are generally 
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associated with stenoses or occlusions of the iliac or femoro-popliteal arteries [8]. 
Claudication in the calf is commonly due the disease in the femoral arteries. Staggeringly, 
75.0 % of patients with this symptom are underdiagnosed despite its significant impact on 
life expectancy, functional status and on the quality of life [8]. Particularly, PAD is an 
important marker given the strong correlation that exists to CAD and CVD, who are both 
linked to stroke, heart attack and death [22, 45, 46]. The population is poorly informed 
about symptoms and consequences of PAD (i.e., definition, risk factors, limb symptoms, 
amputation risks and cardiovascular risk events) [57]. In fact, only one third of patients 
having PAD symptoms report them to their physicians [7]. Therefore, they frequently loose 
the opportunity to initiate primary care with their general practitioners. Thus, it is essential 
that physicians are proactive in identifying intermittent claudication in patients. 
In that matter, proper diagnostic tools need to be offered in order to allow clinicians 
to select a treatment plan that can alleviate pain, improve functional ability and reduce the 
future risk of cardiovascular events when PAD symptoms are present [13]. Presently, 
imaging technologies provide the best option to enable stenosis/occlusion location and 
quantification for an appropriate therapeutic intervention (pharmaceutical, endovascular or 
surgical) in asymptomatic and symptomatic patients. Duplex US can provide non-
invasively this information without any additional visits to the clinic at first consultation 
and sometimes based on this sole imaging reference, angioplasty treatments and even 
surgical revascularisation can be planned [27, 58, 59]. Clinically, DSA is the standard to 
plan invasive therapy (surgical or endovascular interventions) and it is used as well to 
visualize calf arteries of patients with severe proximal stenoses and calcified vessels 
difficult to detect with duplex US [27, 60]. However, it presents its own set of challenges as 
the procedure is invasive for the patients. MRA and CTA provide more additional 
information than angiography for preoperative planning, but they are expensive, not easily 
accessible and present risks linked to the toxicity of contrast agents (CTA, MRA) and can 
be contraindicated.  
Compared to other diagnostic imaging technologies, US imaging is an excellent 
diagnosis tool for detecting and quantifying lower limb stenoses. It is the least invasive 
method that is the safest for clinical investigation of the arteries with no ionizing radiation 
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and no known adverse effects compared to MRA, CTA and DSA. Moreover, this 
convenient technology has the lowest cost and is the most routinely used in clinic to offer 
real-time imaging in an anatomical region of interest. Already, many clinical reports 
showed agreement in grading severe stenoses for duplex US compared to angiography and 
MRA [61-63]. The echogenicity of atherosclerotic lesions in B-mode also permits 
classification, detection of plaque morphology and stenosis identification [64]. Also, 
functional information on the hemodynamics of stenoses is made available with Duplex 
US. Nonetheless, in US imaging measures depend on the US probe angle of insonation, the 
variability among observers and the limited accuracy in multi segmental arterial lesions 
[26, 44, 56, 58, 59, 65]. 
Additionally, US imaging does not provide a vascular road map of lower limb 
steno-occlusive disease which is necessary to indicate the length and localization of stenotic 
lesions for therapy planning. Usually, preoperative planning treatment in patients with 
symptoms of lower limb PAD is based on duplex US imaging, exclusively done by 
dividing the leg into arterial segments [60] or by prevalent imaging modalities that can 
render the entire map of lower limb vessels (e.g., DSA, MRA and CTA). It is known that 
atherosclerotic lesions develop preferentially at curved and bifurcated regions of the artery 
[31]. These sites are often difficult to access with an US probe to render an appropriate 
view and are challenging to reproduce even with a skilled clinician. Thus, poor 
visualization and quantification of stenoses are consequently inevitable with 2D-US 
imaging. This is even more so in lower limbs, due to the length of the vascular bed to be 
imaged. However, many 2D slice views acquired at arbitrary orientations and positions can 
analyse and reproduce more accurately the geometry of interest when they are summed up 
together in the form of a 3D representation. Consequently, a 3D reconstructed model of 
lower limb vessels can improve diagnostic confidence and offer the possibility of 
monitoring systematically the extent of atherosclerotic disease. Furthermore, a 3D-US 
imaging technology that can render correctly the entire vascular tree of lower limbs offers 
the best option to define precisely the stenosis degree. 
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In this context, the main objective of the present thesis was the development of a 
3D-US imaging method based on a robotic scanning system for the application in hand. 
The following chapter summarizes the current knowledge on 3D-US imaging technologies. 
The rest of this thesis is presenting, in three consecutive chapters, our robotic strategy to 
address this issue. A discussion and conclusion conclude this document. 
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Chapter 2 
Literature Review of 3D-US Imaging systems  
 
It is the tension between creativity and skepticism that 
has produced the stunning and unexpected findings of 
science. 
 
Carl Sagan 
 
This chapter presents the literature review behind 3D-US imaging systems. First, 
basic 3D-US imaging system principle are revised, then sensorless and sensorbased 
tracking systems are described, followed by robotic developments. For each system, the 
clinical application is explained as well as the advantages and limitations of the technology. 
Thereafter, the hypothesis and objectives are stated and the thesis is outlined. 
2.1 3D-US imaging system 
3D-US systems offer the best potential to precisely locate and quantify 
atherosclerotic lesions. This technology allows direct visualization of 3D anatomy where 
2D slice views can be generated at arbitrary orientations. Volume and other 3D-based 
measurements can be obtained more accurately than in 2D [66]. For academic and 
industrial research, 3D-US offers opportunities to visualize the entire volume of the 
scanned area [66, 67]. Already, many successful systems were developed and validated in 
various clinical applications notably obstetrics, cardiology, and vascular imaging to 
increase diagnosis confidence [68]. Thus, a physician has the possibility to perform 
different image post-processing after patient volume scanning such as generation of 
multiplanar (MPR) or volume rendering (VR) reformations and re-evaluate the diagnosis 
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with experts across networks at remote locations [68]. Nonetheless, to have an expending 
use in clinic, 3D-US performance needs to be equal or surpass the current 2D-US methods. 
There exist several acquisition methods to generate a volume from a region of 
interest. In most cases, a series of image planes are acquired from the volume and the major 
difference in 3D-US technologies comes from the specific method used to locate the 
position of the slice within the volume [68]. Most existing techniques focus on tracking the 
probe position in freehand (with or without position sensors) and by using a mechanical or 
robotic approach. For each strategy proposed, many developments were reported in the 
literature. The following sections will discuss these approaches employed to locate 2D-US 
image planes in a volume for 3D-US reconstruction. In our application, an accuracy of 1.0 
mm or less is required for the position measuring system to generate a high-quality volume 
data. 
2.2 3D Sensorless systems 
2.2.1 Pseudo tracking 
Most commercially available US scanners can produce 3D-US images by stacking 
2D slices together to reconstruct a final 3D result [69] (i.e., pseudo-tracking). In this matter, 
the acquisition sequence is important because the acquired tomographic images are 
assembled in 3D regardless of orientation and positioning of the US probe. However, 
pseudo-tracking is limited particularly to scan linear geometries since positions of 2D-US 
images are not tracked. In addition, it does not guarantee that distances are reliable and 
should not be used to measure arterial geometry (e.g., distances and areas, etc.) [70]. 
2.2.2 Decorrelation techniques 
3D-US can be acquired by finding the separations of a frame pair by using 
information on the acquired US images themselves. Basically, this sensorless approach 
attempts to estimate the relative 3D position and orientation of a probe in space by 
analyzing the speckle (i.e., reflected spatial energy pattern that comes from the interaction 
of a coherent energy source with scatterers) in the US image using decorrelation or linear 
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regression [70-73] (see Fig. 2.1). The degree of decorrelation in the speckle is proportional 
to the distance between the two images and depends on many transducer parameters 
including the degree of focusing and depth. By using a pre-calibrated decorrelation curve, 
this approach can compute the elevation separation. 
 
Figure 2.1: Speckle decorrelation technique.16 
Nevertheless, this method depends on the speckle to be fully developed [74]. In 
reality, tissue contains regions of coherent scattering that decorrelate at a slower rate than 
regions with fully developed speckle. Moreover, other sources can cause speckle 
decorrelation such as noise, in-plane motion, transducer rotation, tissue compression and 
physiological motion; all these factors might appear as elevation movement [74]. In 
addition, most decorrelation techniques do not provide the direction of the B-scans; it 
assumes the probe motion is monotic with no intersecting frames. Given these limitations 
on position accuracy, most studies agree that sensorless methods are far from being optimal 
use in clinical applications [71-74]. 
2.2.3 Integrated position sensors and 3D probes 
Alternate methods integrate position sensors within the transducer probe. These 
bulky probes can brush a volume at different orientations, where a special mechanism 
inside the probe is used to sweep the plane of the B-scan through a volume of interest. The 
                                               
16
 Source : http://svrwww.eng.cam.ac.uk/~ahg/cp3dus/speckle_decorrelation.gif (Accessed: 23/07/2009). 
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probe movements are usually mechanically produced by a motor that can rotate, translate or 
sweep in a linear, wedge and freehand direction [75] (see Fig. 2.2). This method is easy of 
use and can produce standardized volumes for a densely sampled data without irregular 
gaps since all angles and locations between slices are exactly known [76]. In addition, the 
volume of data acquired (stack of 2D images) is immediately available after acquisition, 
without the need of subsequent reprojection or processing. When needed, post processing 
and generation of multiplanar views from the volumic acquisition can be easily done [30]. 
This approach has been used in numerous clinical research applications such as the carotid 
arteries, heart, foetus, kidney, eye, prostate and breast but also for endoscopic ultrasound 
acquisition such as transrectal, endovaginal or transesophageal imaging [70, 76]. 
 
Figure 2.2: Integrated position sensor probes.17 
Nevertheless, the mechanical scan technique is sensitive to the scanning protocol. 
Thus, a priori knowledge on the geometry must be known precisely to avoid 
misinterpretation caused by distortions and patient motion from rapid 2D image 
successions. The 3D image produced is not isotropic because of the poor elevation 
resolution of the transducer (i.e., the direction perpendicular to the US image plane) and the 
                                               
17
 Source:http://www.escardio.org/communities/EAE/3d-echo-box/3d-echatlas/background/PublishingImages                                  
/Reconstruction-methods/Linear-fanlike.gif 
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scan spacing (i.e., distance between US image planes) [70, 77]. Moreover, this method 
requires the considerable expense of a dedicated machine and is limited to a maximum 
volume dictated by hardware constraints in the probe [78]. This relatively small field-of-
view (FOV), restricts scanning with this probe to only small regions of interest due to the 
high computed time required to generate a volume and the mechanical limitations [75]. 
Thus, it is not possible to cover the entire lower limb vessels and produce an accurate 3D 
representation with these approaches [70]. 
 
 
 
 
Figure 2.3: 2D linear probe array and the process to acquire a 3D volume is shown.18 B-scans lie in the x-
y plane, while the C-scans (coronal planes or B-scans) lie in the elevation direction. 
 
3D-US probes usually consist of multiple linear array transducers (five to seven 
rows 1.5D or 2D) (see Fig. 2.3) that have the ability to steer and focus the beam in the 
elevation direction (C-scans) to permit precise imaging in 3D [30]. These probes are also 
large, heavy and expensive in comparison to 2D probes [71, 79]. This technology can also 
be used to acquire real-time 3D volumes (i.e., 4D) [67]. In fact, this approach is often used 
in echocardiography to provide and allow correct anatomical examination of the heart 
structure with the aid of computerized software [80]. The major benefit accorded to 3D 
probes is a comprehensive view of cardiac valves and congenital abnormalities, along with 
immediate feedback for surgical interventions in intraoperative and postoperative settings 
[81, 82]. More specifically, it has shown great potential to become a new clinical standard 
in the assessment of the severity of mitral stenosis by means of accurate mitral valve area 
                                               
18
 Source:http://www.ntnu.no/eksternweb/multimedia/archive/00009/1D2DArray_150_150_9928a.gif and 
http://www.4engr.com/images/research/b1a1bbc1e891b19f5ea4453cb95e1dbd.gif (Accessed: 23/07/2009). 
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measurements [83]. 
However, complex acquisition, lengthy data analysis and high associated cost have 
limited the use of 3D echardiography in daily clinical practice [80, 84]. Moreover, their 
resolution is said to be poorer in the elevation direction because it is dependant on the 
transducer element width; however compared to regular transducer arrays, they have a 
reduced signal-to-noise ratio [30, 84]. In addition, the scanning protocol is clinically 
different as the 3D probe is required to be held steadily over a volume of interest which is 
relatively very small (i.e., 1 cm x 1 cm with maximum depth of 2 cm). For all these factors, 
3D-US probes cannot be used to evaluate lower limb arteries which are made of long vessel 
segments.  
2.3 3D Sensor based systems 
Sensor based 3D-US freehand systems include positioning information of the US 
probe from tracking devices. Many approaches have been developed for freehand scanning 
that allows the user to manipulate the transducer without significant constraints [70]. Each 
2D image located in space is then used to reconstruct the sampled volume in a manner that 
minimizes distortions and maximizes accuracies. Moreover, since the scanning geometry is 
not predefined, it is imperative that the acquisition of images and positions have no 
significant gaps. This can be achieved by scanning the anatomy at a constant speed 
appropriate for the frame rate of the ultrasound scanner. Of the techniques available, five 
major basic positioning sensing systems have been outlined: articulated arms, acoustics, 
step motors, electromagnetic fields, optics and hybrids. 
2.3.1 Articulated arm  
The first forms of tracking system were made of articulated arms. The US probe 
was mounted on a multiple joint mechanical arm system, where potentiometers located at 
each joint of the movable arms provide information on the relative rotation of the arms 
[70]. The relative position of an US image was determined from the combination of the 
relative angulations of the joints. Accuracy of US image positioning lower than 0.4 mm has 
been reported with short arm links and reduced moveable joints [85]. Commercially 
available systems integrate arms with only three potentiometers in order to achieve 
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sufficient accuracy, while reducing arm size and flexibility (see Fig. 2.4) [84]. This method 
is mostly common in telemedicine applications [85]. Objects can be tracked at high frame 
rate and low latency with minimal interference with the enclosing environment. However, 
this approach is too rigid to be used with US probes because of its limited range of 
movement. Finally, angle measurement errors increase with the number of joints and the 
cumulative length of the arms [71, 86]. 
 
Figure 2.4: Articulated arm19 
2.3.2 Acoustics 
The oldest form of freehand tracking makes use of acoustic positioning systems. 
Basically, this approach exploits the sound-emitting devices (e.g., spark gaps) that are 
mounted on the US probe and small microphones for sound detection. The position and 
orientation of the transducer are determined in real-time from the known speed of sound in 
air, the measured time of flight of the sound pulse from the emitters on the transducer to the 
fixed microphones. This system performance has a manufacturing stated accuracy of 0.1 % 
in the distance from the sound emitter to the microphone. Combining the tracking system 
with a 2.5 MHz phased array US system, the performance was found to be less than 0.4 % 
in error for a 5.08 cm distance in a 3D pin model [87]. This approach has been used to 
measure left ventricular ejection fraction (to determine the systolic function) where the 
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 Source : http:// http://www.electricsco.com/detail115682-hydraulictappingmachine.htm (Accessed: 
14/12/2010) 
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results were found to be comparable and even superior to the standard method of 
equilibrium radionuclide angiography [88]. However, these systems are affected by 
variation of temperature, pressure and humidity [71]. In addition, they require a constant 
line of sight between the speaker and the microphones [76]. Thus, with these restrictions, 
this method is not optimal for the lower limb scanning. 
2.3.3 Linear step motors 
Linear scanning of US using a step motor is a simple form of US probe tracking. In 
this approach, an external mechanical localizer translates the US probe linearly in order to 
acquire parallel 2D images (see Fig. 2.5). Since the spatial sampling interval is known, the 
reconstruction can be pre-computed and obtained immediately after a linear scan is 
performed [70]. This method has been successfully implemented in many carotid artery 
applications to measure the plaque volume using B-mode, color Doppler and power 
Doppler images [77, 89-92]. Because of its restricted range of motion, this method is not 
optimum for lower limb artery scans. 
 
Figure 2.5: Linear Stepper Motor System (Sherline Products Inc., Vista, CA, USA)20 
                                               
20
 Source : http://www.sherline.com/images/InstConex4.jpg (Accessed: 19/04/2010) 
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2.3.4 Electromagnetic sensors 
Electromagnetic positioning is the most popular tracking method used in 3D 
freehand ultrasound systems [71]. This approach is based on the spatially varying magnetic 
field from a source transmitter (generated by either AC of DC current) where a receiver 
mounted on the transducer measures its intensity. The sensor is composed of three 
orthogonal coils that capture these signals and transform them into position and orientation 
information relative to the source [76]. Manufacturers claim positioning accuracy between 
0.76- 1.8 mm for popular device brands such as Fastrack (Polhemus) (see Fig. 2.6) and 
Flock of Birds (Ascension) [71], however, system performance in locating a point target 
precisely was found experimentally to be within 1.7-3.5 mm [86, 93, 94]. This technology 
has been used extensively in research because of the great freedom of motion advantage it 
offers to track the US probe without constraint to linear motion and line-of-site. Moreover, 
freehand 3D-US system software which allows accurate acquisition of the raw data and 
immediate visualization of slices through the data is provided with the Stradx free-shared 
package [95]. Vascular applications include the left ventricle [86], the carotid artery [96-
101], the saphenous vein grafts [102-104] and the vertebral artery [105]. Nevertheless, this 
technology is limited in clinical use because it is susceptible to noise and errors up to 8.4 
mm in positional measurements due to electromagnetic interference from metallic objects 
(e.g., aluminum and similar low-permeability/high-conductivity metals such as the US 
probe and materials from the surgical environment) [93, 106, 107]. This distortion can be 
reduced by maximizing the distances from the transmitter (> 120 mm) to the interfering 
equipments because in the near range systematic errors tend to increase [106]. This 
associated inaccuracy is not optimal for clinicians who desire a constant positional accuracy 
performance from 3D-US system of the order of 1.0 mm [84]. 
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Figure 2.6: AC electromagnetic tracking device by Polhemus (Polhemus Inc., Colchester, USA)21 
2.3.5 Optical sensors 
Optical methods use multiple cameras to track markers distributed on a predefined 
rigid structure in its line of sight [71, 84]. A minimal of three markers is necessary to 
determine the position and orientation of the rigid body in space. Additional markers can be 
added to improve the measurement accuracy and the camera visibility. The markers are 
either infrared light - emitting diode (IREDs) in active tracking mode or infrared light 
reflectors in passive tracking mode. In active mode, the IREDs emit light at predefined 
frequencies and the system of cameras detects the location of the emitters by triangulation. 
Whereas in passive mode, emitters inside the housing of the camera fire infrared light at the 
highly reflective spheres and the cameras localize them from the reflection detected from 
the spheres. This mode is very sensitive to large positional errors. The most common 
systems used are the two-camera model of Polaris by NDI (Northern Digital, Toronto, ON, 
Canada) and the three-camera model of Optotrack also by NDI or the FlashPoint 5000 
(Boulder Innovation Group Inc., Boulder, CO, USA) [71]. Manufacturer claim positioning 
accuracies with this technology between 0.10-0.76 mm [71] and in laboratory setting to 
1.40 mm [108]. The great advantage of this device is being insensitive to the metallic and 
electromagnetic noisy surgical environment. This technology was tested in various clinical 
applications such as percutaneous pericardial puncture [109], brain shift [108], stereotactic 
ultrasonography [110], image-guided surgery [84] and 3D mapping of the brachial plexus 
[111]. Even so, the main disadvantage of optical tracking is the need to maintain an 
unobstructed line of sight between the markers and the cameras. Positional errors up to      
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 Source: http://www.inition.co.uk/inition/images/product_mocaptrack_polhemus_fastrak.jpg (Accessed: 
19/04/2010) 
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6.67 mm can be recorded by this device if markers are not optimally visible [112]. Thus, 
the limited freedom of movement and variable positional accuracy in a cluttered clinical 
setting make this choice of tracking device not optimal for lower limbs. 
 
 
Figure 2.7: Optical tracking system with 2 cameras from Polaris NDI (Northern, Digital, Toronto, ON, 
Canada)22 
2.3.6 Hybrid sensors 
Hybrid sensors attempt to compensate for the shortcomings of each tracking 
technology (e.g., ultrasonic, magnetic and optical tracking sensors with accelerometers) by 
combining several multiple measurements to produce precise and robust results [113]. To 
satisfy registration accuracy requirements, most of them integrate magnetic sensors that are 
known to be very robust but unreliable in positional readings with an optical tracking 
system to compensate its errors on location [114, 115]. This kind of hybrid sensor offers 
many advantages because it can track multiple targets without restrictions of line-of-sight  
and can correct magnetic distortions [116, 117]. Improvements in the average positional 
error can be reduced by a factor of 3 with both technologies; the average position error with 
the optical tracking system was found to be 2.1 mm whereas it was 6.1 mm solely with the 
magnetic tracker [115]. This system has been applied mostly in augmented reality systems, 
where it is necessary that objects appear at the same physical location for all users of the 
system [115]. Hybrid sensors have also been used in autonomous navigation of mobile 
robots and material handling in virtual environments [117]. Finally, a 3D-US system with 
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 Source : http://www.tech-ex.com/images/products/0008/8580_2008819154957.jpg (Accessed: 19/04/2010) 
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an augmented reality visualization has been tested in laparoscopic surgery and ultrasound-
guided needle biopsies [116, 118]. The main limitations of this approach are the need for an 
additional calibration procedure to integrate each tracking system to each other and the high 
computation time. 
2.4 US robotic developments 
Robotic systems represent a promising approach for lower limb artery imaging as 
they simultaneously control and standardize the 3D-US acquisition process for long 
scanning distances and complex geometries. In addition, they are viewed as an accurate and 
repeatable technology enabling generation of reliable 3D volumes with a potential to 
improve clinical management [119]. Many medical US prototype robots have been 
developed distinctively to explore these advantages. Main areas of development are 
presented below. 
2.4.1 Telemedicine 
Robotized telemedicine is a research area in US imaging that permits medical 
experts to perform highly skilled (i.e., operator-dependant) tasks from a center remotely 
located to a patient [120, 121]. Tele-operated robotic chains acquire real-time US images 
for medical diagnosis over the abdominal area of a remote patient with a light-weight or 
parallel manipulator [120]. The real probe is placed on the slave robot end-effector where 
its control is transmitted from a remote location with tracked movements of the expert’s 
hand during a scan with a fictive probe. To correct probe positioning, the system is 
monitored via videoconference between the expert and the operator. 
Different systems exist in tele-ecography with specialized applications in research. 
The most notable developments are discussed. TERESA is a project with a tele-operated 
system conceptualized to follow up on astronauts’ cardiovascular system in microgravity 
environment or to perform a quality US exam on a geographically distant patient [122]. It 
make use of a fictive probe and an electromagnetic tracker to control at distance a 4 degree 
of freedom (DOF) light-weight mechanical robot that enables positioning of the US probe 
according to 3 degrees in rotation and one translation along the probe axis. The OTELO 
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project consists of a mobile tele-echography system that employs an ultra-light robot design 
to achieve reliable US imaging at an isolated site distant from a specialist clinician [120, 
121]. The system is configured with a pseudo-haptic fictive probe in which the medical 
expert interacts to control a 6 DOF light-weight robotic system with a strain gauge force 
sensor embedded in the probe holder to measure the contact force (see Figure 2.8). The 
TER tele-operated system is one of the more recent developments where a new architecture 
design for a low-weight portable slave robot that is cable-driven, nonrigid in structure is 
proposed [123, 124]. A haptic PHANTOM device in the master site provides total control 
of the echographic probe with a realistic perception of the normal force of contact on the 
patient’s skin. This system also is distinctively actuated by the movements of the patient’s 
abdomen. 
 
 
 
 
 
 
 
 
Figure 2.8: OTELO: the mobile tele-echography system using an ultra-light robot23 
 
ORB, another system, used a two-axis joystick to control a parallel robot design 
applied over a patient’s abdomen, where angle and position of the probe are monitored by 4 
miniature force sensors fixed at the side plate of the probe holder [125, 126]. While, all 
these developments seem promising, tele-echography systems primary concern is to 
support a robust communication link where data can be exchanged between the two stations 
safely between patients and experts that include US images, robot controls and tracking 
information with a suitable bandwidth [127]. Most research efforts aim to improve the 
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 Source : http://wwwlasmea.univ-bpclermont.fr/jnrr03/I/I11-OTELO-Patient-Expert_p.jpg (Accessed: 
28/04/2010) 
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telecommunication aspect by streaming wirelessly in real-time medical images of quality 
[128-130]. Moreover, in these systems, the impact of position errors of the slave robot is 
less important for medical experts since no 3D-US reconstruction is envisioned. The error 
in probe positioning can be corrected by the physician based on the feedback given by the 
echographic image rather than the position of the real probe on the patient’s surface [123]. 
Given the limited accuracy of these systems for 3D applications and their architecture not 
adapted to perform scanning on lower limbs and acquire 3D-US data, they cannot be 
applied to our clinical application. 
 
 
 
 
 
 
Figure 2.9: (a) Brachytherapy treatment performed manually24. (b) Robotic system for brachhytherapy25. 
2.4.2 Brachytherapy 
Prostate cancer has recently gained much attention in US robotic developments 
because of brachytherapy, a successful treatment with low side effects and high benefits 
[131]. This method localizes irradiation of the prostate gland by the insertion of radioactive 
seeds using hollow needles inserted through the perineum of the patient in the lithotomy 
position with a trans-rectal US (TRUS) guidance (see Fig. 2.9a) [132]. This intervention 
distributes uniformly radioactive doses throughout the entire volume of the prostate without 
overdosage then minimizing side-effect on adjacent organs. Normally, a template is used to 
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 Source : http://www.urologyassociates.com.au/uploads/31417/ufiles/prostate_cancer_brachytherapy.jpg 
(Accessed: 02/05/2010). 
25
 Source : http://www.na-mic.org/Wiki/images/thumb/b/b0/ProstateDiagram.png/200px-
ProstateDiagram.png (Accessed : 02/05/2010). 
(a) (b) 
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insert manually the needles under ultrasound guidance along a grid of horizontal lines 
[132]. However, the mobility of the prostate and surrounding tissues make this task 
difficult. Robotic systems were developed to standardize this procedure. This robotic 
system integrates a positioning system and a driver for the TRUS, thus allowing needle 
positioning to insert the seed [131, 133, 134]. Planning of the needle trajectory can be 
performed firsthand to guide and control its insertion [135, 136] with less than 1.0 mm 
targeting errors [134, 137]. Also, software developed with these systems permit 3D-US 
images of the organ acquired with a mechanical rotation of the probe [134, 136]. However, 
these robotic systems, normally small in architecture, can only accommodate TRUS probes 
and needles for rotation and positioning. 
2.4.3 Cardiovascular diseases 
Cardiovascular disease prevention is another research area that benefited greatly 
from US robot developments. Hippocrate represents a first example where a robotic system 
was developed to manipulate US probes on the patient’s skin with an exerting effort to scan 
the carotid and femoral arteries (see Fig. 2.10) [138-140]. The objective of this system was 
to enhance clinician capabilities in terms of accuracy, reproducibility and force control in 
order to generate a 3D vessel reconstruction and volume quantification of atheromatous 
plaques. This robotic system can record successive 2D acquisitions with a constant force at 
a regular step and a cardiac synchronization to generate a 3D reconstruction of the vessel. 
 
Figure 2.10: Hippocrate robot26 
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 Source : http://www.emeraldinsight.com/fig/0490300110002.png (Accessed: 02/05/2010 ) 
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The architecture is a 6 DOF serial manipulator with revolute joints suspended above the 
patient’s bed for efficiency and safety; other security controls are also included. The 
movements of the robot are guided by a graphical user interface and a force/torque position 
controller. Clinicians can manually handle the robot in ‘teaching mode’, and in ‘replay 
mode’, the robot can reach the pre-defined taught path. A high repeatability of 0.05 mm and 
0.5 mm absolute accuracy are claimed with this robot. However, these measures have not 
been tested thoroughly and the preliminary 3D reconstruction of the carotid artery was poor 
[140]. To our knowledge, no follow-up studies exist to support the efficiency of this design, 
except its use in holding a probe to evaluate brachial artery wall shear rate [141]. It was 
also tested to improve skin harvesting process in robotized reconstructive surgery [140, 
142]. 
Another approach developed at the University of British Columbia was a visual 
servoing method to track in real-time the carotid artery [143, 144]. The motivation behind 
this design was to minimize the occurrence of musculoskeletal disorders secondary to 
ergonomic problems associated with prolonged periods of probe holding leading to a stress 
on the cervical spine, shoulder and arm of the operator. This tele-operated system consists 
of a master hand controller (joystick/haptic interface), a slave manipulator carrying the US 
probe and a computer control [106, 145]. The operator can remotely position the US probe 
at a relative position to the patient’s body where the motion of the robotic arm and the hand 
controller are simultaneously based on measured positions and forces, acquired US images 
along with taught positions and force trajectories.  
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Figure 2.11: UBC image-guided robot-assisted diagnostic ultrasound27 
An algorithm that detects the boundary of the carotid artery and determines its center of 
gravity is tracked in real-time to control the robot. Also for safety controls, the 6 DOF 
robotic arm was designed light-weight with limited force capability, counter-balanced with 
backdrivable joints. To control the US probe only 3 DOF are possible because of the US 
image servoing where one axis is reserved for motion and others for the image plane. The 
robot’s tracking algorithm has been tested on a US phantom composed of 3 aligned tubes 
and the neck of 1 patient. It has reconstructed in 3D the mimicking vessels with less than 
0.7 mm average absolute error and showed great potential for the carotid artery [146]. The 
feasibility of the tele-operated remote examination through the internet was also 
demonstrated successfully. However, the architecture of this robot is limited to small recti-
lined segments such as the carotid artery. 
In the cardiovascular sector, most developments have been so far oriented towards 
architectural control and safety designs. While meeting design and safety requirements are 
significantly important for US medical robotics, this does not necessarily guarantee that 
clinical needs are met. Consequently, it is very important that new medical hardware and 
software designs are validated. In just the past decade, some surgical robot prototypes have 
been FDA approved (e.g., ROBODOC, DaVinci, etc.). However, US medical robots have 
not yet been approved. This certifies that improvements for patient care and safety are still 
needed in US medical robots to ensure that the technology matures. 
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 Source: http://www.ece.ubc.ca/~tims/Ultrasound/index.html (Accessed: 03/05/2010). 
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2.5 Prototype 3D-US medical robot 
Recently, a new medical 3D-US robotic imaging system was developed by our team 
[147, 148]  to provide accurate 3D-US scanning of lower limb vessels. This 3D-US 
imaging robotic system includes three principal components: the computer workstation, the 
robotic arm and the US scanning system. An overview of this system is shown in Figure 
2.12. Our robotic arm is managed through custom made software installed on the computer 
workstation. Namely, the robotic arm carries the US probe to scan a volume. Then, B-mode 
or color Doppler images are acquired with corresponding probe positions for 3D-
reconstruction. 
This robotic system offers a great alternative for 3D-US imaging and quantification 
of lower limb stenoses. This is particular by true for the detection and the quantification of 
long tortuous arterial segments in lower limbs (approx. 80 cm in length) that require high 
positioning accuracy. Accurate 3D representation generated by this robotic system should 
be higher than 3D freehand systems since the volume is regularly sampled. In addition, it is 
thought to provide a satisfactory level of resolution comparable to other 3D imaging 
modalities given it incorporates a robotic arm to track 2D-US images. Most importantly, 
detection and quantification of stenosis performance should be enhanced with this new 
technology from the 3D reconstructed models of patients’ lower limb vessels. Furthermore, 
therapy planning and follow up of diseased vessels can be more optimally managed. 
 
Figure 2.12: The 3D-ultrasound (US) robotic imaging system. The F3 CRS robotic arm carries a probe 
from an US system (GE Vivid-5). 
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2.7 Objectives 
The general objective of this thesis is to optimize and validate our prototype medical 
3D-US imaging robotic system to localize and quantify arterial stenoses in lower limbs. At 
first, the performance of this system is evaluated without US images in terms of position 
and distance accuracies as well as repeatability with a lower limb-mimicking phantom. 
Secondly, with US images, the optimal calibration transform to register the B-scan into the 
robot’s coordinate system for the most accurate 3D-US vessel representation is assessed. 
Then, the robotic system ability to localize and quantify stenoses is investigated in vitro on 
a replica of PAD and in vivo, on a patient with PAD disease. These results were compared 
to the one obtained with a clinical diagnostic imaging technology. 
2.7.1 Thesis plan 
The principal achievements of the thesis are presented in the form of scientific papers. 
Chapter 3. This chapter introduces the first paper of our study and presents the 
performance evaluation of our medical robotic 3D-ultrasound imaging system. The 
prototype medical robot’s architecture and operation are described in details. The robot’s 
positioning and inter-target accuracies are assessed throughout the robot workspace with a 
lower limb mimicking phantom. 
 
Chapter 4. In this chapter the second paper is presented. The validation of 3D 
reconstructions of a mimicked femoral artery with the ultrasound imaging robotic system is 
performed. A Z-phantom calibration procedure is showed and characterized to obtain the 
best 3D vessel representation. An in vitro femoral artery is used as gold standard. 
 
Chapter 5. The third paper is given in the fifth chapter. The 3D-US imaging robotic system 
feasibly to localize and quantify lower limb arterial stenoses is performed. A short realistic 
multimode vascular phantom was used to evaluate in vitro the system’s performance to 
represent a 3D vessel, to localize and quantify stenoses. Analyses were compared to the 
CTA, the clinical gold standard for 3D vascular imaging. The clinical feasibility to evaluate 
these parameters is also investigated in vivo on long lower limb vessels. 
 50 
 
Chapter 6. We summarize the results of the thesis and put them in perspective to current 
work and discuss potential future work. 
 
Annexes. We present US image characteristics, the conference proceedings related to work 
in chapters 3, 4 and 5 as well as the authorization from the editors for the reproduction of 
published papers. 
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Chapter 3 
Performance evaluation of a medical robotic 3D-
ultrasound imaging system 
 
I'll be more enthusiastic about encouraging thinking 
outside the box when there's evidence of any thinking 
going on inside it.  
 
Terry Pratchett 
 
3.1 Forward 
This chapter presents the published paper in the journal Medical Image Analysis by 
the authors Marie-Ange Janvier, Louis-Gilles Durand, Marie-Hélène Roy Cardinal, Isabelle 
Renaud, Boris Chayer, Pascal Bigras, Jacques de Guise, Gilles Soulez and Guy Cloutier28. 
This paper describes the methods used to evaluate the clinical performance of the 
robotic system. In most 3D-US imaging systems, the US probe positioning accuracy (i.e., 
tracking) is the cornerstone for anatomy models to be reconstructed accurately in 3D. Thus 
a lower limb mimicking phantom was conceptualized to simulate the vessels over long and 
tortuous segments starting from the iliac artery down to the popliteal artery below the knee. 
After, registration of this phantom in the robot referential, the robotic system, repeatability, 
positioning and inter-target accuracies (i.e., difference between measurements and ground 
true values) for the clinical evaluation of lower limb vessels were evaluated throughout the 
                                               
28
 The co-authors Louis-Gilles Durand, Pascal Bigras and Jacques de Guise are responsible for the idea 
concept of the prototype medical 3D-US robot to detect lower limb arterial stenoses. Boris Chayer designed 
the lower limb-mimicking phantom. Isabelle Renaud provided expertise for the calibration algorithm and 
Marie-Hélène Roy Cardinal helped in editing and organizing the manuscript. The co-authors Gilles Soulez 
and Guy Cloutier also initiated the idea concept of the robotic US scanner and were the supervisors of the 
thesis. 
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robot workspace. A preliminary 3D vessel reconstruction was performed and stenoses were 
evaluated. 
3.2 Abstract 
3D-ultrasound (US) imaging systems offer many advantages such as convenience, 
low operative costs and multiple scanning options. Most 3D-US freehand tracking systems 
are not optimally adapted for the quantification of lower limb arterial stenoses because their 
performance depends on the scanning length, on ferro-magnetic interferences or because 
they require a constant line of sight with the US probe. Robotic systems represent a 
promising alternative since they can control and standardize the 3D-US acquisition process 
for large scanning distances without requiring a specific line of sight. The performance of a 
new prototype medical robot, in terms of positioning and inter-target accuracies (i.e., 
difference between measurements and ground truth values) was evaluated with a lower 
limb mimicking phantom throughout the robot workspace. The teach/replay repeatability 
(i.e., difference between taught and replayed points) was also assessed. A mean positioning 
accuracy between 0.46 mm and 0.75 mm was found on all scanning zones. The mean inter-
target distance accuracy varied between 0.26 mm and 0.61 mm. Teach/replay repeatability 
below 0.20 mm was also obtained. Additionally, a 3D reconstruction of in-vitro stenoses 
was performed with the robotic US scanner. The quantification error of a 80 % area 
reduction (AR) stenosis was 3.0 %, whereas it was -0.9 % for a less severe 75 % AR 
stenosis. Altogether, these results suggest that the robot may be of value for the clinical 
evaluation of lower limb vessels over long and tortuous segments starting from the iliac 
artery down to the popliteal artery below the knee. 
3.3 Introduction 
Atherosclerosis is the major cause of peripheral arterial disease [149], which leads 
to progressive narrowing of lower limb arteries [27, 51]. Atheromatous infiltration in PAD 
is usually diffuse with more than one stenosis affecting adjacent vessels. Different PAD 
evaluation strategies are used in clinical practice. The ankle/brachial systolic blood pressure 
ratio measured with a cuff and a manometer is the oldest non-invasive index still utilized to 
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assess the global disease of lower limb vessels [150]. Pulsed-wave Doppler ultrasound (US) 
and color Doppler flow imaging are the most popular non-invasive imaging techniques 
currently in use to investigate the severity of specific lesions along the lower limb vascular 
tree [151, 152]. Nevertheless, in most centers, a pre-intervention mapping by digital 
subtraction angiography [36], magnetic resonance angiography [36] or computed 
tomography angiography (CTA) is necessary to provide a complete 3D representation of 
the lower limb vessels to plan an appropriate therapy [51]. With these 3D imaging methods, 
the scan is performed over long segments usually starting from the abdominal aorta within 
the abdomen, following with iliac, femoral, and then with popliteal arteries to end in the 
tibial vessels of the calf. Although these imaging technologies yield high image resolution 
and 3D rendering, they still do not exhibit the same benefits of US that is low-cost, non-
invasive, non-ionizing, safe and painless. Additionally, US presents multiple options for the 
diagnosis such as blood flow information with color Doppler, angiographic images with 
power Doppler and atherosclerotic plaque visualization with B-mode scanning. However, 
conventional 2D-US assessment of atherosclerotic disease highly depends on the observer 
[89]. As a result, many 3D-US systems were developed and validated in various clinical 
applications notably obstetrics, cardiology, and vascular imaging to increase the US 
diagnosis confidence [75]. 
3D-US systems are based on two-dimensional arrays, mechanical localizers and 
freehand scanning with or without position sensing. Sensorless 3D-US systems include 2D 
linear array transducers (3D probes) [30] speckle decorrelation techniques [70] and pseudo-
tracking [153]. Only small volumes can be scanned using 3D probes. In speckle 
decorrelation techniques, the transducer is moved manually and speckle motion 
measurements are used to determine the distance between 2D images. The decorrelation 
algorithm used to predict the correct distance thus strongly relies on small constrained 
movement of the US probe. This technique can provide 3D-reconstruction if the image 
spacing is accurately determined and if the US transducer parameters are well known. Yet, 
since this approach does not guarantee accurate distances, it is not used to measure organ 
size, area nor volumes. Pseudo-tracking is an option available on many US systems today. 
This mode produces a 3D reconstruction from a 2D image sequence acquired during a 
manual linear scan. However, it does not provide an accurate 3D reconstruction since 
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positions of 2D-US images are not tracked. Therefore, this approach is limited to scan 
regular geometries since a tortuous volume would be misrepresented as a linear one. 
Sensor based 3D-US freehand systems include positioning information from 
tracking devices that are used to locate each 2D image in space and to reconstruct the 
sampled volume [71]. Optical tracking exploits properties of light to follow Light Emitting 
Diode (LED) markers distributed on a rigid structure with charged coupled device (CCD) 
cameras. Electromagnetic (EM) tracking measures the magnetic field between a transmitter 
attached to the US probe and a receiver. Limitations of optical systems are mainly the 
requirement of a constant line of sight [85, 112], and those of EM sensors are errors 
induced by metallic object interference and a variable performance depending on the 
scanning distance [85, 106, 154, 155]. Additionally, uneven volume sampling generated by 
the 3D-US freehand tracking method adds uncertainty to the reconstruction. Consequently, 
these devices are not well suited for lower limb vessel imaging, where the detection and 
quantification of long and tortuous arterial segments requires a high precision. In fact, a 
robust positioning accuracy of approximately 1 mm is likely needed for a tracking device to 
provide a competitive 3D-US quality analysis of stenoses in lower limb arteries. 
Robotic systems represent a promising approach for stenosis quantification as they 
simultaneously control and standardize the 3D-US acquisition process for long scanning 
distances and complex geometries. Medical prototype robots have been developed to 
explore this advantage. For example, Hippocrate, a low-power robot actuated by slow 
stepper motors, is a force feedback medical robot that allows US and tonometry 
measurements with heart rate synchronization [140]. While preliminary in vivo results 
looked promising, the main innovation of this system was the development of a force 
controller with design strategies selected to meet safety requirements imposed by medical 
applications. To our knowledge, no follow-up studies can be found on this robot in the 
literature. Furthermore, no evaluation of the robot accuracy has been performed. Other 
systems such as an image-guided control instrument [146] and a tele-robot [156] were 
developed for 3D-US scanning. The first system was designed for the tele-examination of 
carotid arteries on short rectilinear paths. The control of the US probe movement is shared 
between the operator, the robot controller and the US image processor. This system 
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produces autonomous tracking of the vessel contour in real-time scans to compensate for 
the physiological motion of an artery during probe motion along a 1D trajectory.  Thus, the 
US probe movement is controlled in 3 degrees of freedom (DOF) that are constrained to lie 
in the US observation plane. Nevertheless, this robot operates within a limited range in the 
robot workspace and is restricted to straight line objects of interest (i.e., no tortuous curved 
objects) to obtain visual information. Certainly, the principal accomplishments of this robot 
remain the development of ultrasound visual servoing and control that enable a remote 
assistance for tele-operation. The second design is a tele-robotic system also with remote 
control assistance to facilitate hand-eye coordination necessary to perform echographic 
examination over the abdomen of pregnant women. It is to note that most developments 
have been so far oriented towards architectural control and safety designs. However, it is 
very important that new medical hardware and software designs be validated to meet 
specific clinical needs. 
To provide accurate 3D US scanning of lower limb vessels, a prototype medical 
robot was recently developed by our team. A teach mode that enables the learning of a 
“freehand” scan, and a replay mode to reproduce the manually taught path are available. 
These features, which are also present in Hippocrate, accommodate specific scan routes 
with controlled speed. In addition, when coupled to an US probe, the system captures and 
stores images with their registered 3D spatial location at uniform spacing in replay mode. 
Furthermore, the robot was designed to have a constant high accuracy over its entire 
workspace. Thus, a clinician can integrate their regular scanning operation for each 
patient’s leg by manually teaching a scan path to the robot. The robot replays the path over 
the leg and acquires 2D images for 3D reconstruction. The reconstructed vessel segments 
consequently remain within the US image plane obtained on a pre-determined trajectory for 
each patient scan. A sub-objective of this study was to use a double-stenosis vascular 
phantom to evaluate the feasibility of accurate quantification of stenoses in 3D with the 
prototype robotic scanner. 
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3.4 Materials 
3.4.1 Prototype medical robot 
The robot includes three principal components: the computer workstation, the 
robotic arm and the US scanning system. An overview of this system is shown in Fig. 3.1. 
The robotic arm is managed through a custom made software installed on the computer 
workstation. Namely, the robotic arm carries the US probe to scan a volume. Then, B-mode 
images are acquired with corresponding probe positions for 3D-reconstruction. 
 
 
 
 
 
 
 
 
Figure 3.1: The 3D-ultrasound (US) robotic imaging system. The F3 CRS robotic arm (b) carries a probe 
from an US system (GE Vivid-5) (a). The robotic arm is moved through the user interface software on the 
workstation (c). 2D US images are tagged with the US probe positions acquired from the robotic arm (d). In 
this example, a vascular phantom is scanned. 
The URS software (Ultrasound Robotic Scanner, Integral Technologies Inc., Laval, 
Québec, Canada), which runs on the workstation, provides a user interface to access and 
set-up the robot controls, movements, parameters and tasks. This specialized software was 
developed in Visual C++ and run under Windows. This higher control architecture allows 
three operative states for the robotic arm: teach, replay and idle modes. In teach mode, the 
operator manually moves the robotic arm while the robot controller uploads the real time 
arm positions to the workstation; the positions are then saved in a trajectory file. Thereafter, 
in replay mode, the saved trajectory file is sent back to the robotic arm into movement 
commands. The replayed trajectory is executed at constant speed and contact pressure with 
the patient or object to be scanned. The last robot arm state is the idle mode where the 
operator can freely handle manually the arm without trajectory file processing. Also, the 
(a) (b) (c) Vascular phantom (d) 
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software limits any tool attached to the robotic arm to a maximum linear speed of                     
50 mm/sec in addition to a maximum applied force (i.e., 100 N in the normal direction and 
50 N in the transverse directions). Finally, the workstation communicates with the robot 
controller according to the RS-232 protocol. 
The robot controller (CRS C500C, CRS Robotics Corporation) provides safety 
circuits, power and motion control for the robotic arm. It drives the motors in each joint, 
keeps track of motor position through feedback from encoders, computes trajectories and 
stores robot applications in memory. The modules implemented in the robot controller 
consist of the lower architecture control level. These modules were all written in the RAPL-
3 programming language. They translate the position commands and move the arm as 
requested by the workstation. Additionally, the robot controller triggers the image 
acquisition and sends the corresponding arm position to the workstation. 
The robotic arm is an industrial robot (F3 Articulated Robot, CRS Robotics 
Corporation, Burlington, Ontario, Canada). Note that many groups have used CRS 
industrial robots to develop specialized light-weight precision tasks. In particular, medical 
applications include image-guided surgery [157] and 3D transrectal ultrasound-guided 
prostate brachytherapy [133]. Our industrial manipulator is an articulated robotic arm 
designed for light payload applications (3 kg). Moreover, applications that require complex 
and flexible movements are recommended for this particular model. Our unit has 6 DOF 
with absolute encoders in each arm joint that provide continuous information on the arm 
stance and position to the robot controller. In our system, the robotic arm moves the US 
probe with commands from the workstation and information that comes from the 
force/torque sensor. 
The force/torque sensor (F/T) (ATI, Industrial Automation, Apex, NC, USA) 
connected to the robotic arm is a key element of the 3D US scanner system. This sensor 
allows easy handling and precise positioning of the robot manipulator by the operator. 
Manual handling of the robotic arm is possible because the F/T sensor reports all forces and 
torques applied to the robot controller. This information is then transmitted to the 
workstation where forces and torques are converted into positioning information to move 
the arm and generate the trajectory file in teach, replay and idle modes. Additionally, in 
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replay mode, the workstation employs force feedback. This is performed with repetition of 
the same applied US probe pressure to the patient and safe monitoring of the threshold 
contact force. 
The robotic system assures patient security through many safety controls. Two 
control schemes of watchdog mechanisms were added to the system in case of failure: one 
at the customized software and the other at the robot controller. The watchdog monitors 
continuous digital signals sent from the robot controller and the workstation. If the robot 
controller or workstation goes out of control or does not respond, the emergency stop (E-
stop) is activated. Its activation immediately removes power from the robotic arm and fail-
safe brakes are automatically engaged to prevent movements due to gravity. Moreover, the 
software monitors singularities of joint configurations, joint limits and tracks errors 
between desired and current positions. Furthermore, there is a maximum limit set for the 
US probe pressure and linear scanning speed. Also, three additional E-stop buttons, which 
can be manually triggered, are available in the robot operating workspace. Other safety 
designs include the operator button that needs to be pressed throughout the entire replay 
mode to ensure the monitoring of the replayed trajectory. It is to note that the Hippocrate 
robot as well contains similar security features [140]. 
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Figure 3.2: The 3D-ultrasonic robotic system block diagram. The US probe is attached to the force/torque 
(F/T) sensor (a) incorporated in the robotic arm (b). In teach mode, forces and torques applied to the sensor 
are sent to the F/T sensor controller (c) then to the robot controller (d). The robot controller translates forces 
and torques into positioning information that are transmitted and saved unto the control workstation (e). In 
replay mode, the workstation transfers the saved trajectory to the robot controller (e). The robot controller 
translates this trajectory into robotic positions and commands the robotic arm to move (f). At the same time, 
the robot controller uploads in real time the US probe location to the control workstation (e) and triggers the 
image acquisition card (g). 2D images are thus simultaneously acquired from the US scanner (h) and saved 
into the control workstation (i). Safety control is assured in replay mode with the operator button that 
monitors the robot movements and sends the information to the control workstation (j). Additionally, if any of 
the control workstation (k) or the robot controller modules fail (l), a watchdog mechanism activates the 
emergency stop (m) (E-stop). The E-stop activation automatically removes (n) all the power supplied to the 
robotic arm (o). 
 
The last principal component is the US scanner. It provides images of a scanned 
volume in any available modalities (e.g., B-mode, color Doppler, power Doppler). Any US 
scanner for which it is possible to attach the US probe to the F/T sensor handle on the 
robotic arm can be used. In its current form, the robotic system provides its own 
digitization of US images. 2D-US images are captured at uniform spacing with an image 
acquisition card (PCI-1411, National Instrument, Austin, Texas, USA) mounted in the 
workstation. These US images are then digitized in 480 x 640 pixels format from the 
scanner video output. Simultaneously, US probe positions of the robotic arm are associated 
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to the acquired 2D-US images and saved into the workstation for 3D-reconstruction.              
Fig. 3.2 shows the complete 3D-US robotic system block diagram. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: The lower limb mimicking phantom, top (a), axial (b) and side (c) views. The three paths 
represent classical lower limb vessel scanning trajectories. The phantom contains a total of 37 holes which 
serve as target points for the robotic spherical pointer (SP, see Fig. 3.4). A total of 13 holes were selected for 
the accuracy and teach/replay repeatability measurements. Path 1 is linear with 4 selected targets (L1, L5, L10 
and L15). Path 2 represents the arc path with 4 selected targets (A1, A2, A3 and A4) and path 3 is curved with 
5 targets (C2, C5, C10, C13 and C16). Each target point is labelled according to the corresponding path: L for 
linear, A for arc and C for curved. 
 
3.4.2 Phantom model 
A phantom was specially designed to assess the accuracy of the robot arm to 
position a spherical pointer (SP) within holes manufactured on a leg mimicking geometry. 
Fig. 3.3 shows the phantom where dimensions correspond to the upper half of a thigh and 
where holes are arranged in three different paths. The paths match classical US lower limb 
vessel scanning trajectories. They were designed in linear, arc and curved fashions (see Fig. 
3.3). Paths 1, 2 and 3 contain 15, 6 and 16 holes, respectively. Each hole was manufactured 
with a precision of 0.03 mm, a 8.38 mm diameter and a 4.19 mm depth. To avoid 
(b) 
(c) 
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redundancy in the 3D space explored by the SP, the phantom was designed without 
collinear and coplanar points. 
The SP at the robot end-effector replaced the US probe for the accuracy and 
teach/replay repeatability testing. Fig. 3.4 shows the SP added to the robotic arm where the 
spherical end fits tightly within the phantom holes. Various orientations were possible 
when the SP was in contact with the phantom target points. Even though the center of the 
SP was constrained to the center of a phantom hole, infinite configurations of the robot 
joints were possible. This method, also referred as the single endpoint contact method, is 
usually the preferred approach for robot calibration [158, 159]. 
 
 
 
 
 
 
Figure 3.4: The spherical pointer used to determine the performance of the robotic US scanner. The SP is 
rigidly attached to the US probe handle that is linked to the robot end-effector. The SP translation is a vector 
that is estimated to make the SP center of gravity known in the robot referential. 
 
The phantom was centrally positioned and fixed within each of five designated 
experimental zones in the robot workspace, as illustrated in Fig. 3.5. The orientation of the 
leg phantom in each experimental zone is given as well in Fig. 3.5a. The experimental 
zones were chosen to allow the identification of optimum operating areas in the robot 
workspace. Likewise, selected zones and phantom orientations were chosen to correspond 
to the expected scan positions of a patient lower limb during a clinical exam. 
 
 
 
Spherical pointer (SP)  Robot Force/Torque sensor US probe handle 
SP end point  
SP translation Robot end-effector 
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Figure 3.5: (a) The designated experimental zone in the robot workspace. The lower limb mimicking 
phantom was positioned in five different zones where the patient leg is most likely to be placed. (b) The 
phantom rigidly attached to the platform (wooden plate) with the robot spherical pointer (SP) inserted in one 
of the semi-spherical holes micro-machined in the phantom. 
3.5 Methods 
In order to evaluate the robot performance, the methods required to relate the 
coordinate system of the robot, to that of SP and of the phantom, as identified in Fig. 3.6. 
Because the SP was not considered in the robot referential, a calibration procedure was thus 
needed to determine the SP center of gravity with respect to the robot referential. 
Thereafter, the performance of the robot could be evaluated with the SP. It was quantified 
in terms of positioning and inter-distance accuracies (i.e., difference between measurements 
and ground truth values) with the phantom target points, and in term of teach/replay 
repeatability of the measures (i.e., difference between ‘teach’ and ‘replay’ points). 
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Figure 3.6: The three referential coordinate systems in this study: the robot baseroboteffectorend P −− , the spherical 
pointer (SP) effectorendSPP −  and the phantom G . 
3.5.1 SP calibration 
The robot reports the Cartesian position and orientation of its last joint or wrist, also 
referred as the end-effector. The SP coordinates could be transformed with respect to the 
base of the robot because the orientation and position of the end-effector were known. To 
perform the SP calibration, its translation with respect to the end-effector was calculated by 
using the following equation [93, 160, 161]: 
( )effectorendSPbaseroboteffectorendbaseroboteffectorendbaserobotSP PRPP −−−−−− ×+= ,         (1) 
where baserobot
SP P
−
 defines the unknown position vector of the SP center of gravity with 
respect to the robot referential, baserobot
effectorend P
−
−
 represents the known position vector of the 
robot end-effector in the base referential, baserobot
effectorend R
−
−
 describes the known Euler rotation 
matrices that transform the end-effector orientation in the robot referential, and effectorendSPP −  is 
the unknown translation vector of SP in the end-effector referential. The positions P  are 
3x1 vectors and the rotation matrix R  is 3x3. When a specific phantom target hole is 
reached several times with different tool configurations, Eq. (1) becomes over determined. 
Unknowns can thus be solved using the least-square method. Once the SP vector effectorendSPP −  
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was estimated, the SP position for following experiments could be calculated in the robot 
referential with Eq. (1). 
To perform the SP calibration, the robot arm was operated manually in idle mode. 
In each experimental zone of the robot workspace, two holes on phantom path 1 were 
randomly selected. For each hole and zone, the SP was rotated manually to 32 different 
positions distributed in a hemispherical pattern around each selected phantom target pivot. 
Cartesian position and orientation of the robot end-effector were then recorded for each SP 
configuration. The effectorendSPP −  vector was estimated with Eq. (1) for each experiment (2 
phantom holes in each of five robot workspace zones for a total of 10 estimated SP 
translations). The mean value of this vector was used as the SP translation for subsequent 
performance assessments. 
3.5.2 SP calibration precision 
A precision metric was evaluated since subsequent performance measurements to be 
reported below also depend on the SP translation precision. The precision was defined as 
the ability to locate the same point in space with small position variations. Since it is not 
physically possible to locate the origin of the robot coordinate system because it is inside 
the robot base, it was not possible to accurately measure the location of any object in the 
base coordinate system using rulers [155, 161, 162]. Thus, a point position acquired with 
the robot could not be compared with its true physical location. The SP precision S  was 
computed by using: 
∑∑∑
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where kjix ,,
2σ  is the variance for T=10 SP calibration configuration positions i in the x 
direction for the experimental zone j and target point k. This definition applies as well for 
the y and z directions. The average precision was calculated for L=5 zones, M=2 target 
holes randomly chosen among the selected path 1 (see Fig. 3.3a for the selected target point 
options) for a total sample size of 100 points. It is to note that the data collected for the SP 
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calibration was not used to assess the average SP precision. 
3.5.3 Performance evaluation of the robot 
The relative positioning accuracy, the inter-distance accuracy, and the teach/replay 
repeatability in locating the SP were assessed. The robot referential first needed to be 
transformed into the phantom coordinate system, as described earlier by Eq. (1). For that 
purpose, the position of the selected phantom points indicated in the legend of Fig. 3.3 was 
acquired with four different SP orientations randomly chosen (T = 4 in this case); a sample 
mean was computed for each target point. These mean values corresponded to the phantom 
theoretical central positions of the holes in the robot referential. In the phantom coordinate 
system, the ground truth position of each hole was known from the computer-assisted-
design (CAD) file used to manufacture the mimicking leg. The translation offset between 
the phantom ground truth and the theoretical target points in the robot referential was then 
calculated. The offset baserobot
phantomoffset
−
 was determined for all selected target points in each 
zone and it was averaged to obtain the position of the phantom with respect to the robot 
base. The translation value is different in each zone and consequently it had to be 
recomputed when the phantom was moved. With baserobot
phantomoffset
−
 known in each zone, the 
phantom points targeted with the robot arm could be transformed into the phantom 
referential by using: 
baserobot
phantom
baserobot
SP
baserobot
phantom offsetPP
−−−
+=   ,         (3) 
where baserobot
phantomP
−
 defines the 3x1 position vector of the center target point of the hole 
acquired with the robot and transformed into the phantom coordinate system, baserobot
SPP
−
 is 
the 3x1 position vector of the SP center of gravity with respect to the robot referential, and 
baserobot
phantomoffset
−
 is the 3x1 translation offset vector to position the robot base in the phantom 
referential. It can be recalled that Fig. 3.6 illustrates the three referential objects of this 
study: the robot, the phantom and the SP. 
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3.5.3.1 Position and inter-distance accuracies 
The robot positioning and inter-distance accuracies were evaluated with the leg 
mimicking phantom on a total of 13 target points (see Fig. 3.3). The same targets were 
evaluated in each robot experimental zone and for each hole, taught and replayed data were 
collected. In teach mode, the operator manually moved the SP to a phantom target point. 
The robot arm then replayed the taught path to reach the same target. Data collection 
consisted of the Cartesian position and orientation of the robot end-effector (using T = 4, as 
mentioned earlier). The robot end-effector position and orientation for all collected data 
were transformed into the robot referential with Eq. (1). Data positions were then 
transformed from the robot referential into the phantom coordinate system with Eq. (3). 
The relative positioning accuracy Ps , calculated with Eq. (4), is the mean distance 
between the phantom ground truth point positions and the phantom points collected with 
the robot SP and transformed in the phantom referential. The inter-distance 
accuracy IntDist , given by Eq. (5), evaluates the robot error in segment length 
measurements; it is the mean absolute error between the length separating phantom ground 
truth neighbor points and the length separating the corresponding target points collected 
with the robot SP: 
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In Eqs. (4) and (5), kG  defines the 3x1 ground truth position vector of target point k 
obtained from the CAD file of the designed phantom, baserobotkiphantomP −,  describes the 3x1 
robot target point position vector transformed into the phantom referential of target point k 
for the SP configuration i, T = 4 corresponds to the different SP configurations taken 
around the target point, and M = 13 is the number of selected phantom target points. Ps  
and IntDist  were evaluated in each robot workspace zone (L = 5). The inter-distance 
accuracy IntDist  was computed for only neighbor target points pair in a specific path (e. g., 
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in path 1, inter-distance pairs included L1-L5, L5-L10 and L10-L15). As a result, a smaller 
data sample was used for this evaluation. 
3.5.3.2 Teach/replay repeatability 
The teach/replay repeatability is the distance between the robot teach and replay 
points. It was assessed with the data collected for the robot accuracy measurements. For 
this analysis, it was not necessary to know the translation of the data in the phantom 
coordinate system; the collected data were only transformed into the robot referential with 
Eq. (1). The teach/replay repeatability Rpt  was calculated with: 
∑∑
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where 
ki
teach
baserobot
SPP
,
−
 is the teach position vector with respect to the robot referential of target 
point k for the SP configuration i, 
ki
replay
baserobot
SPP
,
−
 represents the replay position vector with 
respect to the robot referential of target point k for the SP configuration i, T = 4 is the 
number of SP configurations, and M = 13 is the number of target points. Rpt  was 
evaluated in each robot workspace zone (L = 5). 
3.5.3.3 Statistical analyses 
Multiple pairwise comparisons with Bonferonni tests were performed on accuracy 
and teach/replay repeatability results to evaluate differences among the robot operating 
zones and phantom paths. All statistical analyses were performed with the SPSS statistical 
software (version 13.0, SPSS Inc., Chicago, IL). 
3.5.4 3D-US reconstruction of a vascular phantom from a robot scan 
The performance of the 3D-US robotic system for the reconstruction of a vessel was 
evaluated by using a symmetric cylindrical vascular phantom of known length with two 
consecutive stenoses of 80 % and 75 % area reductions. The fabrication phantom ground 
truth values were obtained from micro-caliper measurements performed on the low-melting 
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point vessel lumen prototype. Fig. 3.7 shows the vascular phantom box and lumen mold. A 
complete description of the fabrication process, characteristics and geometric accuracy of 
the phantom is available in [163]. 
 
 
 
 
Figure 3.7: The symmetric cylindrical vascular phantom. (a) The lumen mold of the vascular phantom with 
double stenoses is shown without the box top cover and the agar-mimicking tissue material used to fill the 
phantom. (b) A view of the lumen mold alone is shown, labels S1 and S2 correspond to the first and second 
stenoses with 80 % and 75 % area reductions, respectively. The sugar-based lumen mold is removed when the 
fabrication process is completed by introducing the phantom in water. This allows producing a vessel with 
two stenoses that is filled with degassed water for ultrasound scanning. 
 
For the current evaluation, the vascular phantom was placed in zone 3 of the robot 
workplace (see Fig. 3.5) and scanned along its length. The robotic system was coupled to 
an US scanner equipped with a 10 MHz linear array probe (Model FPA, Vivid-5 US 
system, General Electric, Chicago, IL, USA). In order to reconstruct the vascular phantom 
accurately, a 3D-US calibration was first performed by using a cross-wire phantom. 
Thereafter, the quantification of the diameter and area reduction of stenoses was performed 
on the reconstructed volume obtained from US images captured with the robot system. 
3.5.4.1 Calibration with a cross-wire 
To locate US images within the robot coordinate system, it was necessary to find the 
transformation (rotation and translation) of the US image plane with respect to the probe 
position. This was achieved with a cross-wire calibration phantom made with two crossed 
threads suspended in water. Several scans were performed with a wide range of US probe 
angles and positions. The intersection of the two wires was aligned in the US image for a 
specific depth. The center of the intersection was manually segmented and considered as 
the origin of the phantom coordinate system to solve the following equation [71]: 
S1 
S2
(b) 
(a) 
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where phantombaserobotT −  is the unknown transformation (rotation and translation) of the cross-wire 
phantom with respect to the robot referential, baserobotUSprobeT −  represents the known transformation 
of the US probe with respect to the robot referential for an acquired image, and USprobeimageT  is 
the unknown transformation of the image with respect to the US probe. For each image k, 
ku  and kv  represent the column and row indices with respect to the B-scan origin; xs  and 
ys  are defined as the scaling parameters in mm/pixel estimated from the B-scan depth 
settings. A Levenberg-Marquadt iterative algorithm was employed to compute the 
unknown parameters since the cross-wire position is undefined in the robot referential. 
Once the calibration matrix USprobeimageT  is determined, all cross-wire points in the acquired 
images were reconstructed in the robot referential with Eq. (7) to assess the calibration 
precision 
rmsC : 
N
C
N
i
i
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∑
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σ
,     (8) 
where iσ  is the standard deviations of the reconstructed points for an US image i among a 
total of N images. 
3.5.4.2 3D-US reconstruction 
A US scan with quasi-parallel planes of the phantom was taught and replayed by the 
robot. B-mode images (480 x 640 pixels) were captured, digitized and stored on the 
workstation. Images were cropped to a region of interest and then segmented by using a 
fast-marching method based on gray level statistics and gradients adapted from [41]. It 
provided an outline of the phantom vessel wall boundary. Each segmented contour pixel 
position ( ku , kv ) was then mapped to the reconstruction volume B with the calibration 
matrix USprobeimageT , their respective scaling factors ( xs , ys ) and with the corresponding US 
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probe transformation parameters baserobotUSprobeT − . Thus, each pixel Bx of the 3D surface 
reconstruction was expressed by the following equation: 
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The transformed contours were re-sampled on a rectangular grid and interpolated to provide 
a 3D surface rendering. 
3.5.4.3 Quantification of stenoses 
Stenoses were evaluated from the 3D-reconstruction. The reconstructed volume was 
re-sliced perpendicularly to the longitudinal axis of the vessel. A mean diameter and an 
area were computed for each cross-section. From this data set, 10 samples in regions where 
the area was maximum were used to compute the average dimension of the reference 
vessel refA . In regions where the area was minimum (within stenoses), one value was used 
to compute the average diameter and area of the reduced stenosis minA . Stenoses in the 3D 
volume were quantified according to the following equation: 
% of reduction = 

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
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ref
ref
A
AA min100 .                                             (10) 
The quantification error for both stenoses was determined and compared to the fabricated 
phantom ground truth values obtained from micro-caliper measurements. 
3.6 Results 
3.6.1 SP calibration 
The SP translation magnitude effectorendSPP −  in Eq. (1) was estimated as                            
194.33 ± 0.36 mm. The corresponding translation position coordinates, which represent the 
SP center of gravity in the x, y and z directions with respect to the robot end-effector, are 
listed in Table 2. 
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Table 2: Spherical pointer (SP) calibration results 
SP Position vector Magnitude 
effectorend
SPP
−
 
 
X 
 
Y 
 
Z effectorend
SP
P
−
 
Mean (mm) -12.05 ± 0.64 -1.38 ± 0.27 194.50 ± 0.35 194.33 ± 0.36 
effectorend
SPP
−
is the estimated translation vector of the SP in the end-effector 
referential. 
3.6.2 SP calibration precision 
The mean SP precision according to Eq. (2) was found to be 0.57 ± 0.30 mm for the 
five experimental zones. This mean was calculated with 100 collected points in the robot 
workspace. Fig. 3.8 presents the histogram of the distance between each target position 
acquired with the SP and the corresponding mean target position. Most data acquired at 
different angulations of the SP resulted in a precision below 1 mm. 
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Figure 3.8: The precision histogram of the robot scanner determined by using the spherical pointer.  For 
the five experimental zones, a mean of 0.57 ± 0.30 mm was found. 
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3.6.3 Performance evaluation 
3.6.3.1 Positioning accuracy 
The mean relative positioning accuracy calculated with Eq. (4) was 0.60 ± 0.29 mm 
in teach mode, while it was 0.62 ± 0.29 mm in replay mode. Ninety five percent of the data 
points (248 instead of 260 samples) was collected in teach and replay modes given that 
some holes were not reachable by the robot. Table 3 details the positioning accuracy within 
each designated experimental zones and different phantom paths for teach and replayed 
points. Statistically significant differences were found between the robot experimental 
zones (p < 0.05) for both teachPs  and replayPs  measurements. The pairwise comparisons 
revealed a significantly higher positioning error in zone 1 compared to zones 2 and 5 (p < 
0.001 and p < 0.05, respectively). Furthermore, over all robot workspace zones and for both 
teachPs  and replayPs , a statistically significant difference between phantom paths 3 and 1 
was found (p < 0.05) with the smallest error in the linear path (path 1). However, no 
statistically significant difference was found between the teach and replay positioning 
accuracy over all zones and phantom paths (p = 0.67). 
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Table 3: Robot positioning accuracy 
 
Experimental zones 
 
Phantom paths teachPs  
(mm) 
replayPs  
(mm) 
 
Sample size 
(N) 
 
1 0,69 ± 0,26 * 0,69 ± 0,28 * 12 
2 0,74 ± 0,33 0,75 ± 0,33 16 
3 0,69 ± 0,30 * 0,70 ± 0,30 * 16 
 
Zone 1 
mean 0,71 ± 0,29 ξ, δ 0,72 ± 0,30 ξ, δ 44 
1 0,46 ± 0,27 * 0,59 ± 0,30 * 16 
2 0,46 ± 0,18 0,49 ± 0,19 16 
3 0,55 ± 0,28 * 0,60 ± 0,29 * 20 
 
Zone 2 
mean 0,50 ± 0,25 ξ 0,56 ± 0,27 ξ 52 
1 0,48 ± 0,19 * 0,47 ± 0,18 * 16 
2 0,64 ± 0,26 0,60 ± 0,28 16 
3 0,72 ± 0,35 * 0,73 ± 0,34 * 20 
 
Zone 3 
mean 0,62 ± 0,29  0,61 ± 0,29  52 
1 0,61 ± 0,27 * 0,61 ± 0,27 * 16 
2 0,52 ± 0,29 0,49 ± 0,25 16 
3 0,72 ± 0,37 * 0,75 ± 0,42 * 20 
 
Zone 4 
mean 0,63 ± 0,32 0,63 ± 0,34 52 
1 0,54 ± 0,25 * 0,56 ± 0,22 * 16 
2 0,63 ± 0,21 0,62 ± 0,23 16 
3 0,56 ± 0,24 * 0,55 ± 0,22 * 16 
 
Zone 5 
mean 0,58 ± 0,23 δ  0,58 ± 0,22 δ 48 
All zones Total  mean 0,60 ± 0,29 0,62 ± 0,29  248 
Ps  is the relative mean positioning accuracy which defines the mean 
distance between ground truth and robot measured phantom points. It was 
calculated in the robot teach ( teachPs ) and replay ( replayPs ) modes. δ and 
ξ indicate statistically significant differences between experimental zones 
from pairwise comparisons with p < 0.05 and p < 0.001, respectively. * 
signifies that a statistically significant difference between paths was found 
over all robot workspace zones for both teach and replay modes with p < 
0.05. 
 
3.6.3.2 Inter-distance accuracy 
The mean inter-distance accuracy computed with Eq. (5) in teach mode 
( teachIntDist ) was 0.43 ± 0.32 mm, whereas for the replay mode, replayIntDist  was 0.42 ± 
0.33 mm. Seventy eight percent (188 over 240 holes) of the data points was used for the 
robot inter-distance accuracy measures in teach and replay modes. This is due to the fact 
that this evaluation was limited to neighbor targets located on a specific path and because 
of the limited reach of the robot to some holes. Table 4 shows the inter-target distance 
accuracies. For both teachIntDist  and replayIntDist , statistically significant differences were 
observed between the robot operating zones (p < 0.05). The pairwise comparisons showed 
that the inter-target measurement error in zone 4 was significantly higher than in zones 2 
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and 5 (both with p < 0.05). Furthermore, for both teachIntDist  and replayIntDist , no 
significant differences occurred between phantom paths (p = 0.24) and between teach and 
replay modes (p = 0.60). 
Table 4: Robot inter-distance accuracy 
 
Experimental 
zones 
 
Phantom 
paths 
teachIntDist  
(mm) 
replayIntDist  
(mm) 
 
Sample size  
(N) 
1 0,56 ± 0,43 0,54 ± 0,41 8 
2 0,52 ± 0,23 0,51 ± 0,22 12 
3 0,32 ± 0,16 0,32 ± 0,14 12 
 
Zone 1 
mean 0,45 ± 0,29 0,45 ± 0,27 32 
1 0,37 ± 0,13 0,44 ± 0,22 12 
2 0,34 ± 0,28 0,35 ± 0,29 12 
3 0,29 ± 0,21 0,31 ± 0,21 16 
 
Zone 2 
mean 0,33 ± 0,21 δ
 
0,36 ± 0,24 δ
 
40 
1 0,33 ± 0,17 0,33 ± 0,15 12 
2 0,37 ± 0,28 0,35 ± 0,29 12 
3 0,57 ± 0,35 0,59 ± 0,35 16 
 
Zone 3  
mean 0,43 ± 0,30 0,44 ± 0,30  40 
1 0,34 ± 0,27 0,34 ± 0,25 12 
2 0,57 ± 0,52 0,61 ± 0,43 12 
3 0,63 ± 0,55 0,61 ± 0,53 16 
 
Zone 4 
mean 0,44 ± 0,40 δ
 
0,47 ± 0,36 δ
 
40 
1 0,26 ± 0,18 0,40 ± 0,30 12 
2 0,48 ± 0,35 0,50 ± 0,35 12 
3 0,27 ± 0,28 0,26 ± 0,27 12 
 
Zone 5 
 
mean 0,34 ± 0,29 δ
 
0,38 ± 0,32 δ
 
36 
All zones Total mean 0,43 ± 0,32  0,42 ± 0,33  188 
IntDist  evaluates the robot error in segment length measurements; it is the mean absolute 
error between the length separating phantom ground truth neighbor points and the length 
separating the corresponding target points collected with the robot spherical pointer (SP). It was 
calculated for the robot teach ( teachIntDist ) and replay ( replayIntDist ) modes. δ indicates a 
statistically significant difference between experimental zones on pairwise comparisons with p 
< 0.05. No statistically significant difference was found between phantom paths. 
3.6.3.3 Teach/replay repeatability 
Finally, the teach/replay repeatability computed with Eq. (6) was 0.10 ± 0.22 mm. 
Table 5 summarizes the robot teach/replay repeatability measurements. No significant 
differences occurred between robot workspace zones (p = 0.78) and between different paths 
(p = 0.98) within each zone. 
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Table 5: Robot teach/replay repeatability 
 
Experimental zones 
 
Phantom paths Rpt  
(mm) 
 
Sample size 
(N)  
 
1 0,13 ± 0,18 12 
2 0,08 ± 0,10 16 
3 0,04 ± 0,02 16 
 
Zone 1 
mean 0,09 ± 0,13 44 
1 0,18 ± 0,05 16 
2 0,05 ± 0,06 16 
3 0,12 ± 0,22 20 
 
Zone 2 
mean 0,12 ± 0,26 52 
1 0,06 ± 0,04 16 
2 0,16 ± 0,31 16 
3 0,05 ± 0,05 20 
 
Zone 3 
mean 0,09 ± 0,18 52 
1 0,04 ± 0,02 16 
2 0,15 ± 0,15 16 
3 0,20 ± 0,40 20 
 
Zone 4 
mean 0,14 ± 0,30 52 
1 0,10 ± 0,23 16 
2 0,07 ± 0,08 16 
3 0,07 ± 0,15 16 
 
Zone 5 
mean 0,08 ± 0,16 48 
All zones  Total mean 0,10 ± 0,22 248 
Rpt  is the mean teach/replay repeatability which defines the distance 
between the robot teach and replay points. No statistically significant 
difference was found between the different zones and paths. 
3.6.4 3D-US reconstruction of a vascular phantom from a robot scan 
3.6.4.1 Calibration with the cross-wire phantom 
The calibration matrix USprobeimageT  was computed with 62 images at a depth of 6 cm 
with a cross-wire. The calibration precision 
rmsC  achieved was 2.5 mm (see Eq. (8)). 
3.6.4.2 3D-US reconstruction 
The phantom with two stenoses was scanned also at a depth of 6 cm. A total of 83 
images was captured to reconstruct the vascular phantom. Images were segmented and re-
sampled in a 20 x 20 x 300 grid. The surface rendering achieved with the 3D-US system is 
shown in Fig. 3.9. 
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Figure 3.9: The 3D–ultrasound reconstructed phantom with double stenoses. Quantification errors of 3.0 % 
and -0.9 % were found for the 80 % and 75 % area reduction stenoses, respectively. 
 
3.6.4.3 Stenosis evaluation 
Table 6 shows quantification errors of 3.0 % and -0.9 % for the 80 % and 75 % 
stenoses, respectively. Additional details on diameter measurements and 3D reconstruction 
of the phantom are given in Table 6. 
Table 6 : Vascular phantom 3D reconstruction results 
Vessel parameters 
 
In-vitro phantom 3D reconstruction Error between the 
phantom model and the 
3D reconstruction 
Normal lumen wall diameter 7.98 ± 0.20 mm 7.08 ± 0.36 mm - 0.90 ± 0.16 mm 
1st stenosis diameter 3.57 ± 0.20 mm  2.93 mm - 0.64 mm 
1st stenosis area reduction ratio 80.0 % 83.0 % 3.0 % 
2nd stenosis diameter 3.99 ± 0.20 mm  3.62  mm - 0.37 mm 
2nd stenosis area reduction ratio 75.0 % 74.1 % -0.9% 
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3.7 Discussion 
3.7.1 SP calibration and precision 
The SP calibration resulted in a low variability of 0.36 mm (Table 2). Additionally, 
the precision was close to 0.6 mm over the whole robot workspace indicating an accurate 
calibration procedure (see Fig. 3.8). This means that the location of an image acquired with 
an US probe rigidly attached to the robotic arm handle is expected to be accurately found 
anywhere in the robot workspace. To assure an accurate SP calibration and constant 
precision, the robot arm had to be periodically re-homed. This is due to gradual drift in and 
out of calibration after long periods for which the robot was not operated. 
3.7.2 Performance evaluation 
3.7.2.1 Positioning accuracy 
The positioning accuracy was below 0.75 mm for both teach and replay modes (see 
Table 3). Evermore, it was comparable to the precision of the SP calibration. This 
observation proves again the consistency of the robot, where the relative positioning 
accuracy reflects the precision of the robotic arm combined to the precision of the SP 
calibration procedure. Furthermore, zone 1, the furthest to the robotic arm, showed the 
worst mean positioning accuracy, as shown in Table 3. When zone 1 was compared to 
zones 2 and 5, which had the best mean positioning accuracy with values below 0.63 mm, a 
statistically significant difference was found. The poorer accuracy was due to the 
mechanical stress in the robotic arm to reach the phantom target points within zone 1. A 
smaller sample number of 11 target points was indeed used in zone 1 because some targets 
were out of reach to the robotic arm. While the robot offered an overall acceptable accuracy 
in its workspace, an optimum setting would be where the robotic arm can reach its target 
such as in zone 2 or zone 5. Therefore, for a 3D US scan, a patient leg could be placed 
anywhere in the robot workspace, but the robotic arm positioning accuracy would be better 
for a leg located within an area closer to its reach. 
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Concerning the robot scanning paths, the statistical analysis singled out a difference 
between paths 1 and 3. This can be observed in Table 3 specifically in zones 3 and 4, where 
path 3 showed a significant higher positioning error then path 1. Consequently, scanning of 
tortuous lower limb arterial segments, such as modeled with the curved scanning path 3, 
does increase the mechanical stress on the robotic arm, however the difference in the 
positioning accuracy was nevertheless low (≤ 0.20 mm). 
3.7.2.2 Inter-distance accuracy 
The inter-distance accuracy was found satisfactory within all robot workspaces 
(mean accuracy of 0.43 ± 0.32 mm in teach mode and 0.42 ± 0.33 mm in replay mode). In 
fact, absolute mean distances were always ≤ 0.63 mm. The inter-distance accuracy in Table 
4 showed differences between zones. Zone 4 had the largest variations between 0.34 mm 
and 0.63 mm, and zones 2 and 5 again corresponded to the optimal regions with the lowest 
variations between 0.26 mm and 0.48 mm. However, no differences were found between 
the phantom paths. Hence, in the robot workspace, the optimum zones to perform inter-
distance evaluation are again zones 2 and 5 where the mean inter-distance accuracies stayed 
≤ 0.48 mm. The inter-distance measure is an important parameter as it evaluates the robot 
error in segment length measurements, which can condition the choice of a therapy 
(surgical bypass or endovascular approach) and the selection of the length of an angioplasty 
balloon or a stent. 
In both positioning and inter-distance accuracies, the taught and replayed points 
showed similar results. This confirms, as expected, that the robot can repeat with high 
accuracy a manually taught trajectory. This is important since the robot can replay at a 
constant speed the desired scan path for any given patient leg at a high accuracy for 3D 
reconstruction. 
3.7.2.3 Teach/replay repeatability 
The robot teach/replay repeatability reported in Table 5 was found slightly higher 
than the value specified by the manufacturer, which is 0.05 mm. The higher teach/replay 
repeatability that reached 0.20 mm might be explained by the calibration procedure of the 
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robot SP. Because the SP was not a fixed component of the robotic system, it became 
necessary to transform its physical length into the robot referential with Eq. (1). The 
calibration procedure estimated the SP translation from the robot end-effector. Thereafter 
all robot point targets were computed with the SP translation estimation to obtain their 
location in the robot referential. Hence, since SP was involved in all measures of 
performance, this aspect might explain the difference observed between our study and the 
manufacturer’s specification. 
3.7.3 Comparison to other systems 
Precision and inter-distance accuracies obtained in this study were better in 
comparison to other 3D-US freehand systems evaluated with similar methods. The 
precision of these systems was measured as the standard deviation around a target point, 
which is similar to Eq.(2), and distance accuracies were evaluated according to known 
phantom inter-target lengths, measurements with a ruler or other referential systems such as 
robots. The most popular position localizers in 3D-US systems are optical systems and EM 
sensors. 
Optical systems are known to provide the best level of position tracking accuracy. 
The optical Polaris system (NDI, Waterloo, Ontario, Canada) provided inter-distance errors 
as low as 0.193 ± 0.167 mm with a precision of 0.059 ± 0.047 mm for a 1 m distance 
between the camera and the localized object [164]. However, these results were obtained 
only for optimal placement of the optical reflectors with respect to the tracking camera. If 
not, position accuracies as large as 6.67 mm and mean inter-distance accuracies of                
3.55 mm ± 1.51 mm were achieved [112]. These last measurements were obtained by using 
four different optical systems to evaluate the position of a point target on a phantom that 
was reached with different orientations. In the current study, even though our robot showed 
an optimum scanning zone and path to reach the best positioning accuracy, and an optimum 
zone to measure the inter-distance accuracy, the spatial precision was not severely 
compromised when working in other zones and paths. This would not be the case for 
optical trackers because the position of the camera would not be optimum to scan, for 
example, path 1 on the top surface of the phantom and path 3 on its side. 
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EM position trackers offer the benefit of unrestricted range of motion. However, the 
accuracy is variable because of their sensitivity to metallic environments and because the 
transmitter needs to be near the receiver to achieve a good precision. In the literature, there 
exist discrepancies in the reported precisions and inter-distance accuracies of these devices. 
Precisions varying between 0.61 mm and 1.7 mm, and inter-distance accuracies varying 
between 0.05 mm and 1.7 mm, were found for the EM Flock-of-Bird (Ascension 
Technology, Burlington, Vermont, USA) at distances between the emitter and receiver 
below 61 cm [85, 93, 160, 161]. When comparing the Fastrack (Polhemus, Colchester, 
Vermont, USA) with the Flock-of-Bird system, RMS inter-distance accuracies ranging 
from 0.21 mm to 1.7 mm, and from 0.16 mm to 1.3 mm were measured, respectively with 
both systems, at a distance of 30 cm [85]. In worst case scenarios, for example in clinical 
settings with EM interferences, inter-distance accuracies as large as 6.4 ± 2.5 mm (Flock-
of-Bird) and 3.2 ± 2.4 mm (Fastrack) were obtained for a 9 cm distance between the emitter 
and receiver [106]. For lower limb vessel imaging applications, a setting with metallic 
objects (e.g., US probe, hospital bed) and typical scanning lengths varying between 50 and 
100 cm are expected. Consequently, our robot with a precision of 0.57 ± 0.30 mm (see Fig. 
3.8) and an inter-distance accuracy of 0.42 ± 0.33 mm (see Table 4) is thus superior to that 
of approaches using localizing systems since a constant performance can be achieved in all 
workspaces. 
When compared to the few existing robotic 3D-US systems, our design 
demonstrated its suitability for the proposed clinical application. An articulated mechanical 
arm for 3D-US imaging had a mean positioning error of 0.7 mm [165] compared to the 
position accuracy of 0.62 ± 0.29 mm reported in the current study (see Table 3). With the 
Hippocrate system [140], an absolute positioning accuracy of 0.5 mm and a repeatability of 
0.05 mm were obtained, which is also similar to our results (a teach/replay repeatability of 
0.10 ± 0.22 mm was found with our system, see Table 5). It is to note, however, that a 
direct comparison with the Hippocrate scanner is difficult because no precise information 
was available in [140] on how these measures were obtained. Additionally, in this study, no 
quantitative evaluation of the 3D-reconstruction of an artery was performed. As a result, 
not much information supports Hippocrate performance in term of validation in a clinical 
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mimicking set up. Our 3D-reconstruction showed quantitatively in Table 6 that the robotic 
system can quantify stenoses with a good accuracy. 
3.7.4 Advantages and limitations of our robotic system 
3.7.4.1 Performance 
In this study, the robot was used as a tracking device to provide positions of 2D-US 
images for 3D-reconstruction. According to Rousseau (2003), performance of the tracking 
device includes latency (or lag), update rate, interferences, precision of measures and 
optimum operating space. To identify how closely a robot follows a taught scan pattern 
determined by a clinician, it is first important to discuss latency and update rate. Latency is 
the delay required for the system to detect motion. Update rate refers to the number of 
positions reported by the system per second. Unfortunately, no measurements of these 
characteristics were performed or disclosed by the manufacturer of our robotic system. 
Nevertheless, we did not observe any limitations in scanning mimicking arteries and we can 
assume that latency and update rate frequencies are faster than the frame rate of US 
scanners (typically 30 Hz for most applications). Consequently, we do not anticipate any 
problems for lower limb vessel scanning by a clinician. 
Interferences affecting the robot performance can occur when the operating 
environment is not respected (i.e., temperature, humidity and extreme electrical noise). 
Accordingly, the environment for the current study encompassed the manufacturer 
operative conditions required to preserve robust performances (i.e., room temperature and 
humidity, and normal electrical interferences encountered in industries or hospitals). 
For robotic 3D-US imaging, precision of measures and resolution of US images 
should be comparable. At 10 MHz, US image resolution has approximately, at 3 cm depth, 
a resolution of 0.3-0.4 mm in axial, 1.0-2.0 mm in lateral and 3.0-4.0 mm in out of plane 
orientations [166]. In our study, the positioning accuracy of the robot (≤ 0.75 mm) was 
similar to the combined axial and lateral resolutions of US imaging. However, since the 
sensing technology of the arm relies on the transformation of joint angles into the end-
effector position, the robotic arm will maintain a reliable performance in complex 
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movements if the robot joints are operated within the safe boundary of their limits. It is to 
note that bending of the arm is very unlikely because our design is based on a robust 
industrial robot. However, excessive vibrations may limit the performance. 
Other performance limitations include the use of the system under clinical 
conditions for scanning patients of different anatomy. Currently, our robotic system is 
limited to accommodate each scan of a patient’s leg with a manual taught path made by a 
clinician. Henceforth, the robot replays this path over the leg and acquires at a constant step 
US image planes based on a pre-determined trajectory. Of course, movement of the 
patient’s leg between the taught and replay modes would eventually need to be addressed. 
The patient leg may be either immobilized or an automatic tracking of the vessel and 
registration during replay may be required. However, these solutions are beyond the scope 
of the present article. 
Finally, the robot performance was evaluated for position and inter-distance 
accuracies and for teach/replay repeatability at different locations within its operating 
workspace. A map zone that characterizes the robot performance limitations inside its 
workspace was achieved (see Figure 3.5 and Tables 3-5). It was found that the robot 
positioning accuracy limits varied between 0.46 mm and 0.72 mm, the inter-distance 
accuracy boundaries were between 0.26 mm and 0.63 mm, and the teach/replay 
repeatability was from 0.04 mm to 0.20 mm. Thus, a clinician can generally expect these 
performances when operating inside the robot workspace during the scanning of a patient. 
3.7.4.2 Design 
In this study, we identified the limits of accuracy from the base of the robotic arm 
that extends to SP for scanning lower limbs. The level of accuracy we can achieve with our 
robotic system is greatly influenced by the mechanical design specifications of the robotic 
arm. More specifically, the number of mechanical joints and link dimensions (i.e., member 
lengths of the robotic arm) are significant elements. Including SP in the evaluation certainly 
reduced the reported accuracy of our robotic system. It would be possible to improve 
accuracy with SP by adding mechanical joint limits to the robotic arm to restrain the 
workspace for optimal operation [119]. An alternate way to improve and preserve 
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performance would be to change the physical design of the robotic arm by computing a 
model of optimal link dimensions and joint orientations (i.e., kinematic parameters) with 
SP. The Jacobian, a matrix that depends on a kinematic model to relate joint velocities to 
the end-effector, would be a solution to provide a better positioning accuracy measured at 
the end-effector with SP [158]. 
Elastic joints are another source that can influence the level of accuracy achievable 
by a robot. Under this assumption, our robot has intrinsic compliant elements at the joints 
(e.g., six revolute joints, F/T sensor and cables) that have to be considered. Elasticity of 
mechanical transmission is often the cause of positional errors at the end-effector when a 
robot works in contact with the environment [167]. This is often due to static deformations 
caused under gravity in position tracking and interaction tasks. Given our robotic system 
was designed to interact with humans, and was in contact with a lower limb mimicking 
phantom for this study, this aspect is thought to be important to explain the reported 
positioning accuracies. Nonetheless, when the robot interacts with humans, these effects 
can be reduced to ensure a high performance with the design of a compliance control in the 
Cartesian space of the robotic system. 
3.7.5 3D-reconstruction of a vascular phantom from a robot scan 
3.7.5.1 Calibration with a cross-wire and 3D-US reconstruction 
The calibration matrix obtained with the cross-wire showed a precision suitable for 
a preliminary 3D-reconstruction. However, the calibration precision affected the geometry 
of the reconstructed vessel in the longitudinal axis. This can be seen in Fig. 3.9, where the 
3D reconstructed is slightly shifted in the x-y plane along its length (z axis). It is important 
to remember that the vascular phantom had a symmetric geometry along its length. For 
future work, we expect that it may be feasible to improve the calibration precision as the 
accuracy of the method relies on how well the intersecting point can be detected in the B-
scan images and on how the cross-wire location can be precisely estimated in the robot 
referential. While the precision affected the 3D reconstructed central axis, it did not seem to 
influence severely the overall geometry. Thus, the stenosis severity could satisfactorily be 
evaluated from the 3D volume. Nevertheless, a better accuracy than 3.0 % (see Table 6) 
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may be expected and a z-phantom calibration device may be a solution for this problem 
[71]. 
3.7.5.2 Stenosis evaluation 
Imaging lower limb stenoses is an important application for 3D-US. This non-
invasive imaging technique may become an alternative to 3D reconstruction of arterial 
segments obtained with magnetic resonance imaging and computed tomography 
angiography. Carotid artery atherosclerotic plaque progression was evaluated in patients 
with a 3D-US linear step motor system [89]. Already, the vascular risk factors promoting 
plaque progression were monitored and analyzed with this system [90]. Another study 
validated the 3D-US Flock-of-Bird EM system to measure a phantom and blood conduit 
geometries [102]. Dimensions of uniform and stenotic 3D-reconstructed phantoms were 
measured. This system was able to detect diameter reductions up to 28 % corresponding to 
an area reduction of 48 %. More recently, a study with a similar EM system evaluated the 
error in stenosis quantification for the 3D-US reconstruction of carotid bifurcation 
phantoms and found errors of -1.2 % for detecting a 70 % stenosis [99]. We found similar 
results with errors of 3.0 % for detecting a 80% stenosis, and errors of -0.9 % for 
quantifying a 75 % stenosis (see Table 6). 
3.8 Conclusion 
The prototype medical robot proved to be a suitable tracking device that offers a 
constant performance and control to acquire 3D positions with a high precision, and good 
position and inter-distance accuracies. The computed positions in the robot referential of 
the acquired US images were satisfactory to quantify stenoses in a 3D reconstructed vessel 
phantom. Of course, further developments and validations of the robotic system are 
necessary to provide a platform that would meet clinical needs. Developments include a 
more robust 3D-US image calibration procedure to improve the accuracy of the 3D 
reconstruction from B-mode, color and power Doppler images. The integration of 
electrocardiogram data in the robot control system to gate the US image acquisition would 
also eliminate deformations of the reconstructed volume due to the pulsation of the vessel 
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wall. Acquisition of US images with controlled applied pressure may also be of interest to 
enable non-invasive elastographic measurements of pathological biological tissues [168] or 
to detect deep venous thrombosis with objective vessel compression measures [169]. 
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Chapter 4 
Validation of 3D reconstructions of a mimicked femoral 
artery with an ultrasound imaging robotic system  
 
Divide each difficulty into as many parts as is feasible 
and necessary to resolve it. 
 
Rene Descartes 
 
4.1 Forward 
This chapter presents the paper published in the journal Medical Physics by the 
authors Marie-Ange Janvier, Gilles Soulez, Louise Allard and Guy Cloutier29. 
This paper describes the methods developed to characterize the calibration 
transform that relates the US image plane of the robotic system. A Z-phantom calibration 
procedure was employed and different clinical image acquisition settings were investigated. 
The accuracy of the calibration transform was evaluated with a vascular phantom, where a 
lower limb mimicking artery was reconstructed in 3D. 
4.2 Abstract 
Purpose: The degree of stenosis is the most important criterion to assess peripheral 
arterial disease manifested by atherosclerosis mainly in lower limb arteries. Ultrasound 
(US) imaging offers low-cost, safe, and convenient options to evaluate this disease, but 
most US freehand approaches cannot optimally locate stenoses and map lower limb arterial 
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geometries. A 3D-US imaging robotic system that can control and standardize image 
acquisition by scanning typically-encountered diseased arterial lower limb segments is 
presented and validated with phantoms. 
Methods: A Z-phantom calibration procedure was used to characterize spatial 
transformation of the US probe image plane for different clinical image acquisition settings. 
Moreover, the accuracy of the calibration transform to reconstruct a lower limb mimicking 
vessel geometry was evaluated with a vascular phantom. 
Results: A 3D calibration precision of 0.47 ± 0.27 mm was achieved. 
Reconstruction errors were less than 1.74 ± 0.08 mm in all 3D vessel representations, and 
the cross-sectional areas of each image section were close to those of gold standard 
phantom measures. The best reconstruction accuracy (smallest error) was 0.40 ± 0.03 mm. 
Conclusion: Altogether, these results demonstrate the potential of the robotic 
scanner to adequately represent lower limb vessels for the clinical evaluation of stenoses. 
4.3 Introduction 
Atherosclerosis is the principal cause of peripheral arterial disease that leads to the 
progressive narrowing of lower limb arteries [7, 45, 46]. The 3D location of lesions and the 
degree of stenosis are the most common criteria for assessing the severity of PAD. 
Moreover, a map of the entire lower limb vessel is required to prepare an appropriate 
intervention (e.g., the diameter and length of an angioplasty balloon and stent) [170, 171]. 
In fact, most medical centers perform digital subtraction angiography, computed 
tomography angiography or magnetic resonance angiography for the complete 
representation of lower limb arteries [26, 38]. Although these technologies yield good to 
excellent image resolution and even some 3D rendering, they are either too costly, invasive 
or ionizing. 
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Different ultrasound (US) imaging techniques, namely pulsed-wave Doppler, color 
Doppler flow imaging, power Doppler angiography and B-mode imaging, are currently 
able to detect arterial lesions in lower limbs safely, non-invasively and at low-cost [51, 151, 
152, 172]. However, it is not easy, with these modalities, to visualize the entire lower limb 
vascular tree with accuracy within an acceptable time frame. Moreover, the evaluation of 
atherosclerotic disease with conventional 2D B-mode US is highly operator-dependent 
[32]. 
3D-US imaging can precisely define the degree of stenosis and map its location 
along the lower limb vascular tree. Already, many 3D-US systems have been successfully 
developed and validated in various clinical applications, notably, obstetrics, cardiology, and 
vascular imaging, to increase diagnostic confidence [68]. Most of them rely on a freehand 
US probe-tracking method that produces uneven geometric sampling, adding uncertainty to 
the reconstruction. Moreover, popular freehand tracking devices (optic and 
electromagnetic) have operating restrictions: scanning of small distances, the necessity of a 
constant line of sight, and avoiding metallic interference [71, 85, 106, 155, 173]. 
Robotic systems represent a promising alternative for lower limb stenosis 
quantification and location [119] because they can simultaneously control and standardize 
3D-US acquisition without the limitations of 3D freehand devices. Some medical 3D-US 
prototype robots have been developed but are exclusively deployed in research [123, 140, 
174, 175] because they focus mainly on architectural control and safety designs so that their 
potential clinical performance has not been evaluated. We proposed a medical robot [148] 
for 3D-US scanning of lower limb vessels. The principal features of this system are its 
teaching mode that enables the learning of “freehand” scanning accommodated to patients’ 
legs, and its replay mode that reproduces the manually-taught path. Clinicians would 
acquire with this system 2D cross-sectional US images at a controlled speed with x, y and z 
registration of coordinates and constant contact pressure for 3D reconstruction. Based on 
our previous report with this system [148], a high positioning accuracy of the robot end-
effector and repeatability were achieved. In the context of the current study, these first-step 
results were required to assure robustness of this technology to track the US probe position 
into the robot 3D referential. 
A major challenge in either freehand or robotic 3D-US is the precise localization of 
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the image into the referential positioning system (i.e., calibration transform for rotation, 
translation and scaling) [71, 176]. This information is particularly important as errors in 
image transform propagate through subsequent stages of 3D reconstruction in image 
analysis and scaling [177]. These errors thus have a major impact on the quality of the 
reconstructed geometry that enables precise 3D visualization, planning, and accurate 
image-guided interventions. 3D-US calibration techniques usually require imaging a 
phantom of known geometry and physical properties with key features that are easily 
identifiable. The simplest and most common phantom is the point-target (i.e., crossed wires 
or spherical ball) except that calibration is very tedious, time-consuming, and susceptible to 
image artifacts produced by the US beam [160, 161, 178]. A calibration wall phantom 
allows the fastest registration of US images [78, 176, 179] but for calibration to be valid, it 
needs to be scanned at a proper range with a specific protocol. Moreover, reverberations of 
the US beam by the wall can also affect calibration quality. The Z-phantom is the most 
efficient method for fast and precise calibration from a single B-scan [178-181]. In 
comparison to other calibration methods, it provides the best performance in terms of 3D 
point reconstruction accuracy [178]. To the best of our knowledge, no 3D-US studies have 
validated the effect of calibration transforms on 3D reconstructed vascular models. The 
objectives of this study were to adapt a Z calibration procedure for the 3D-US imaging 
robot and to evaluate its performance in terms of precision and reconstruction accuracy on a 
3D vascular geometry with double stenoses. 
4.4 Materials and methods 
4.4.1 Prototype medical robotic 3D-US imaging system 
The robotic system illustrated in Fig. 4.1 includes a computer workstation, the 
robotic arm (F3 articulated robot, CRS Robotics Corporation, Burlington, Ontario, Canada) 
and an US echograph. This 3D acquisition scanner, described in detail elsewhere [148], can 
capture US images at uniform spacing during probe displacement. In the current study, a 
Vivid-5 echograph system (General Electric, Milwaukee, WI, USA) equipped with a FPA 
10-MHz linear array probe was employed. US images were digitized in 480 x 640 pixel 
format. 
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Figure 4.1: Overview of the prototype medical robotic 3D-US imaging system [148]. The robotic arm is 
moved by a user interface software on the workstation. 2D-US images are tagged with US probe positions 
acquired from the robotic arm. In this example, a vascular phantom is scanned. 
 
 
 
 
 
 
 
 
 
Figure 4.2: A complete view of the calibration phantom. It consists of a square platform, a container and a 
Z-phantom. 
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4.4.2 Calibration procedure 
4.4.2.1 Calibration phantom, experimental set-up, data acquisition and processing 
A precise calibration procedure based on a Z-phantom was developed for the 3D-
US robotic system (i.e., to identify features that best relate the US image plane location to 
the phantom space within the robot referential). The design (Fig. 4.2) consists of a base 
platform, a container, and the Z-phantom.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: (a) Top view of the Z-phantom that illustrates a single Z-fiducial (i.e., segment wires BA , AD  
and DC ). An US plane (i.e. dashed line) intersects these wires in collinear points Q, P, and R. (b) Example of 
an US image that contains multiple points of Z-fiducials in its field of view. (c) Side view of the complete Z-
phantom is shown with (d), a grid of the entire 19 Z-fiducials constructed. 
The square platform incorporates 4 holes to fix the phantom to a table in the robot 
workspace. This platform also contains 4 hemispherical steel holes, each 8.38 mm in 
(d) (c) 
(b) (a) 
Q P R 
Q 
Q 
P 
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R 
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diameter and 4.19 mm in depth, which serve as markers to localize the phantom in the robot 
referential. The Z-phantom, inspired by previous works [178-181], was immersed in 
distilled water at room temperature within the container. It consists of 2 parallel Plexiglas 
plates (110 mm wide × 90 mm high × 9.53 mm thick) positioned 60 mm apart and 
maintained by 4 spacers made of high density polyethylene. Each plate encloses 24 drilled 
holes of 0.46 mm diameter aligned in 5 different rows with 10-20 mm gaps. A surgical blue 
monofilament polypropylene suture wire of 0.07-0.099 mm diameter (8726 Prolene 6-0, 
Ethicon Inc., Piscataway, NJ, USA) was interwoven through the holes to construct 19 Z-
shaped patterns (i.e., Z-fiducials), as depicted in Fig. 4.3. 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: The coordinate system involved in the calibration method: Z-phantom Z, US image I, US probe 
P and robot R. The calibration transform was determined from a series of coordinate frame transformations 
that relate Z features to I and R. 
The US probe was fixed with a holder to the robotic arm. The probe was held 
perpendicular over the Z-phantom to facilitate the US scan plane intersection with Z-
fiducials (Fig. 4.4), and to minimize the blurry effect that the finite thickness of the US 
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beam has on images. Then, transducer motions were taught to the robotic arm to locate the 
Z-fiducial markers while acquiring US images. 
Because peripheral arteries in lower limbs have a 3- to 8-cm depth range [182], 
operator-dependent adjustments of US image settings are required for a given scan. 
Consequently, such settings were evaluated because of the impact on calibration transforms 
[71, 183]. The US image acquisition parameters included 4 depths (5, 6, 7 and 8 cm) at no 
zooming, with a fixed focus depth of 4-5 cm, and 3 focus beam depths (2-4 cm, 4-5 cm and 
5-7 cm) at a fixed 7-cm depth with no zooming. The focus beam depth provides the best 
lateral resolution of the US transducer to distinguish small adjacent structures perpendicular 
to the beam’s major axis. At the 7-cm depth, with the best focus beam depth that had 
previously been found, 3 amplifications (i.e. zooms), corresponding to window sizes of 2, 3 
and 4 cm, were also used. The zoom setting of the US scanner allows the display of only a 
selected region of interest remote from the transducer, where a smaller window size 
represents a higher magnified ROI. For each setting, 10 US scans were acquired, and, for 
each scan, 10 frames were selected to compute 10 calibration transforms. The ROI was 
cropped, and visible Z-fiducials identified and segmented manually. 
4.4.2.2 Calibration equations 
Different coordinate systems are involved in the calibration procedure and each one 
is related to the others by Eq. (11) (Fig. 4.4). Every transformation matrix T contains 3 
rotations (α, β, γ) and 3 translations (x, y, z). The standard notation throughout this 
manuscript is B
AT , where the coordinate system B is defined into the referential A. 
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        (11), 
In the above equation, R
zT  is the unknown transformation of robot referential R into the Z-
phantom, P
RT  represents the known transformation of US probe P into robot referential R 
for an acquired image, and I
PT  is the unknown calibration transformation of image I in US 
probe P. For each image, k, ku  and kv  are column and row indices with respect to the B-
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scan origin; xs  and ys  are scaling parameters in mm/pixel, estimated from B-scan depth 
and zoom settings. Thus, a point in the thk  US image is localized in the Z-phantom 
referential with xk, yk and zk. 
4.4.2.2a Identification of Z-fiducials 
US images depicted multiple dots that could be used to identify Z-fiducials (see Fig. 
4.3). Each feature point in an US image I were identified in the Z referential by 
trigonometry, an approach similar to that in [178]. In particular, when the US image plane 
intersects the Z-shape phantom wires, it forms multiple collinear points similar to QPR  
(see Fig. 4.3) in the US image. Usually, these crossings are unknown in the Z referential. 
However, while not visible in the US image, the A, B, C, D location points are known in the 
Z referential due to the manufacture of Z-fiducials (Fig. 4.3). Thus, with similar triangles ∆, 
it was possible to calculate the location of the homologous point P that expresses the 
location of image plane I in the Z-phantom. The following equations are derived from the 
similar ∆APQ and ∆DPR that define point P.  
( )ADAP xxhxx −⋅+=  (12) 
( )ADAP yyhyy −⋅+=  (13) 
( )ADAP zzhzz −⋅+=  (14), 
where h is the ratio of distance AP  to distance AD  that is equivalent to the ratio of 
distance QP  to distance QR . By identifying the location of point P inside the US image 
plane I (Fig. 4.3), this corresponds to the detection of the same feature location point in the 
Z-phantom referential (i.e., xk, yk and zk in Eq. (11)). In practice, several Z-fiducials were 
localized within a given US image plane to determine the relative position and orientation 
of the scan. 
4.4.2.2b Localization of the Z-phantom 
A calibration procedure with a spherical pointer that fits tightly into the robot 
markers of Fig. 4.2 was first used to localize the Z-phantom in the robot referential R. A 
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complete description of the method appears in [148]. For each robot marker, 10 
independent sets of points corresponding to different articulations of the robotic arm were 
taught, then replayed and recorded by the robotic system. An iterative closest point (ICP) 
algorithm with Delaunay tessellation was employed to fit the measured robot points to the 
real Z-phantom robot marker point coordinates (MatLab open source code ICP, version 1.4, 
by Per Bergström, March 7, 2007). Thus, rigid body transformation RzT  between the Z-
phantom model and the robot marker points could be determined with this method. 
4.4.2.2c Calibration algorithm 
A calibration algorithm served to determine the calibration transform that defines 
the spatial relationship between US image I and US probe P. Eq. (11) presents an over-
determined system of non-linear homogeneous equations where most of the Z-phantom 
parameters can be estimated. The remaining unknown parameters, i.e., the calibration 
transform of image I into US probe P ( IPT ), were computed by the Levenberg-Marquardt 
iterative algorithm, with a detailed description provided in [71, 78]. 
4.4.2.3 Calibration performance evaluation with the Z-phantom 
The precision of the calibration procedure was evaluated by measuring variations in 
the x-y position of the US image plane due to spatial calibration errors [177]. It is not a 
measure of accuracy of the calibration parameters but of their repeatability. Ten different 
US images of the Z-phantom were assessed: 6 fiducial markers in each image were 
identified and reconstructed into the phantom referential with the calibration transform of 
Eq. (11). The precision of calibration 
rmsC  was computed by: 
( ) ( )∑∑
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−+−=
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 (15), 
where ( ) jixx ,− is the variation from the mean location x  for fiducial positions i in the x 
direction for image j (see Fig. 3.4 for the identification of the image coordinate system 
I(x,y)). This definition applies as well to direction y. For every US image setting (i.e., depth, 
focus beam depth and zooming), 10 calibrations (i.e., 10 measures of Crms) were performed 
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to obtain the mean precision that was calculated with M = 6 fiducial markers and N = 10 
US images. The total sample size thus corresponded to the identification of 600 points on 
the Z-phantom. Note that this is the same equation as Eq. (8) in [148] but with a different 
notation. 
4.4.3 3D reconstruction performance evaluation on a lower limb-
mimicking artery 
4.4.3.1 Vascular phantom geometry and experimental set-up 
A phantom, mimicking a lower limb femoral artery, was fabricated to evaluate the 
3D reconstruction performance of the robotic scanner. It contained 2 axisymmetrical 
stenoses of 80.0% (S1)  and 75.0% (S2) in area reductions with a ‘disease-free’ diameter of 
7.87 ± 0.11 mm (i.e., gold standard dimension). The vessel central axis was positioned at 
3.4 cm from the top of the phantom. The entire fabrication process, characteristics and 
geometric accuracy of the vessel lumen embedded in this phantom are available in [163]. 
The mathematical model describing the vessel lumen geometry can be found in [186]. This 
geometry served as the gold standard reference for all subsequent measures that follows. 
The vascular phantom was fixed tightly into the robot workplace and scanned along 
its length. A quasi-parallel plane US scan path was taught and replayed by the robot, and B-
mode images were acquired at the same settings as those used for precision assessment with 
the Z-phantom (i.e., 4 depths, 3 focus beam depths and 3 zooms). For each US image 
setting, 10 scans were captured to reconstruct 10 vessels in 3D. 
4.4.3.2 3D-US reconstruction process 
At first, the vessel lumen of every US scan was segmented with a fast-marching 
method based on gray level statistics and gradients adapted from [41]. Each pixel of the 
segmented lumen contour was then mapped into the robot referential with the best 
calibration transform computed and the corresponding probe positions. The transformed 
lumen contours were re-sampled on a 300 x 20 rectangular grid and interpolated to provide 
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a 3D surface rendering of the reconstructed vessel. After that, the reconstructed polygon 
models were transformed to generate contours normal to the vessel center axis, as in [184]. 
4.4.3.3 3D reconstruction performance evaluation 
The accuracy of 3D reconstructions was assessed by determining lumen surface 
map and vessel area errors from cross-sectional planes along the 3D-reconstructed vessel. 
Reconstructed and gold standard model-matching were performed by finding the center of 
gravity of both 3D vessel lumens, and by computing the appropriate transformation matrix 
(translation and rotation) that minimized the difference between both referential systems. 
Lumen surface map error was evaluated by measuring the absolute distance between the 
reconstructed geometry and that of the gold standard vessel, as expressed by: 
( )),,(),,(
,,
kjiSkjiMabsE kji −=  (16). 
where M is the surface map of the reconstructed vessel, S the surface map of the 
gold standard vessel, 1 ≤ i ≤ X for X the number of grid points along the x axis depicted in 
Fig. 4.5, 1 ≤ j ≤ Y for Y the number of grid points along the y axis, and 1 ≤ k ≤ Z for Z the 
number of grid points along the z axis. 
For each reconstruction, the error in area was also evaluated with a polygon-specific 
function of Matlab, Polyarea, which computes the average number of pixels inside a closed 
contour. Thus, for each US image setting where 10 reconstructions were performed, these 
measures (surface map and area errors) were tabulated independently into 1 mean (sample 
sizes = X × Y × Z for the surface map accuracy and X for the area accuracy, where X also 
corresponds to the number of cross sections). 
4.4.4 Statistical analysis 
Analysis of variance with multiple pair-wise comparisons by the Bonferroni method 
was performed on the calibration and 3D-reconstruction results to evaluate differences 
among US imaging settings. All statistical analyses were done with the SPSS statistical 
software (version 13.0, SPSS Inc., Chicago, IL, USA). 
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4.5 Results 
4.5.1 Calibration performance evaluation with the Z-phantom 
Table 7 presents calibration precisions 
rmsC  achieved with the robotic scanner. At 4 
different image depth settings (i.e., from 5 to 8 cm), fixed focus depth of 4-5 cm, and no 
zooming, precision improved as the US image depth was increased (
rmsC varied from 1.19 
to 0.58 mm); 5 and 6 cm had significantly lower precision than other depths (p < 0.001). At 
the fixed image depth of 7 cm and no zooming, 
rmsC  varied from 0.67 to 0.78 mm as a 
function of focus beam depth, 5-7 cm being the poorest (p < 0.001), and 4-5 cm, the best (p 
< 0.05). Note that a smaller sample size served to determine calibration performance at the 
2-4 cm focus beam depth because not enough Z-fiducials were visible to localize the US 
plane on some scans. At the same 7-cm fixed depth and the best focus beam depth of 4-5 
cm, optimum mean precision was achieved at maximum zooming (2:7) (p < 0.001) and 
degraded with less magnification (precision varied between 0.47 and 1.10 mm). 
 
Table 7: Calibration precision 
 
US image parameters 
 
Settings rmsC  
(mm) 
 
Sample size 
(N) 
 
5 cm 1.19 ± 0.91 δ 600 
6 cm 0.93 ± 0.47 δ 600 
7 cm 0.60 ± 0.38 600 
Image depth at fixed           
4-5 cm focus beam 
depth and no zoom 
8 cm 0.58 ± 0.36 600 
2-4 cm 0.72 ± 0.41 540 
4-5 cm 0.67 ± 0.32 £ 600 
Focus beam depth 
at fixed 7-cm image 
depth and no zoom 
5-7 cm 0.78 ± 0.37 δ 600 
2:7 0.47 ± 0.27
δ
 
600 
3:7 0.75 ± 0.41 600 
Zoom 
at fixed 7-cm image 
depth and 4-5 cm focus 
beam depth 4:7 1.10 ± 0.60 600 
rmsC  is the reconstruction precision of the medical robotic system 
 evaluated  with Eq. 5 for different US image settings. N is the total  
number of sample points used. δ indicates a statistically significant  
difference on pair-wise comparisons between settings on a US image  
parameter with p < 0.001 and £ signifies p < 0.05. 
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Table 8: Reconstruction accuracy 
 
US image parameters 
 
Settings 
Reconstruction 
error 
(mm) 
 
Sample size 
(N)  
 
5 cm 0.87 ± 0.08 7 
6 cm 1.20 ± 0.02 10 
7 cm 1.74 ± 0.08 10 
Image depth at fixed           
4-5 cm focus beam 
depth and no zoom 
8 cm 1.45 ± 0.12 10 
2-4 cm 1.71 ± 0.03 10 Focus beam depth 
at fixed 7-cm image 
depth  and no zoom 4-5 cm   1.11 ± 0.003 10 
2:7 0.93 ± 0.04 9 
3:7 0.40 ± 0.03 10 
Zoom 
at fixed 7 cm image 
depth  and 4-5 cm focus 
beam depth 4:7 0.46 ± 0.03 10 
Reconstruction accuracy of the medical robotic system evaluated in terms of  
distance errors for different US image parameters. Each value represents  
the mean ± standard deviation computed over 1 reconstruction from N total  
number of models used. Each pair of multiple comparisons between settings  
of US image parameters was significantly different (p < 0.05). 
 
 
4.5.2 3D reconstruction performance evaluated on a lower limb-
mimicking artery 
Fig. 4.5 presents examples of the worst (Panel a) and best (Panel b) 3D 
reconstructions at different views with labeled stenoses. In Fig. 4.5a, vessel shape showed 
large distortions, whereas in Fig. 4.5b, overall geometry appeared to be acceptable. 
Corresponding lumen surface map errors are reported in Fig. 4.6. Note that similar distance 
errors were found for the 9 other reconstructed lower limb-mimicking vessels at the 
specified US image settings. Table 8 summarizes the accuracy of all 3D reconstructions. 
The best reconstructions were obtained at the 3:7 zoom setting, for an image depth of 7 cm 
and a focus beam depth of 4-5 cm (0.40 ± 0.03 mm, Fig. 4.6b) (p < 0.05). No vessel 
reconstructions were computed at the 5-7 cm focus beam depth because we assumed that 
worse results would be obtained (because the focal depth was the farthest with respect to 
the vessel central axis depth of 3.4 cm). 
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Figure 4.5: Examples of 3D-reconstructed vascular geometries with axisymmetric double stenoses (S1 and 
S2). (a) The worst 3D vessel reconstruction is displayed at 7-cm image depth and 4-5-cm focus beam depth 
with no zooming. (b) The best 3D reconstruction is obtained at 7-cm image depth, 4-5 cm focus beam depth 
and 3:7 zoom setting. 
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Figure 4.6: Reconstruction errors with respect to the axisymmetric cylindrical gold standard model. (a) 
Error map of the worst reconstruction corresponding to Panel a of Figure 4.5. (b) Error map of the best 
reconstruction corresponding to Panel b of Figure 4.5. Note that the same projected view is used on both 
Panels, differences are associated with reconstruction errors. 
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Figure 4.7: Mean areas of 3D-reconstructed vascular geometries with respect to gold standard dimension at 
different US image settings (for each curve, standard deviations between reconstructions are not displayed to 
facilitate reading): (a) at 4 image depths, 4-5 cm fixed focus beam depth and no zooming, (b) at a fixed image 
depth of 7 cm, no zooming and 2 focus beam depths, and (c) at 7-cm fixed image depth, 4-5 cm fixed focus 
beam depth and 3 zoom settings. For each panel, * indicates a statistically significant difference between US 
settings on pair-wise comparisons with p < 0.05. 
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Fig. 4.7 shows the reconstructed vessel areas at all tested US image parameters 
(legends indicate comparisons with significant differences, * p < 0.05). In general, an 
underestimation of cross-sectional areas was noted, except for the best setting in Panel c 
(3:7 zoom) where the vessel geometry was adequately reconstructed. In 6-, 7- and 8-cm 
image depth settings, at a fixed focus beam depth and no zooming, significantly 
underestimated areas were found (p < 0.05) (Fig. 4.7a), whereas in focus beam depth 
settings at a fixed image depth and no zooming, the areas revealed no statistical difference 
(p = 0.11) (Fig. 4.7b). In zoom settings, at fixed depth and focus beam depth, differences 
were generally in the most underestimated areas: 2:7 and 4:7 (p < 0.05). 
4.6 Discussion 
4.6.1 Calibration performance evaluation 
In this study, for all image settings, the mean 
rmsC  calibration precision ranged from 
0.47 to 1.2 mm (Table 7). This indicates that the calibration transform is variable from one 
US image setting to another and that parameters can be adjusted on US scanning equipment 
to improve 
rmsC . However, some scanner parameters that may affect rmsC  could not be 
improved or modified, such as the axial, lateral and elevational resolutions that respectively 
depend on the wavelength propagating in the medium (US frequency), on beam focusing 
and transducer lenses shape. Such parameters were not specifically considered in our study 
but their impact on 
rmsC  can be approximated, according to a study realized using a similar 
scanner with a linear array probe of 10 MHz [166]. In that study, reported US image 
resolution was 0.3-0.4 mm in axial, 1.0-2.0 mm in lateral and 3.0-4.0 mm in elevational at a 
3.0 cm depth. It is clear that the use of an US scanner with better resolutions would have 
positively impact our results, especially lateral and elevational resolutions. Nevertheless, 
these are typical parameters of modern US scanners. 
As also noted, each adjusted parameter (image depth, focus beam depth and 
zooming) individually impacted the precision of the 3D robotic US scanning system. For 
the image depth setting with no zooming at a fixed 4-5 cm focus beam depth, 
rmsC  was 
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minimum at either 7 or 8 cm with a mean value close to 0.60 mm (no statistical differences 
were noted between both measures). This result was not anticipated since 
rmsC  performance 
was expected to become poorer as US image depth increased [160, 185, 186] because pixel 
density (i.e., axial and lateral) decreased. 
In addition to the US scanner parameter selection, variations in the calibration 
transform were found dependent on points chosen in the B-scan. A greater number of 
points from the Z-phantom provided a more defined plane that could result in better 
calibration precision. Thus, at the smallest depth settings, lower precisions can be attributed 
to the limited field of view of the Z-phantom in US images, giving less Z-fiducials 
available for establishing the calibration transform of Eq. (11). Other studies with Z-
phantoms have also found improved calibration precision at deeper US image settings for 
the same reason [178-181]. In the case of the focus beam depth and referring to Figs 4.2 
and 4.3, the best 
rmsC  performance was achieved at the 4-5 cm setting (0.67 ± 0.32 mm), 
which corresponds to the mid depth of the Z-phantom with a dimension of 9 cm. 
Accordingly at this setting, more Z-fiducials with optimum resolution could be imaged, 
thus improving the calibration transform. As also seen in Table 7, the zoom amplification 
ratio of 2:7 provided the best precision, with 
rmsC  = 0.47 ± 0.27 mm. Image quality and 
definition were maximized with zooming and enhanced the calibration precision. However, 
for the calibration transform to be estimated adequately with zooming, care had to be taken 
to note the (x, y) position of the zoomed ROI within the whole US scan plane. 
We also noted in this study that it was difficult to align the scan plane with the Z-
fiducials because the finite US beam thickness (elevational resolution) caused point targets 
to appear in the B-scan even if they were not exactly in the mid position of this scan 
dimension [179]. Thus, dots that resulted from the intersection of Z-fiducials with the 
scanning beam appeared as smeared ellipses. This US beam offset could render the 
segmentation of Z-fiducials challenging in B-scans, and affect 
rmsC . In summary, the most 
repeatable calibration transform should be identified before scanning a vessel, and this 
requires testing different US image settings. Nevertheless, the results do not guarantee 
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accurate reconstruction of a lower limb artery because this measure only represents the 
consistency of the calibration parameters and not their accuracy. 
4.6.1.1 Comparison with the literature 
Calibration precision provides a measure that allows a fair evaluation of 3D-US 
system advantages and limitations. Previous Z-phantom studies with 3D-US freehand 
systems have reported similar findings as our 0.60-mm RMS (Root Mean Square) (600 
measures) calibration precision at 7 cm US image depth, no zooming, with a 10-MHz linear 
array [178-181]. Precisions of 1.0-4.5 mm and 1.0-2.0 mm RMS (20 image samples each) 
have been obtained for the electromagnetic sensor system at respectively 9 and 16 cm US 
image depths with a 3.5-MHz sector-phased array [179]. For the optical tracking system, 
precisions of 0.7 mm and 1.2 mm (10 image samples each) have been presented for US 
image depths of 8 and 15 cm, respectively, using a 3.75-MHz curvilinear probe [180]. Still, 
other similar studies with a 7.5-MHz curvilinear probe have found this measure to 
deteriorate to 1.6-2.7 mm (36 measures) between 6-12 cm US image depths [187], or, 
alternatively, to improve to 1.04 ± 0.84 mm (1,830 measures) with a 10-MHz linear probe 
array [178]. While our results seem to perform better than these previous studies (especially 
when zooming is considered), comparison between other reports should be undertaken with 
caution because differences do exist in the US echograph, probe frequency, image settings, 
3D tracking device, and performance evaluation method utilized. In comparing precision 
for different 3D-US calibration methods [71], smaller values were obtained when it was 
computed as the residue of the non-linear minimization problem of Eq. (11) [78, 183], or, 
alternatively, when it was assessed as an average measure [177, 178, 180, 187] rather than a 
RMS. It is noteworthy that most recent studies in 3D-US calibration present calibration 
precision as an average metric; our results would definitely be artificially improved if they 
were computed this way. 
Calibration precision also depends on probe motions. It has been shown that 
acquisitions by linear translation of the probe give significantly better precision than 
acquisition by titling [178] which is a difficult task to achieve in freehand tracking. In 
addition, the reproducibility of calibration is limited in freehand. To ensure reproducible 
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3D-US freehand results, a pivoting cradle for mechanical sweeping was even incorporated 
into the probe calibration procedure in [181]. The robotic scanner has the advantage of 
being repeatable in scanning paths for US image acquisitions . This key feature is what 
permitted the in-depth analysis of US image parameters to characterize calibration 
performance. 
Another benefit in this study is our adaptation of the Z-phantom with micrometer 
size non-water absorbable material wire (i.e., polypropylene). Previous studies showed 
drawbacks in identifying Z-fiducials in US images [179, 180]. Smaller wires (i.e., 0.2-mm 
diameter), higher frequency probes (i.e. 10 MHz) [178], or mounting a thin rubber 
membrane on top of the Z-phantom were thought to improve this task [180]. Better 
calibration precision was achieved in our study compared to prior works. 
In the literature on robotics, calibration precision can be compared with a limited 
number of studies. Using the same 3D-US robotic system and a 10-MHz US linear probe at 
a 6 cm US image depth, an improvement in precision to 0.93 mm RMS (600 observations) 
has been obtained with the Z-phantom compared to the X-wire calibration method that 
allowed us to obtain a 3.5 mm RMS precision (76 observations) [148]. Moreover, our 
system showed a better precision at 0.58 ± 0.36 mm RMS (600 observations) for a 8 cm US 
image depth compared to another robotic system evaluation with a plane wire calibration 
method that achieved 1.23 ± 0.65 mm (780 observations) [176] mean precision with a 14-
MHz linear array probe at the same image depth of 8 cm. 
Some disadvantages exist with the Z-phantom calibration procedure. Our method 
was tedious because segmentation of wires was manual and images contained speckle 
noise. Automatic segmentation methods of Z-fiducial collinear points in predefined search 
regions have already been developed, but these approaches are known to have larger 
variations than a manual operator [178, 180]. These promising algorithms could enhance 
the efficiency of Z-phantoms if segmentation becomes more robust. Also, errors are 
introduced into the calibration performance when the medium (polypropylene wires 
immersed in water) has a different speed of sound than human tissues (1540 m/s) assumed 
by the US scanner [71, 180]. The speed of sound impact on calibration has not been 
explored in this study because we judged it to be minimal. 
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Finally, in this work, we have demonstrated that satisfactory results could be 
achieved with a Z-phantom to calibrate a 3D-US imaging robot. Precisions favorably 
comparable to other studies have been obtained for different US image settings. In clinical 
practice, the calibration procedure needs to be fast and repeatable. To improve efficiency, 
this calibration procedure should be performed only once to characterize US image settings 
that match the target clinical application. A special adapter that ensures repetitive and 
precise attachment between the robot handle and the US probe should be conceptualized for 
this purpose. Also, a robust automatic segmentation algorithm should be used with 
typically gel-based agar incorporated into the Z-phantom to reduce US image artifacts due 
to possible reverberation. Another alternative would be to use raw digital radiofrequency 
signals [188, 189] instead of B-mode images to improve segmentation. However, this 
would require further hardware and software developments into the 3D-US robotic system 
and post processing of RF signals. 
4.6.2 3D reconstruction performance evaluation on a lower limb-
mimicking artery 
In this study, reconstruction accuracy to represent a 3D vessel geometry was 
evaluated between 0.40 and 1.74 mm (Table 8) with significant differences observed for all 
US image settings investigated. Vessels reconstructed were more accurate at smaller depths 
(0.87 ± 0.08 mm) even if the calibration transform used provided less precision under these 
conditions (Table 7). This can be attributed to the higher pixel density around the vessel at 
smaller depths; the “disease-free” vessel lumen covered a range from 3 to 3.8 cm within the 
phantom. According to Table 8, the optimum reconstruction was obtained by placing the 
focus beam depth slightly below the vessel, at 4-5 cm. Reconstruction accuracy was the 
best when the depth setting of 7 cm was zoomed at 3:7 (0.40 ± 0.03 mm). This result was 
not anticipated, as the highest magnification 2:7 zoom was expected to provide the best 
reconstruction accuracy because the optimum precision of 0.47 mm was obtained for these 
settings. Poorer accuracy can be produced by US image artifacts becoming larger with 
zooming. 
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Area is another measure that we used to express the accuracy of the 3D vessel 
geometry. Most area profiles showed underestimations with 2 axisymmetric stenoses 
spaced apart at approximately the same distance for different US image settings (Fig. 4.7). 
This information reveals distortions in vessel shape where an oval and near elliptical 
geometry could be reconstructed. At 7-cm depth, 4-5 cm focus beam depth and 3:7 zoom 
setting, reconstructed vessels showed the best fidelity to the circular gold standard 
geometry. These observations reflect reconstructed accuracies of Table 8. 
Overall, errors in vessel representations are attributed to the phantom fabrication 
process, segmentation of US images, robot intrinsic performance, and to the reconstruction 
procedure. Firstly, the fabrication process of the vascular phantom has -1.4% error in 
diameter [163]. This small contribution may nevertheless be important because the gold 
standard geometry was based on this model. Secondly, the segmentation algorithm used to 
detect the vessel lumen was adapted from a method implemented for IVUS images [41]. 
The segmentation accuracy in our images remains unknown and not comparable to IVUS 
reports. A slight error of a few pixels in segmentation can translate into errors of some mm 
in 3D vessel representation. Thirdly, another contributor to the vessel reconstruction quality 
is the robot performance in localizing an object in space. As reported earlier [148], our 
robot has a positioning accuracy of 0.46-0.75 mm that is repeatable at 0.20 mm, and an 
inter-distance accuracy of 0.26-0.61 mm. Among these performance measures, only the x, 
y, z inter-distance accuracy can be compared with reconstruction errors reported in Table 8 
(0.40-1.74 mm). As expected, reconstruction errors were slightly larger than the robot inter-
distance accuracy because the former measure includes all together the abovementioned 
contributing uncertainties (i.e., phantom, segmentation and reconstruction performances). 
Because 3D vessel reconstructions were co-registered with the gold standard vascular 
phantom geometry before assessing errors of Table 8, the robot positioning accuracy and 
repeatability are less relevant in this discussion. Lastly and to conclude this section, we 
support the hypothesis that the reconstruction procedure was the main source of error of 
Table 8 because it derives directly from the accuracy of the calibration transform (Eq. (11)). 
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4.6.2.1 Comparison with the literature 
The 3D lower limb-mimicking artery was evaluated for different calibration 
transforms. Performance was assessed in terms of distance (reconstruction) accuracy and 
areas. Other similar calibration studies but with different calibration methods (i.e., X-wire, 
wall, three-wires, Cambridge phantom, etc…) also examined performance of 3D-US 
systems in distance accuracy but only on 1-D or 2-D reconstructed feature-based target 
points from the calibration phantom itself or from a simple independent geometric object 
(e.g. balloon or pin heads). We summarize their results relative to our 0.87-1.74 mm 3D 
vessel reconstruction accuracy obtained for the 5 to 8 cm US image depths, fixed 4-5 cm 
focus beam depth and no zooming (Table 8). Recall that our findings were obtained with a 
10-MHz linear array probe for 10 vessel reconstructions (approximately 6,000 points per 
reconstruction). 
Z-phantom studies with an electromagnetic freehand tracking and a 3.5-MHz 
phased array have reported 0.23 ± 2.89 mm distance accuracy for 960 inter-steel bead 
measurements at 9 cm US image depth [179], whereas inter-Z-fiducial analyses using 
optical freehand tracking devices with a 10-MHz linear array probe had 1.15 ± 0.43 mm 
distance accuracy for 810 measurements at 8 cm US image depth [178]. Other Z-phantom 
studies report results for inter-targets and feature length measurement accuracy between 0.2 
and 1.2 mm with optical systems and probes ranging from 3.5 to 7.5 MHz at 6-12 cm US 
image depths with less than 30 samples [181, 183, 187]. 
Moreover, alternative phantom calibration methods (i.e., X-wire, wall, three-wires, 
Cambridge phantom, etc…) with electromagnetic and optic freehand tracking devices in the 
literature have inter-target distance accuracies that range from -0.19 µm to 3.0 mm [71, 78, 
161, 177, 180, 185]. Of course, it is not possible to directly compare the accuracy of all 
these studies to our results because many differences exist in calibration phantoms, US 
probe frequencies, US image settings and distance accuracy metrics. 
Generally, performances of our calibrations for accurate vessel reconstructions are 
of similar magnitude as the inter-target distance accuracy reports of 3D-US optical systems 
(best positional accuracy [71]). Electromagnetic systems seem to show significantly better 
 110 
results in inter-target distance accuracy than other systems. However, most of these 
reported measures in the literature are misleading because unsigned values are computed 
into their average, thus improving their overall accuracy. Also note that valid clinical 3D-
US system accuracy cannot be extrapolated from these inter-target measures because they 
have no relation to the clinical context aimed. 
Studies performed in clinic with 3D-US freehand systems have preferred to directly 
show the clinical potential of their technologies for monitoring human vessel pathologies 
over time [100, 190-192]. Because most studies have not validated their 3D reconstruction 
with a gold standard, the validity of their 3D systems to accurately represent a 3D geometry 
is unknown, and if they did [99], no information is available to assess the calibration 
method used and its performance. Consequently, diseased vessels can be misdiagnosed 
when unidentified systematic errors intermingle with the pathology in their 3D 
representations. 
Also, our study has the advantage of being comparable to 2 others that employed a 
similar vascular phantom and the same US scanning equipment and probe. In the first 
investigation, the accuracy to reconstruct vascular phantom diameters varied between                
-0.37 and -0.90 mm at 6 cm US image depth with a previous X-wire calibration method and 
the same 3D-US robotic imaging system [148]. In our experiment, reconstruction accuracy 
was 1.20 mm at this particular depth. The results varied between studies because of the way 
measurements were assessed. In , the diameter at specific cross-sections of the 3D 
representation was taken into account and evaluated on gold standard geometry with micro-
caliper measures (unsigned errors). In the current paper, entire points of surface 
reconstruction were assessed on gold standard geometry, and 10 reconstructed samples 
were computed for the mean measure. Evidently, the present report is more rigorous than 
our previous work in [148] to validate the 3D-US imaging robotic system. The second 
study, with similar vascular phantoms, evaluated in-stent restenoses in vitro with an 
electromagnetic system and a linear step motor for 3D reconstructions [193]. A value of  
1.0 ± 0.1 mm RMS calibration accuracy was achieved with the STRADWIN software at 
4.5 cm US image depth with no available information on zooming and focus beam depth. 
Our system showed better results with 0.87 ± 0.08 mm reconstruction accuracy at 5 cm US 
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image depth. However, the in vitro in-stent restenoses study provided no information 
relative to precision analysis of calibration parameters. Thus, their suggestive results 
remain inconclusive and not equivalent. 
The goal of calibration is to find the correct (or optimum) transform that allows 3D 
geometry to be reconstructed accurately. Our study attained this objective by evaluating the 
performance of different US image settings that affect calibration transformation accuracy 
to reconstruct a 3D lower limb-mimicking artery. Our validation was the first of its kind for 
lower limb 3D-US vessel reconstruction. In this work, reconstruction errors and cross-
sectional areas completely allowed the quantification and identification of distortions 
obtained with the robotic scanner on our 3D vessel representations. Future analyses will 
include the reconstruction of complex lower limb arterial geometries, multimode imaging 
comparisons, stenosis quantification, and a possible clinical study to demonstrate the 
benefits of this robotic scanning system. 
4.7 Conclusion 
The 3D-US robotic scanner was validated to adequately reconstruct a 3D lower 
limb-mimicking artery. A Z-phantom calibration procedure was completed with this robotic 
system and, as a result, calibration transforms were characterized with US image settings 
according to precision and 3D reconstruction accuracy. Calibration precision was found to 
perform best at deeper US image settings with focus beam depths corresponding to target 
Z-fiducials located on the US scan and at the highest zoom. Reconstruction accuracy was 
evaluated in terms of distance accuracy with respect to a gold standard geometry of a 
vascular phantom. The cross-sectional area was also analyzed along the length of the 
reconstructed vessels. Optimum US settings to accurately reconstruct the vessel were at 
lower US image depths, a focus beam depth slightly below the vessel, and a mid-sized 
window zoom to reduce artifacts. These results are likely suitable for the clinical evaluation 
of stenoses. Further developments and validations of the robotic system are nevertheless 
necessary to provide a platform that would meet clinical needs. 
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Chapter 5 
A 3D ultrasound imaging robotic system to detect and 
quantify lower limb arterial stenoses: in vivo feasibility 
 
A painter told me that nobody could draw a tree 
without in some sort becoming a tree; or draw a child 
by studying the outlines of its form merely . . . but by 
watching for a time his motions and plays, the painter 
enters into his nature and can then draw him at every 
attitude . . . 
 
Ralph Waldo Emerson 
 
5.1 Forward 
This chapter presents the submitted paper in the journal IEEE Transactions on 
Biomedical Engineering by the authors Marie-Ange Janvier, Louise Allard, Gilles Soulez 
and Guy Cloutier30. 
This paper describes the methods developed to evaluate the robotic system’s ability 
to localize and quantify arterial stenoses. An in vitro study is first performed on a lower 
limb mimicking vascular phantom with a realistic geometry. Then, the feasibility in vivo is 
executed on a lower limb artery. The CTA is employed to analyse the geometry and to 
localize stenoses. 
 
                                               
30
 The co-authors Gilles Soulez and Guy Cloutier are the supervisors of the thesis. The co-author Louise 
Allard helped in structuring the experimental design, organizing and editing the manuscript. 
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5.2 Abstract 
The degree of stenosis is the most common criterion used to assess the severity of 
lower limb peripheral arterial disease. 2D-ultrasound (US) imaging is the first-line 
diagnostic method for investigating lesions, but it cannot render a 3D map of the entire 
lower limb vascular tree required for therapy planning. We propose a prototype 3D-US 
imaging robotic system that can potentially reconstruct arteries from the iliac in the lower 
abdomen down to the popliteal behind the knee. A short, realistic, multimodal vascular 
phantom was first conceptualized to evaluate the system’s performance in vitro. Geometric 
accuracies were assessed in surface reconstruction and cross-sectional area in comparison 
to computed tomography angiography (CTA). Mean surface map error of 0.55 mm was 
recorded for 3D-US vessel representations, and cross-sectional lumen areas were congruent 
to the CTA geometry. In vitro, stenotic lesions were properly localized and severe stenoses 
up to 98.3% were evaluated with –3.6 to 11.8% errors. The system’s feasibility in detecting 
in vivo stenoses on a femoral artery segment was also investigated clinically and compared 
to CTA. Altogether, these results encourage future developments to increase the robot’s 
potential for adequately representing lower limb vessels and clinically evaluating stenotic 
lesions for therapy planning and recurrent non-invasive and non-ionizing follow-ups. 
5.3 Introduction 
Atherosclerosis is the principal cause of peripheral arterial disease (PAD) that forms 
diffuse lesions in lower limb vessels [7]. An arterial diameter reduced by more than 50% 
represents a significant stenosis where invasive therapy (i.e., endovascular or surgical 
revascularization) could be judged necessary [194]. Usually, these procedures require 
planning with precise information on stenosis severity, location, length and non-diseased 
vessel diameter. It is common to follow the patency of endovascular or surgical therapies to 
detect restenosis or progression of atheroslerosis [195]. Indeed, the rate of restenosis after 1 
year following balloon dilatation and stenting of the femoro-popliteal artery is around 40 to 
60 % [52]. The patency of vein graft bypass also requires long-term surveillance because of 
the occurrence of stenoses due to myointimal hyperplasia [196]. 
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Ultrasound (US) is the first-line imaging method employed clinically to investigate 
lower limb arterial lesions. Diagnosis relies on pulsed-wave Doppler and color Doppler 
flow assessment, and B-mode imaging to define atherosclerotic plaque morphology [26]. 
Because most US-based evaluation methods are limited to 2D image plane views, they do 
not provide sufficient information to guide interventional therapies. Following screening by 
US, symptomatic peripheral arterial disease requiring invasive therapy  are planned with 
computed tomography angiography (CTA), magnetic resonance angiography (MRA) scan 
or invasively with digital subtraction angiography (DSA) [26, 194]. While these latter 
imaging techniques can map the entire lower limb vascular tree in 3D rendering, CT 
imaging is ionizing and requires injection of allergenic iodine contrast agent, whereas MRA 
is costly. The gadolinium-based contrast can induce nephrogenic systemic fibrosis in 
patient with renal failure and its accessibility is limited by several contra-indications related 
to high magnetic field. Given the importance of quantifying stenoses and mapping their 
localization for therapy planning and patient follow-up, the development of a precise non-
invasive US-based 3D mapping technique is of clinical importance for lower limb vascular 
evaluation. 
 
3D-US imaging is an economical and safe technology mainly used in research for 
anatomical or volumic representation. Since it can provide the physician with a complete 
mapping of lower limb vessel, it has the potential to increase diagnosis confidence and 
provide accurate stenosis localization and quantification. Already, in vivo feasibility in 
imaging carotid arteries, lower limb venous bypass and the brachial plexus (i.e., nerve 
fibers running from the spine that runs to the neck, armpit and the arm) have been 
demonstrated using 3D-US systems based on linear step motors, electromagnetic and 
optical freehand tracking techniques [91, 99, 111, 197, 198]. These devices are ideal to 
localize lesions on short segments, but the restricted range of probe motion detection, signal 
interference or tracking visibility limits their utility in long and tortuous lower limb arteries 
[106, 155, 173]. 
 
Robotic systems represent a novel alternative for lower limb stenosis location and 
quantification because they can simultaneously control and standardize the 3D-US image 
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acquisition process with high precision and flexibility. While most 3D-US prototype robots 
attempt to increase the capability of clinicians in prostate brachytherapy and tele-
echography of the abdomen [175, 199, 200], only two designs exist for vascular 
examination. Hippocrate is the first feedback medical robot designed with safety strategies 
to scan short vessel segments, such as the carotid artery, and to perform tonometry 
measurements synchronized with the heart rate [140]. To the best of our knowledge, no 
other follow-up study has been conducted with this robot besides a non-invasive 
investigation of endothelial function [141]. In fact, the robot’s mechanical architecture was 
later adapted to a new design for reconstructive skin surgery [201]. The University of 
British Columbia’s medical US image-guided robot is designed for performing tele-
examination scanning of the carotid artery [146]. Shared control between operators, the 
robot controller and US image processor make the real-time visual servoing of US probe 
movements possible.  Nevertheless, this robot’s architectural design has constrained 
movements in its workspace and a limited 3 degrees of freedom controller because it is 
specialized for short, close to rectilinear paths such as the carotid artery. 
 
To provide accurate 3D-US scanning of lower limb vessels, a 3D-US imaging robotic 
system was developed by our group [148]. The system can scan short and long segments of 
leg arteries in “freehand”, using a ‘teach’ mode, and reproduce the manually-taught path in 
‘replay’ mode. When scanning along a path with this robot, clinicians can expect to acquire 
2D axial US images with their corresponding x, y and z positions at a constant speed and 
contact pressure to correctly represent vessels in 3D. The robust positioning accuracy and 
repeatability achieved previously over the robot’s entire workspace disclosed the broad 
operational range of our system for tracking lower limb vessels [148]. Also, we recently 
showed, with a Z-fiducial calibration procedure, that we could adequately register 2D-US 
images into our robot referential to reproduce a mimicked axisymmetric vessel artery with 
fidelity [202]. The present study aims to demonstrate the performance efficacy of this 
robotic system under conditions closer to the clinical context. Two objectives were 
targeted: (1) to assess the accuracy of the robotic imaging system in vitro in locating and 
quantifying lower limb vessel stenoses with a phantom mimicking a realistic geometry; and 
(2) to evaluate the ability of this robotic imaging system for 3D mapping of a diseased 
femoral artery in vivo. For both objectives, 3D US reconstructions were compared with the 
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CTA as a gold standard examination. 
5.4 Materials and methods 
5.4.1 3D-US imaging robotic system 
As illustrated in Fig. 5.1, the 3D-US imaging robotic system contains a robotic arm 
(F3 Articulated Robot, CRS Robotics Corporation, Burlington, Ontario, Canada), an US 
echograph and a personal computer with the US robotic scanner software (Integral 
Technologies Inc., Laval, Quebec, Canada). A Vivid-5 scanner (General Electric, Chicago, 
IL, USA) equipped with a FLA-10 (10 MHz) linear array probe was used for in vitro 
experiments, whereas a HDI-5000 (Philips Healthcare, Andover, MA, USA) with a L12-5 
(12 MHz) linear array probe allowed scanning the patient with lower limb arterial disease. 
Digitized 480 x 640 pixel format B-mode and color Doppler flow images were acquired 
with corresponding robotic arm positions stored for future 3D reconstructions. This robotic 
system has previously been described in details [148]. 
 
 
                        
Figure 5.1: F3 CRS robotic arm used in the 3D-ultrasound (US) imaging robotic system. 
 
 
Where the US probe 
is attached to the 
robotic arm 
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5.4.2 In vitro analysis of a realistic vessel segment 
5.4.2.1 Vascular phantom and experimental set-up: 
The geometric accuracy of the robotic system in reconstructing 3D vessels was 
evaluated with a phantom replicating a human iliac artery with multiple stenoses. This 
model was created from a 3D reformation of a multi-detector computed tomography (CT) 
scan acquisition in a patient with a peripheral arterial disease of the iliac artery. The 
phantom was prepared according to a manufacturing process described previously [203]. 
Fig 5.2 shows a 3D vessel representation obtained from the CAD (computer-aided design) 
file employed to prepare the moulding prototype. This segment presents two severe 
stenoses identified as S1 and S2 with 97.3% and 98.3% area reductions, respectively. The 
vessel’s central axis at both ends was positioned at 3.4 cm from the top cover of the 
phantom box; it was 4.0 cm at the location identified on the figure (Fig. 5.2b), and the 
length L of the scanned iliac segment was 98.7 mm from the aortic bifurcation. 
 
Dimensions of CAD 3D representation of the vessel were measured on cross-
sectional planes. The maximal diameter of the non-diseased vessel segment was D = 6.5 
mm and the minimum diameters at stenoses were S1 = 1.4 mm and S2 = 1.2 mm (Fig. 
5.2a). Lengths of stenoses were measured as the distance between pre-stenotic and post-
stenotic maximum vessel diameters (L1 = 14.0 mm and L2 = 28.1 mm). The distance 
between maximum diameter reductions at both stenoses S1 and S2 was LS = 20.0 mm. 
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Figure 5.2: (a) CAD representation of a realistic vascular phantom embodying an iliac artery with 2 severe 
stenoses (S1 and S2). L1 and L2 represent their respective lengths, and LS, the shortest distance between 
maximal points of the stenoses. L is the total length of the vessel and D is the non-diseased vessel diameter. 
(b) B-mode cross-sectional image of the vascular phantom where its location is indicated by an arrow in (a). 
The shadowing on the B-mode image is attributed to the presence of a polyurethane membrane mimicking the 
vessel wall and used to avoid the diffusion of CTA contrast outside the vessel lumen. 
 
5.4.2.2 3D-US vessel representation  
As in [202], a Z-phantom calibration procedure of the 3D-US imaging robotic 
system was first required to assure correct vessel representation. This procedure estimates 
the calibration transform that registers the US image plane into the robot referential. Then, 
the vascular phantom filled with degassed water was set firmly into the robot’s workspace. 
US gel (Parker Laboratories, Fairfield, NJ, USA) was applied on the phantom’s top cover, 
and US images were acquired at a 7-cm image depth, a 4-5-cm single focus beam depth and 
a 3-cm window size zooming (3:7 setting on the Vivid-5 scanner) to match scanning 
conditions producing the best accuracy for 3D vessel representation [202]. Then, a quasi-
parallel plane US scan path was taught to the robot by a technician and automatically 
replayed 8 times. During the robot ‘replay’ mode, cross-sectional US images of the 
mimicked diseased artery were captured to reconstruct 8 3D representations of the vessel 
with surface rendering. For 3D reconstruction, the vessel lumen of each US image was 
segmented with a fast-marching method based on gray level statistics and gradients adapted 
from [41]. Then, each pixel of the segmented lumen contour was mapped into the robot 
referential using the calibration transform and corresponding x, y, z probe positions [202]. 
To provide a 3D surface rendering of the reconstructed vessel, the transformed lumen 
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contours were re-sampled on a 300 × 20 rectangular grid, interpolated and realigned normal 
to the vessel center axis, as in [184]. 
5.4.2.3 CTA representation of the vessel 
Because CTA imaging has the best accuracy for PAD evaluation [26], a Somatom 
Sensation 64-slice scanner (Siemens, Erlangen, Germany) was utilized to acquire images of 
the vascular phantom according to a standard clinical protocol. The imaging settings were: 
217-mA current density, 120-kV peak voltage, 1.0-mm slice thickness, 0.6-mm 
reconstruction interval, and 38.0-cm field of view for a 512 × 512 matrix size. The phantom 
lumen was filled with a 2.8% v/v (volume concentration) solution of 430 mg/ml 
iothalamate meglumine (Conray 43, Mallinckrodt Medical, Pointe-Claire, Quebec, Canada) 
diluted in 0.9% NaCl solution. 3D-CTA image representation was achieved with a 
maximum intensity projection (MIP), a volume rendering reformation and 2.0-mm axial 
reformations, with the Visual software (version 1.4, Object Research System (ORS), 
Montreal, Quebec, Canada). This representation was later transformed into a 3D binary file 
that was converted into 3D contour points with MatLab (version 6.5, The MathWorks Inc., 
Natick, MA, USA). 
5.4.2.4 Geometric evaluation of 3D vessel representations 
The reconstructed lumen surface, vessel cross-sectional areas, localization and 
quantification of stenoses imaged with the 3D-US robotic system were compared to the 
CTA gold standard method. Given that each imaging approach presents its own sources of 
errors, accuracy in 3D vessel representation was also determined with the CAD file used to 
produce the vascular phantom. 
5.4.2.4a Comparative analyses of the reconstructed surfaces 
Before comparing vessel geometries, a rigid registration was performed by using an 
iterative closest point algorithm to align the two 3D vessel models [204]. This method, 
applied on free-form curves, surfaces and 3D-shapes, efficiently matches 2 ranges of data 
points without requiring pre-processing or feature extraction. The algorithm uses a closest 
point estimation method and an iterative absolute orientation algorithm [205]. The result is 
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an optimal transformation matrix (translation and rotation) that minimizes the mean square 
distance between the two 3D models. 
 
Surface reconstruction errors were evaluated by measuring the absolute distance 
between points on the 3D evaluated geometry and on the gold standard vessel 
representation, as expressed by: 
),,(),,(
,,
kjiSkjiSE reftestedkji −=  (17) 
where Stested is the surface points of the 3D reconstructed vessel evaluated, Sref is the surface 
points of the reference method, 1 ≤ i ≤ X where X is the number of grid points along the x 
axis, 1 ≤ j ≤ Y where Y is the number of points along the y axis, and 1 ≤ k ≤ Z where Z is the 
number of points along the z axis. If the number of cross-sections differs between US, CTA 
and CAD 3D models, Eq.(17) uses for reference the representation with the minimum 
longitudinal distance X. For all comparisons of 3D reconstructions between US (B-mode, 
color flow), CTA and CAD files, the absolute value of this measure was tabulated into one 
mean (sample size = X × Y × Z where chosen dimensions were those of the reference 
model).  
5.4.2.4b Lumen cross-sectional areas 
Cross-sectional areas were measured along the x-axis of each 3D-reconstructed 
vessel on US (B-mode and color flow) and CTA, and on the CAD file. The area was 
evaluated with Polyarea, a polygon-specific function of Matlab, which computes the 
average number of pixels inside a clockwise closed contour. For all 8 US reconstructions, 
the mean ± standard deviation of cross-sectional areas were assessed over the vessel length 
(sample size = X, which is the number of cross sections). 
5.4.2.4c Localization and quantification of stenoses 
Stenoses were localized at perceived stenotic sites. Quantification of stenoses was 
described as the percentage of lumen reduction compared to a reference vessel in surface. 
This measure, Sarea, was expressed by Eq. (18) and was evaluated with respect to the known 
degree of vessel narrowing, as determined by the CAD file of the 3D vessel representation 
(see S labels in Fig. 5.2). 
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where iA  defines the area of a cross-sectional vessel lumen, DA expresses the reference 
measure where the maximal value is identified in the non-diseased vessel segment (see 
label D in Fig. 5.2). The degree of stenosis was the maximal quantified value at the stenotic 
site. Dimensions of stenoses were measured in terms of length using the CAD file 3D 
representation of the vessel for reference (see Section 5.4.2.1 and labels L1, L2 and LS in 
Fig. 5.2). 
5.4.3 In vivo feasibility study 
5.4.3.1 3D-US imaging robotic system: experimental set-up, data acquisition and 
processing 
To evaluate the feasibility of the robotic system, a pilot study was conducted on 1 
patient, an 82-year-old man with evidence of occlusive PAD, as shown by a previous CTA 
exam. The study received approval from our institutional review board, and informed 
consent was obtained from the patient. 
The volunteer lay supine with the target limb rose at the height of a supportive 
pillow. The radiologist first manipulated the US probe attached to the robotic arm in “teach 
mode” (i.e., a mode enabling the learning of a “freehand” scan with minimum torque 
applied on robot articulations) to inspect the femoral artery, starting from the femoral 
bifurcation down to the distal femoral artery. Both B-mode and color Doppler flow exams 
were performed in teach mode to store the femoral artery’s path. These taught trajectories 
were then replayed by the robot at a constant speed with x, y, z coordinate registration for 
each acquired cross-sectional image. 
US image settings in both B- and color flow modes were an image depth of 6 cm, a 
2-4 cm focus beam depth and no zooming. In B-mode, the scan path was close to 
perpendicular with respect to the vessel longitudinal axis. In color flow mode, optimal 
angles allowing Doppler shift to fill the vessel lumen, according to the perception of the 
clinician, were chosen along the scan path (the mean angle was determined in post-
processing from the x, y, z coordinates of each acquired image and it was 54.4o). The wall 
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filter was set to 87 Hz. The patient’s leg remained seemingly immobile throughout the 
entire examination but movements were not monitored. Collected images were then 
analyzed and processed for 3D vessel reconstructions according to the same methods 
described for the in vitro study in Section 5.4.2.2. 
5.4.3.2 CTA: Experimental set-up, data acquisition and processing 
The lower limb CTA exam was performed with the same scanner and afore-
mentioned parameter settings as in the in vitro study (see Section 5.4.2.3). The patient was 
placed in a supine position, feet-first in the scanner with legs at the isocenter and a sweep 
was executed from the abdominal aorta to the patient’s foot with a 40.0-cm field of view. A 
120 cc bolus of a non-ionic contrast agent Omnipaque 370 (iohexol 370 mg iodine/ml, GE 
Healthcare, Buckinghamshire, UK) was injected at a rate of 4 cc/s with an intravenous 
superficial brachial catheter. Collected data were processed to reconstruct in 3D the right 
femoral artery with the method outlined in Section 5.4.2.3. Calcifications in CT scans were 
excluded from the vessel lumen based on threshold methods.  
5.4.3.3 Geometric evaluation of 3D vessel representations 
Geometric analyses of the lower limb femoral artery reconstructed from US and 
CTA images were conducted by aligning the corresponding segment from the femoral 
bifurcation. The reconstructed surface and lumen cross-sectional areas were then compared; 
quantification of stenoses was also performed. All methods for 3D rigid registration and 
performance assessment metrics were described earlier in the in vitro study of Section 
5.4.2.4.  
5.4.3 Statistical analysis 
Pairwise analysis of variance tests (ANOVA) were performed with the Bonferroni 
method for geometric analyses of in vitro 3D vessel comparisons between the 3D-US 
imaging robotic system, the CTA scanner and the CAD file. These comparisons were also 
assessed in vivo between B-mode and color Doppler flow geometries. All statistical 
analyses were completed with OriginLab (version 7.5, OriginPro, Northampton, MA, 
USA). Results are mean ± one standard deviation. 
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5.5 Results 
5.5.1 In vitro analysis of a short, realistic vessel segment 
5.5.1.1 Comparative analyses of 3D vessel representations 
Figure 5.3 gives examples of the vascular phantom lumen imaged with the 3D-US 
system in B-mode and CTA scanner, and the corresponding gold standard CAD file. Table 
I tabulates the total artery length and surface area of these three vessel maps. 3D-US 
provided the shortest vessel representation and the smallest surface, whereas CTA had the 
largest surface area when compared with the CAD file. Figure 5.4 presents comparative 
surface error maps for CTA and 3D B-mode US comparisons, CAD versus 3D-US and 
CAD versus CTA. For 3D B-mode US assessment, 8 reconstructions were used for 
comparisons and results were tabulated into one mean to display a surface error map. 
Significant differences based on one-way ANOVA were found among all mean surface 
error maps (p < 0.05). 
 
 
 
 
 
 
Figure 5.3: 3D vessel representations of the short, realistic vascular phantom with 2 severe stenoses (S1 
and S2) illustrated by (a) 3D-US, (b) CTA, and (c) the CAD file. 
 
In the displays of Fig. 5.4, surface contour points were compared with the closest 
surface contour points of the reference model. Since the number of cross-sections differs 
between US, CTA and CAD 3D maps, in Eq. (17) the representation with the minimum 
longitudinal distance X was used for reference. Thus overestimations with respect to the 
reference 3D maps (B-mode in Fig. 5.4a and CAD in Fig. 5.4b and c) are shown in green-
S1 
S2 
(b (a) 
S1 
S2 
S1 
S2 
(c) 
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yellow to red; whereas underestimations are displayed in navy-blue to dark blue. Therefore, 
in the evaluation performed between each representation, missing lengths (i.e., missing 
cross-sections) at the extremity resulted in large errors because closest reference surface 
points used in Eq. (17) were enlarged; we kept this information but it should not be viewed 
as an image distortion. 
 
Table 9: Comparative analysis of 3D-reconstructed surfaces  
of the short, realistic vascular phantom 
 
 
3D vessel 
representations 
 
Total length L 
(mm) 
 
Total surface 
(mm2) 
 
Sample size 
(N) 
3D-US (B-mode) 89.4 ± 0.7 1884.5 ± 7.1 8 
CTA 95.9 2073.2 1 
CAD 98.7 2015.9 1 
 
 
As shown in Fig. 5.4a, CTA (tested geometry) provided an overestimated vessel 
representation of the reconstructed surface compared to 3D-US (which is the gold standard 
reference here). The absolute mean error of 8 vessel samples was 0.55 ± 0.04 mm with a 
range of 0.03 - 3.6 mm (these statistics exclude artifacts at the extremity). For each error 
map where the CAD file was the gold standard reference (Fig. 5.4 b-c), the surface 
reconstruction error of the tested geometry generally indicates an overestimation of the 
vessel size, except for B-mode US around the S2 stenotic site and the non-diseased area for 
the CTA where an underestimation is noted. 3D-US (B-mode) had an absolute mean 
surface error of 0.96 ± 0.54 mm (Fig. 5.4b, range of 0.06 to 3.6 mm,). CTA disclosed the 
smallest errors of 0.60 ± 0.39 mm (Fig. 5.4c, with a range going from 0.05 to 2.2 mm). 
 
Figure 5.5a shows an example, from one B-mode US reconstruction, of the cross-
sectional lumen x, y, z orientation along the vessel axis, whereas Fig. 5.5b compares 
quantitatively areas obtained in B-mode US (n = 8), CTA and CAD. There was a 
significant statistical difference (p < 0.05) based on one-way ANOVA between each mean 
cross-sectional area along X compared to the CAD file as well as for the 3D-US and the 
CTA comparison. CTA gave the largest representation of the vessel lumen compared to the 
CAD file, with a mean cross-sectional area error of 10.7 ± 11.3 mm2 along X, whereas 3D 
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B-mode US resulted in a smaller mean cross-sectional area error of 4.3 ± 12.6 mm2. The 
3D-US vessel cross-sectional areas compared to CTA had a mean error of -6.4 ± 9.8 mm2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: Comparative analysis between 3D vessel representations of the realistic vascular phantom with 
2 severe stenoses (S1 and S2). (a) On the B-mode 3D-US vessel representation, mean surface reconstruction 
comparison between CTA and 3D-US is displayed. On the CAD file, the respective surface reconstruction 
errors are shown with the (b) 3D-US (B-mode) and the (c) CTA. 
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Figure 5.5: The cross-sectional lumen areas of the 3D-US, CTA and CAD file representations are shown 
for the realistic vascular phantom. S1 and S2 represent severe stenoses and D is the non-diseased vessel 
diameter. 
 
 
5.5.1.2 Localization and quantification of stenoses 
Stenoses S1 and S2 were localized in each 3D vessel representation (Fig. 5.5). They 
were then quantified according in (2) and summarized in Table 10. Both stenoses, in area 
reduction, were better assessed in 3D B-mode US compared to CTA. Table 11 summarizes 
lengths of stenoses; errors were either larger, equivalent or smaller with 3D-US than CTA, 
when compared to the CAD file. 
 
 
S1 
S2 
D 
S1 
S2 
D 
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Table 10: Quantification of stenoses of the realistic vascular phantom 
 
B-mode US (N=8 
samples) 
CTA (N=1 sample) Stenoses 
(%) 
Measurement Error Measurement Error 
CAD S1 
(97.3) 
85.6 ± 6.1 -11.8 ± 6.1 81.5 -15.8 
CAD S2 
(98.3) 
94.8 ± 1.9 -3.6 ± 1.9 91.5 -6.9 
 
Table 11: Lengths of stenoses of the realistic vascular phantom 
 
B-mode US (N=8 
samples) 
CTA (N=1 sample) Length 
(mm) 
Measurement Error Measurement Error 
CAD L1 
(14.0) 
14.4 ± 2.5 0.4 ± 2.5 12.0 -1.96 
CAD L2 
(28.1) 
31.6 ± 2.0 3.5 ± 2.0 29.1 1.0 
CAD LS 
(20.0) 
19.0 ± 2.6 -1.1 ± 2.5 28.1 -1.1 
 
5.5.2 In vivo feasibility study 
Figure 5.6 shows a curved 3D-CTA MPR of the patient’s right femoral artery 
displaying calcification and multiple stenoses. Figure 5.7a provides the CTA vessel 
representation with zooming of the middle segment in panels b & d to show comparisons of 
surface maps with 3D B-mode US and 3D color Doppler US. Corresponding error maps are 
presented in panels c & e, and quantitative assessments of the middle segment total length 
and surface area in each mode are summarized in Table 12. The B-mode 3D vessel 
representation provided a larger surface and length, and Doppler, shorter ones. As reported 
in Fig. 5.7c and 5.7e, both 3D-US vessel representations overestimated the CTA middle 
segment reconstructed surface points (p < 0.05 for both CTA-B-mode and CTA-Doppler 
comparisons). The absolute mean surface reconstruction error using Eq.(17) of the B-mode 
3D vessel representation compared to CTA was 1.82 ± 1.31 mm with a range of 0.02 to 6.1 
mm (Fig. 5.6c). It was doubled for color Doppler, indeed the absolute mean error was 2.99 
± 2.10 mm and the range was from 0.03 to 9.31 mm (Fig. 5.7e).  It is to note that both 
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statistics exclude artefacts at the extremity. Similar conclusions can be made regarding the 
cross-sectional lumen areas evaluated in the middle vessel section in Fig. 5.8. In 
comparison to the CTA, significant differences (p < 0.05, one-way ANOVA) were found 
between the mean cross-sectional lumen area errors in B-mode (13.4 ± 11.1 mm2) and color 
Doppler (25.2 ± 15.4 mm2). Two moderate stenoses of 49.9 % and 56.3 % were quantified 
in the CTA longitudinal segment of [-60, -40] and [-20, 20] mm (see Fig. 5.8). In Doppler, 
the corresponding stenoses were localized at [-40, -20] and [0, 20] mm and quantified to 
71.3 % and 78.6 % respectively. In B-mode, stenoses were localized at [-40, 0] and [0, 20] 
mm with a quantification of 88.9% and 89.8 %. 
 
 
 
 
 
 
 
 
Figure 5.6: A volume rendering 3D reformation of the CTA on patient’s right femoral artery. 
 
Table 12: Comparative analysis of 3D-reconstructed surfaces of the Middle segment of the 
patient’s right femoral artery 
 
 
3D vessel 
representations 
 
Total length 
L 
(mm) 
 
 
Total 
surface 
(mm2) 
 
Sample 
size 
(N) 
B-mode 136.6 2868.6 1 
Doppler 115.8 2431.8 1 
CTA 128.7 2702.7 1 
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Figure 5.7: Entire CTA vessel representation of the patient’s right femoral artery divided in 3 segments: 
proximal, middle and distal (a). The middle segment (from 220-370 mm) is presented in B-mode (b) and 
surface map errors on the 3D-US vessel representation (c). The same middle vessel segment in color Doppler 
flow is shown (d) and the surface map errors of the CTA representation (e) are displayed. 
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Figure 5.8: CTA 3D vessel representation of the middle segment of the patient’s right femoral artery in B-
mode (a) and color Doppler flow (b). The corresponding cross-sectional lumen areas are also presented. 
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 132 
5.6 Discussion 
5.6.1 Analyses of 3D vessel representations 
In this study, in vitro and in vivo 3D-US vessel representations showed geometries 
similar to those obtained with the clinical CTA gold standard. The in vitro investigation 
revealed that 3D-US reconstructed surfaces had a mean difference from CTA of less than a 
mm (0.55 mm); in vivo a larger mean difference of 1.82 mm was noted. Larger errors noted 
at the extremities exist because of differences in length between 3D representations. 
Although comparable B-mode (or color Doppler) versus CTA results were obtained, the 
reliability of computed tomography can be discussed since the true gold standard CAD file 
was available in vitro. CTA overestimated the true vessel size (surface area of 2073 versus 
2016 mm2 for CAD, Table 9; also see Fig. 5.5b). This can be explained by the MIP and VR 
algorithms used for outlining the lumen boundary of CTA images and by the smooth 
filtering applied along the longitudinal axis. With these algorithms, significant loss of 
details in CTA scans can occur because they use only one gray threshold to identify the 
lumen vessel. Consequently, the CTA post-processing techniques are user-dependent [206]. 
In addition, the resolution of CTA limits delineating arteries that are less than 1.2 mm 
[207]. Because the in vitro phantom had stenoses with diameters within this range (1.2-1.4 
mm), even with contrast agent, a loss of details and an overestimation of the lumen surface 
were expected. Regarding 3D-US assessment versus CAD, our findings demonstrated an 
error of 1.13 ± 0.56 mm (Fig. 5.4b, range of 0.06 to 7.1 mm). Reported errors are explained 
by the surface reconstruction procedure of the robotic system explained further in [202].   
 
Some factors can be identified regarding the performance of the 3D-US imaging 
robotic system when comparisons are made either with 3D CTA or CAD mappings. 
Already, there are considerable differences observed between B-mode representations and 
CTA in vitro (Fig. 5.4 and 5.5) and in vivo (Fig. 5.7 and 5.8): the B-mode representation 
was closer to CTA in vitro than in vivo. While different segmentation method was used for 
both CTA scans, it is important to note that the most significant challenge faced with in 
vivo images was to identify the vessel lumen from surrounding tissue and exclude vascular 
calcifications. Thus, errors in segmentation could have been introduced into the in vivo 
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CTA representation. Regarding 3D-US, discrepancies with CTA could results from image 
resolution, number of image samples along the x-axis (longitudinal axis), segmentation of 
the vessel lumen, and 3D calibration precision of the robotic system. Also, contrary to CTA 
representations that were smoothed along the longitudinal axis, our 3D-US mappings were 
presented by juxtaposing raw x, y, z segmentation points of each cross-sectional image 
(e.g., see Fig. 5.5a and Fig. 5.8a and b). Altogether, these errors were found, in a previous 
study, to contribute to up to 0.40 mm in surface points reconstruction and are thoroughly 
discussed in [202]. Other sources of errors could reside in the fabrication process of the 
vascular phantom with reported errors up to 5.7% in diameter compared to the CAD file 
[203]. However, all above mentioned sources of errors do not explain entirely 3D mapping 
discrepancies with CTA or CAD reconstructions, especially in vivo (Fig. 5.8). 
 
An additional challenge in vivo was the presence of calcium within the artery wall 
producing severe acoustic shadowing and preventing the vessel lumen from being 
adequately visualized along its length, thus resulting in unusable data for the 3D-US 
reconstruction. Because color Doppler uses blood flow velocity signals, it could map the 
arterial lumen better than in B-mode. However, it tended to map the vessel lumen outside 
its true boundary because of the sensitivity of this method to the gain setting [30]. Thus, in 
this mode, the segmentation of the vessel lumen was larger, as observed in Fig. 5.8c. 
 
Note that in vivo, the same calibration transform sources of errors (i.e., Z-phantom 
calibration, section 5.4.2.2) were faced as in vitro, except that the location of the calibration 
phantom into the robot workspace was found to have an effect on the 3D vessel dimensions 
and geometry. The Z-phantom calibration was configured to reconstruct accurately a small 
scanning distance of 90 mm into the robot space. In vitro, the position of the Z-phantom 
and that of the scanned vascular phantom coincided, as in [202], whereas in vivo the Z-
phantom was approximately located within the robot workspace. Indeed, the patient’s leg 
was first scanned, markers were indicated on the scanning bed and then the Z-phantom was 
positioned approximately at the location of the middle segment of the femoral artery, 
depicted in Fig. 5.6a. That explains why only the middle segment of the femoral artery was 
reconstructed and compared to CTA. For future works, two solutions are envisaged: either 
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designing a longer Z-phantom matching the length of a typical human leg (with markers on 
the scanning bed to properly position the leg), or repeating calibrations by moving the 
current Z-phantom at different locations on the scanning bed. In addition, because patient 
motion was not monitored in this study, changes in the leg position during acquisition 
might also have contributed to geometric distortions. The robot tags positions in US images 
and assumes the vessel to be static between the freehand teach and automated scanning 
modes. In addition, with movement during scanning, x, y, z image positions might be 
relayed with delay thus incorrectly registering the actual location of the US image in the 
robot referential. Of course, this preliminary in vivo result is not enough to characterize the 
3D-US imaging robotic system, but holds great promise for future clinical perspectives. 
 
5.6.2 Analyses of localization and quantification of stenoses 
Severe in vitro stenoses were detected, localized and quantified (see Fig. 5.5 and 
Table 10). Compared to CTA, the lumen areas of S1 and S2 were underestimated by less 
than 4.1%. The difference was much larger with CAD file representations (see Table 10), 
where stenoses were generally undervalued by up to 11.8%. The difference in stenosis 
quantification was mostly due to the poor assessment of the non-diseased vessel segment, 
where dimensions (in area) were larger with CTA compared to the CAD file and 3D-US 
representations (Table 9 & Fig. 5.5). Also, S2 was more accurately quantified than S1 
probably because in the fabrication of the vascular phantom this segment was more 
congruent to the CAD file (Fig. 5.5). In Table 12, lengths of stenoses in 3D-US and CTA 
representations had errors of similar magnitude with the CAD file (<3.5 mm). In vivo, 
detection and quantification of stenoses on 3D-US vessel representations (both B-mode and 
Doppler) were more difficult because vessel axes did not perfectly overlap with CTA (Fig. 
5.7). It is to note severe stenoses were not easily identifiable as well on the CTA 
representation. Moderate in vivo stenoses were quantified on 3D-US vessel representations 
up to 89.8% in B-mode and up to 78.6 % in Doppler (see Fig. 5.8 zones [-40, 0] and 
[0,20]mm) (the CTA was quantified up to 39.0 % in Fig. 5.8 zones [-60,-40] and                        
[-20,20]mm). This was mostly attributed to differences in the non-diseased geometry 
segment of 3D-US vessel representations. Because the true vessel area is unknown in vivo 
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and because only 1 subject was used, it is premature to conclude on the capability of the 
robotic scanning system to quantify stenoses in patients. 
5.6.3 Comparison to the literature 
5.6.3.1 Analyses of 3D vessel representations 
Reconstruction of an in vitro, realistic vessel segment (89.4 mm length) was 
achieved reliably with the 3D-US robotic imaging system compared to CTA. A mean 
surface-reconstructed error of 0.55 mm, which translates across its length as 0.65% 
variability (% of surface-reconstructed error/length) was reported, and a mean lumen cross-
sectional error of -6.4 ± 9.8 mm2 with respect to CTA was found. In vivo, the middle 
segment of a lower limb artery imaged in CTA was reconstructed with US (136.6 mm 
length). This portion was biased with a mean point surface error of 1.82 mm in B-mode that 
translates across its length into 1.34% variability (% of surface-reconstructed error/length), 
and a mean lumen cross-sectional area error of 13.4 ± 11.1 mm2. The same analyses were 
doubled in value for the color Doppler representation. In the literature, it is difficult to 
compare our results to other 3D-US studies using electromagnetic freehand tracking 
because they have not evaluated the accuracy of their system and focused mainly on 
demonstrating their technology’s potential to monitor pathological changes in reconstructed 
vessels during a fixed period. For example, in a carotid study, 4 asymptomatic subjects with 
almost non-existent atherosclerosis plaque were used to evaluate the reproducibility of a 
freehand system to assess the vessel lumen volume [100]. The carotid artery lumen volume 
had 5% (cm3) reproducibility but only a 1-cm segment of its bifurcation was analyzed. In a 
vein graft investigation, the cross-sectional lumen area was monitored at affected sites (e.g., 
valves and diffused intimal hyperplasia) [196] where in 10 patients, the reproducibility was 
6.9% (2.5 mm2) for lengths ranging from 16 to 75 mm. Other studies examining the carotid 
artery evaluated the reproducibility to 1.4% rms precision in vitro with phantoms that 
consisted of water-filled balloons, and showed the reconstruction of 2 in vivo pathological 
geometries without performing any analyses [192]. Another study validated their 
reproducibility with anthropomorphic pulsatile phantoms of the carotid bifurcation of 
approximately 40 mm in length [99]. Errors in cross-sectional areas were up to -6.5%         
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(-1.5 mm2) and their lumen volume up to -5.5% (-89.9 mm3). The applicability of this 
system was tested in vivo on 4 pathological patients with no image reference for analyses. 
 
All these methods seem promising to reproduce results with high fidelity in vessel 
segments. Our data have also shown comparable reproducibility for vessel reconstruction in 
vitro and in vivo across its length. However, we have also demonstrated the accuracy of 
vessel representations in vitro and compared our in vivo results to a reference model 
produced by another clinical imaging modality. As we have reported, solely assessing 
reproducibility does not verify accuracy in reconstructing the entire vessel geometry. This 
measure just demonstrates stability of the system in reproducing the same 3D 
representation. This sort of assessment is usually biased because the environment is 
controlled and does not represent the clinical context. In our study, we have shown the 
potential to accurately represent lower limb arteries in vitro with a realistic vessel geometry 
by surface-reconstruction analyses and cross-sectional area measurements. We have 
investigated these geometries with CTA, a clinical diagnosis tool with the highest standard 
of accuracy, and assessed errors with the CAD file representing the geometry of the lumen. 
The feasibility of producing a 3D vessel representation of a lower limb superficial femoral 
artery with stenoses in vivo was also tested by emulating, at best, the clinical context. The 
3D-US imaging robotic system to detect, localize and quantify lower limb arterial stenoses 
was presented in full scope in a manner that identifies clinical benefits and pitfalls, and 
further developments required to enhance the clinical application. 
5.6.3.2 Analyses of localization and quantification of stenoses 
Stenoses in this study were detected and quantified in terms of area reduction and in 
lengths. In vitro, stenoses up to 98.3% (corresponding approximately to 82% in diameter) 
were detected with errors <4.1% with respect to CTA (<11.8% error compared to the CAD 
file). In the literature, only a few in vitro studies performed with an electromagnetic 
tracking device had similar objectives. In a saphenous vein bypass graft study, stenoses up 
to 58.0% in diameter reduction were detected with <-1.4 mm accuracy [102]. Using a 
similar tracking device, another study assessed in vitro stenoses up to 70.0% in diameter 
reduction at the bifurcation site of the carotid artery with <3.0% error; in vivo stenoses up 
to 74.0% in diameter reduction were also detected with no gold standard reference [99]. 
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This method quite accurate in vitro was restricted to this small arterial segment, however 
since no other clinical imaging modality was used to verify the in vivo results, only the 
potential of the technology can be claimed. 
Because there is no true reference standard for vessels in vivo, clinical investigations 
are often conducted in multimodal comparison. In our work, we evaluated in vitro and in 
vivo data with CTA. This clinical diagnosis tool is known to accurately detect the presence 
of stenoses in more than 90% of small and moderate-sized arteries, but sometimes 
overestimates the degree of stenosis in heavily-calcified arteries [26]. Our 3D-US system 
had difficulty detecting and localizing severe stenoses in the middle segment of the 
patient`s femoral artery because the geometry was distorted and data was missing. The 
calcified artery was the cause of this problem because strong shadow was observed on US 
images and the lumen was often unidentifiable. It is important to remember for this same 
segment, severe stenoses could not be identified on the CTA vessel representation for the 
same reason.  Still, comparison of our study with others is not appropriate, especially when 
stenosis grading is highly dependent on the examination method and post-processing 
technique [194]. Improvements in stenosis quantification may be achieved in vivo by using 
image compounding because acquiring different US views may improve the signal to noise 
ratio of images. 
Limitations of the robotic arm also include its inflexibility to cover certain areas of 
the patient’s lower limb for the acquisition of cross-sectional US images. It would currently 
not be possible with 1 full scan to cover the entire vascular tree from the iliac to the tibial 
vessels without constraints from the robot’s safety controls and architecture [148]. To 
improve the patient’s lower limb workspace and to comply with safety issues, it would be 
necessary to improve the robot’s kinematics design. A new medical robot architecture, 
specially designed for this application with strong compliance to safety concerns is 
currently in development by our group [208]. Moreover, to enable detection of stenoses at 
the same location compared to CTA, an improvement of the procedure should be 
incorporated to keep the limb static, with the design of a holder that could monitor changes 
in position with embedded sensors to correct for movements. 
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5.7 Conclusion 
The 3D-US imaging robotic system was validated in vitro with a short, realistic 
vascular phantom. The 3D-US reconstructions obtained were analyzed for geometry and 
quantification of stenoses. Their standards were compared to CTA and their errors 
compared to the CAD file of the phantom lumen geometry. We also verified the feasibility 
of this system in vivo and compared the 3D reconstruction with CTA imaging. The results 
showed promise in detecting stenoses on a portion of a long vessel (i.e., femoral artery) of a 
pathological patient. Of course, further developments are necessary to ensure the complete 
representation of lower limb vessels. The use of a new robot architecture that incorporates 
safety guidelines and arm lengths with kinematics design to cover the whole leg surface is 
in process [208]. The design of a new Z-phantom calibration device may also be necessary 
to scan long vessels accurately. In the future, comparative analyses could adopt multiple 
imaging modalities, including duplex US (i.e., anatomy and blood flow), to situate the 
accuracy level of our 3D-US robotic imaging system for quantifying stenoses with 
spatially-registered Doppler spectral waveforms [104]. In addition, a clinical study with 
more patients could validate application in the medical context by following lower limb 
vessel pathology over a fixed period of time, evaluating their therapy and monitoring 
plaque progression [196]. 
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Chapter 6 
Discussion 
Making your mark on the world is hard. If it were 
easy, everybody would do it. But it's not. It takes 
patience, it takes commitment, and it comes with 
plenty of failure along the way. The real test is not 
whether you avoid this failure, because you won't. It's 
whether you let it harden or shame you into inaction, 
or whether you learn from it; whether you choose to 
persevere. 
 
Barack Obama 
 
6.1 Summary and original contributions 
The goal of this thesis was to validate and optimize a prototype medical 3D-US 
imaging robotic system to localize and quantify arterial stenoses in lower limbs. Three 
research objectives were targeted by this project and their achievement contributed to a 
combination of publications. The first paper presented the performance of our medical 
robotic 3D-US imaging system, the second paper demonstrated validity and accuracy of 3D 
reconstructions in vitro on a mimicked femoral artery and the last paper showed its 
feasibility to localize and quantify lower limb arterial stenoses in vitro and in vivo. The 
conclusions drawn from this research project provide a clear analysis on the performance 
and limitation of our system for an eventual clinical application. The calibration and 
geometric evaluations of 3D vessel representations were the general theme discussed in this 
project. 
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6.1.1 Calibration 
The cornerstone of any 3D-US imaging system is its performance in navigation, 
compatibility and performance in a clinical environment [71]. Considering the technical 
specifications of our medical robot, there is a real potential to generate accurate 3D 
reformations (i.e., reconstructions) with high repeatability, positioning accuracy, precision 
and improved clinical decision. However, the efficiency of the robot relies on the accuracy 
of the 3D data. A calibration method was required to integrate kinematic links and US 
images into the robot’s frame of reference, and also to compare CAD and CTA models to 
the corresponding 3D vessel representations. 
6.1.1.1 Robot kinematic calibration 
Robot kinematics are determined by the length of the links and the angulation of 
each joint of the robotic arm to perform accurately in its workspace. Normally, the end-
effector, the last component of the robotic arm, is tracked and kinematic parameters are 
identified by measuring several robot’s joint configurations [209]. The robotic literature, 
the sources of end-effector positioning errors are largely due to geometric and elastic 
structural deformations that occur in the robotic arm [167, 210-212]. The precision of 3D 
navigation systems can change during the course of experimentation if there is any 
variation in the direction of the target of interest [71, 112].  To overcome this limitation, 
validation techniques are usually performed repeatedly with a stylus to assess precision and 
positioning accuracy for the clinical application under investigation [112, 160, 162, 185, 
213]. 
In chapter 3, we evaluated the performance of our medical robotic imaging system 
by combining calibration kinematic principles in comparison with standard 3D-US 
freehand tracking validation techniques. A rigid pointer was incorporated into the robotic 
arm to extend the robotic point targets into a lower limb mimicking phantom. Point target 
precision was ≤ 0.57 mm, the positioning accuracy was ≤ 0.75 mm and the inter-target 
accuracy was ≤ 0.48 mm in the 5 designated zones of the robot workspace for both ‘teach’ 
and ‘replay’ modes. These results were comparable to the literature where point-target 
precision varies between 0.61 mm and 1.7 mm and inter-target accuracies vary between 
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0.05 mm and 1.7 mm for EM devices [85, 160, 161, 185]. In lower limb arterial vessel 
segments, differences as low as ≤ 0.20 mm were found in zones close or remote to the 
robotics’ arm base. Hence, the robotic arm is appropriate for our clinical application.  The 
creation of a map of optimum zones in the robot workspace was helpful to characterize and 
improve the system’s performance. In robotics, this contribution is paramount to optimize 
robot limb lengths, improve accuracy and predict its performance for investigating lower 
limb vessels. Also, to our knowledge, this characterizing process provided for the first time 
a rigorous method of evaluating a 3D-US medical robot with competitive performance to 
other common 3D-US freehand tracking systems used for similar clinical applications. 
Nevertheless, it is important to note that the performance of the robot could be improved in 
the order of microns using sophisticated metrology equipment such as laser tracker 
(volumetric accuracy of 20 microns), a linear interferometer system (accuracy of 1 micron), 
a measurement arm (volumetric accuracy of 18 microns) and a telescopic ballbar. 
6.1.1.2 US image calibration 
Appropriate location of US images in the robot coordinate system is another form of 
calibration necessary to allow every 2D-US image to be registered correctly according to 
their position and orientation with respect to the patient anatomy [71]. This additional 
calibration step is mandatory in 3D-US freehand tracking systems to compute the 
transformation (rotation, translation and scaling) between the tracking sensor mounted on 
the probe and the image plane itself. This registration should provide a spatial relationship 
between the native 2D frames to reconstruct accurately a 3D geometry. However, the 
calibration problem is still challenging because much variability is introduced from noise in 
the 3D position localizers and the limits imposed from US image resolution. These issues 
have been addressed extensively in the literature mostly with 3D-US freehand systems as 
summarized in [71]. Solutions to minimize variability focused mainly in the conception of 
calibration phantoms and identification of features on the US images that can also be 
located in the tracking coordinate system. While the concept of calibration itself is relevant 
for robotic systems, much of the techniques used the freehand approach. In the freehand 
method, human operators are not capable of executing exact trajectories with high precision 
and good reproducibility [214]. Most approaches in the literature have neglected the impact 
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of the probe movements on the calibration transform. It is well known that tracking 
accuracy directly determines the accuracy and precision of 3D geometry and the visual 
perception of the model. All tracking devices used in freehand systems record the position 
and orientation (pose) of the sensor on the probe, not the US image plane itself [71]. 
A similar challenge was faced with our robotic system with the US probe now 
attached to a handle of the end-effector. In chapter 3, we first used a classical cross-wire 
phantom [160] to determine the calibration transform. We achieved a precision of 2.5 mm 
to locate the point target repeatability. While the accuracy of the calibration transform 
could not be measured directly, we evaluated its apparent performance visually on 3D 
reconstruction of the vascular phantom. We observed a shift along the reconstructed vessel 
longitudinal axis. In chapter 4, we improved our method by using a more robust calibration 
technique with a Z-phantom conceptualized for our robotic system. We evaluated the effect 
of US imaging parameter settings on the performance of a 3D reconstruction of a vessel. 
This was possible because the robot could repeatedly execute the same trajectory for all 
specified settings with high precision and accuracy. For different US image parameter 
settings (i.e., 4 image depths, 3 focus image depths and 3 image zooming), we found a 
precision between 0.47 mm and 1.2 mm and an accuracy between 0.40 mm to 1.74 mm. 
The characterization of the system provided an optimum setting to represent accurately a 
lower limb mimicking artery and this quantification could be used to either compensate or 
to predict the calibration performance in other US image settings. Other studies using 
different 3D-US freehand systems (i.e., optics and electromagnetics) evaluated design 
efficiency, performance of distinct US probes or alternate calibration methods with a 
calibration with the Z-phantom [179-181, 215]. In the 3D-US calibration literature, it is 
well known that a rigorous protocol is necessary to acquire calibration data. Ideally, the 
acquisition protocol should be organized into predefined settings in translation, rotation and 
relative position between the tracking system, phantom and probe in order to select a 
calibration transform for each US image data set [178]. In addition, the correctness of the 
probe calibration should be verified immediately with 2D and 3D quality measurements 
[187]. In that matter, precision was found more sensitive to calibration errors than accuracy 
because it only processes the variations caused by spatial calibration parameters as opposed 
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to combining other sources of errors [177]. For all the reasons listed above we decided to 
use a Z-phantom to calibrate our robot and evaluate our 3D vessel representation. 
6.1.1.3 Image registration 
Image registration was a necessary step required to validate the accuracy and 
precision of our reconstructed 3D vessels. This form of calibration method aligns the 
position and orientation of two different 3D representations enabling an objective 
comparison of these reformations. This technique is very common in augmented reality, 
where virtual objects and users need to merge into the same environment. In that matter, the 
scope of challenges is broader because of the lack of accurate wide-area sensors to track in 
real-time objects’ locations and orientations [114, 115]. In medical robotics, the potential to 
augment clinician’s ability to perform image guided therapy with an improved precision 
and accuracy with CT, US or fluoroscopic images have been explored [157, 216-218]. In 
this case, pre-operative and per-operative patient imaging or localization are performed 
followed by a process of image registration that establishes the spatial relationship between 
images of the patient’s and the actual patient.  
A major issue in medical robotics and 3D-US freehand systems is to ensure that the 
robot positioning is accurate because this will impact precision of the guidance and 
eventually the outcome of the intervention [157, 160, 162, 213]. Generally, this measure is 
difficult to assess in clinical setting due to the lack of fixed and well-defined landmarks 
inside the patient [108]. Normally, precisely built phantoms are used to assess the overall 
system’s accuracy. In our study, we used a vascular phantom to validate our 3D-US 
reconstructed vessel geometry. In chapter 4, the reference standard in vitro came from a 
mathematical model in [219] and, in chapter 5, from a realistic model of stenosed vessel 
embedded in a phantom [203] and in vivo 3D vessel representations from clinical CTA 
images. Registration techniques discussed in chapters 4 and 5 were used to match our 3D-
US vessel reconstruction to these reference models. In chapter 4, this form of validation 
allowed to detect and quantify distortions in vessel shape. In case of poor 3D 
reconstructions, an elliptical geometry was identified whereas the best robotic 
reconstructions were very close to the reference model. The differences in the 3D 
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representations could easily be linked with the accuracy of the calibration transform 
because the method of 3D reconstruction was the same for all acquired data. In chapter 5, 
multi-mode image comparisons of vessel representations were made available in vitro with 
our 3D-US system, the CTA and the CAD mould because of an image registration 
algorithm which allows features to be matched directly. Moreover, a feasibility evaluation 
in vivo was realized with our 3D-US system and the CTA vessel representation could be 
used as reference. Thus, from these evaluations a strong validation of our 3D-US system 
was obtained for the localization, detection and quantification of stenoses in lower limb 
vessels. 
6.1.2 Geometric evaluations of 3D vessel representations  
3D-US systems are developed to perform volumic acquisitions that could be used in 
a clinical setting instead of more expensive or invasive imaging modalities such as MRA 
and CTA. They are usually evaluated on the quality of 3D representations they produced 
[192]. Repetitive volumic evaluation of an object with a balloon shape embedded in a 
phantom is often used to evaluate the accuracy of length and different 1D, 2D and 3D 
measurements taken from 3D US acquisitions [187, 192]. Accurate volume estimation 
required the use of small inter-slice distances, however, distances less than the elevation 
resolution do not result in increased accuracy [77]. In a clinical setting, benefits of 3D 
volume measurements were reported to quantify prostatic lesions and carotid 
atherosclerosis plaque volumes [77, 91, 220]. A good reproducibility of the volume 
quantification is required to be clinically useful. Errors of volume measurement can result 
from compensatory random errors in locating the points defining the volume [160]. Cross-
sectional area measurements are also used in clinic to analyse the progression of stenotic 
lesions in a vessel. The reproducibility of cross-sectional area measurements can improve 
the confidence in the 3D representation method especially in case of vessel sinuosity where 
2D measurement can be erroneous [103, 190].  
In chapters 4 and 5, we evaluated the adequacy of our 3D vessel representation not 
only in repeatability but also in accuracy. Matching our 3D representations to a reference 
standard allowed us to evaluate the reconstruction accuracy in distance and the cross-
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sectional area errors. Iterative measurements allowed us to establish the repeatability of our 
system.  
In chapter 4, the accuracy of our 3D-US reconstruction in distance ranged between 
0.40 – 1.74 mm and the comparison of cross-sectional areas at optimum setting had a good 
fidelity in representing the shape of the vascular phantom.  
In chapter 5, mean length estimation of 3D-US reconstruction and cross-sectional 
area analyses in vitro were found to be underestimated with respect to the CTA (0.03 – 3.6 
mm) and overestimated compared with the CAD file (0.06 – 3.6 mm). In vivo, mean length 
estimation of 3D-US reconstruction and cross-sectional areas were overestimated compared 
to the CTA in B-mode and in Doppler. The differences of the results obtained in vitro and 
in vivo can be explained principally by some factors such as the calibration parameters for a 
long length vessel, the calcification in arteries, and the movement of the patient leg. These 
factors are not controlled in vivo.  
Stenoses evaluated from these geometries were quantified in vitro in chapter 3, on a 
vascular phantom with double stenoses of 75.0 % and 80.0 % area reductions. Stenosis 
quantification errors from 3D-US reconstruction were estimated at -0.9 % and 3.0 %, 
respectively.  
In chapter 5, severe stenoses up to 97.3 % (area reduction) in vitro were quantified 
with ≤ -11.8 % error (4.1% error when compared to the CTA). Stenoses in vivo were not 
easily identifiable in B-mode, color doppler and the CTA because of calcified arteries. This 
resulted in distortions overall the 3D vessel representations. Also, in US reformations not 
all the sections of the lower limb vessel were reconstructed. Other groups that have used 
similar methods to evaluate the accuracy of their 3D reconstructed geometry in vascular 
application have not characterized the performance of the system both in-vivo and in-vitro 
with error estimation of the length and shape of the reformation and its impact on stenosis 
quantification. Either they used phantoms or balloons [71, 192, 221, 222], animals [223] 
and cadaver organs [222]. Even if they have performed in vitro and in vivo 3D-US 
reconstruction of arteries [99, 102], their analyses were not in depth to identify the 
advantages and limitations of their system for the clinical application. 
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6.2 Future research 
6.2.1 New robotic design 
To counter the current limitations of our present 3D-US robotic imaging system, a 
new prototype parallel robot has been specifically designed to enable 3D US scanning of 
lower limb vessels [208]. This new robot architecture offers a larger workspace to cover the 
patient’s leg anatomy. Moreover, the safety of the system is improved because it is made 
with parallel arms which a tool holder is attached to carry the US probe (see Fig. 6.1). Also, 
real-time visual servoing and force control are planned to be incorporated with this robot, 
where the clinician could place manually the starting position for scanning on the artery 
with the desired applied force, and the robot could track the center of the vessel 
accordingly. This system shared control approach has already been proposed by the 
research group at the University of British Columbia [146], except that the system is tele-
operated by the operator with a mouse or joystick for this last prototype. While this 
scanning method is restricted to straight lines, it could be improved to handle more 
complex shaped objects in its control features such as in [224]. 
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Figure 6.1: New parallel robot architecture for 3D-US medical imaging. 
Adaptive visual servoing is also a method that could be used to control the US probe 
for an optimum procedure to determine the best spatial calibration parameters [225]. This 
technique could be adapted with our Z-phantom method and the new robot design to 
provide an automatic calibration [225]. Robust segmentation methods such as the fast 
marching algorithm [41] could also be incorporated to provide in real-time the lumen 
boundary, where the center of gravity of the vessel could be more adequately determined. 
Subsequently, multiple artery tracking could be integrated for a more complete 
representation of the lower limb arterial vascular tree. Of course, a force feedback control 
loop similar to [140] need to be implemented in order to apply appropriate forces on the US 
probe.  
Since we are using a teaching approach, our present 3D-US robotic system also 
repeats the force exerted by the operator. However, it will not change the Cartesian position 
to adjust the force error. This function will be added to our new design. In addition, since 
the scan is a high interactive process, the force control feedback should be controlled by the 
clinician or operator to enable correction if necessary. 
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While the new robot architecture was designed mechanically for safety, all phases 
of the robot must be tested before clinical implementation. Software and electrical safety 
are important aspect to consider in the operation of the device. Verification and validation 
of this safe medical robot with innovative software is going to be crucial in order to 
integrate the operation of this new technology for the clinical application [226]. Basic 
principles include: redundancy in safety controls s, speed and power controls in actuators; 
rigorous design analysis, documentation, and testing protocols; multiple emergency stop 
and checkpoint/restart facilities; etc [218]. After considering all safety issues, another 
validation will be required to characterize the precision and accuracy of this new robot 
architecture, as done in this thesis. 
To solve the leg motion problem many strategies may be proposed for the new robot 
architecture because simply tying the leg will not prevent all motion artefacts. Furthermore, 
a method to track displacement of the leg is needed. An external tracking device that 
monitors the leg motion is the first approach suggested. Using a magneto-optic hybrid 
tracker, a technology very common in augmented reality visualization, the leg movements 
can be monitored and the robot’s path can be adjusted to this reference for navigation [113, 
115-117, 227]. Of course this procedure would require an additional calibration step of the 
two systems for registration. Another alternative is to use camera sensors [228, 229], shape 
tape (i.e., a motion capture sensor) [179], or even a combination of accelerometers and 
gyroscopes [230] to construct a virtual representation of the lower limb to track its 
movement in real-time. These are all well known orthopaedic devices that are used to 
capture human motion for monitoring the physical activity of lower limbs and evaluating 
their performance. Perhaps combining human locomotion principles to our new robotic 
design could be applied to correct leg motion. 
6.2.2 3D Image processing 
Many sources of errors and artefacts encountered in our study were a result of the 
image processing algorithms applied to our data [70, 75]. Improvements in the 3D-US 
reconstruction techniques can be provided to include a voxel-based (volume) reconstruction 
with our feature-based (surface contour) method. This preservation of original data (2D 
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image planes) extended into a 3D grid volume could allow new information surrounding 
the anatomy of the vessel to be explored. Thus, a variety of rendering techniques could be 
applied to the image volume for repetitive review. Moreover, a class of options in 
segmentation and rendering algorithms for volume or surface operations could be made 
available for the same 3D volume data [70, 75]. These methods could be facilitated through 
computer aided software where a user interface is developed to allow clinicians to control 
the viewing of the 3D reconstructed image. This interaction should preferably be in real-
time for a visual effective management of the lower limb vessel examination. Stradx 
(University of Cambridge, Cambridge, UK), a real-time acquisition and visualization 
software, has been developed for freehand 3D-US devices [66, 95]. This software does not 
construct a voxel array but exploits arbitrary slices directly from the raw B-scans for 
viewing. Perhaps, an integration of this software to our new robot architecture could be 
performed for a real-time 3D viewing of lower limb vessels.  
For the robot design reported in this thesis, centering the vessel manually (teach 
mode) presented a challenge in vivo. Much artefacts were observed in the vessel 
reformations. In the robotic literature, a number of motion tracking algorithms have been 
implemented to evaluate the feasibility of US image servoing in centering the vessel.  
These approaches discussed in [146] are feature-based algorithms such as the star and 
discrete snakes where the vessel boundary is sought on US images.  The extracted 
information is then used to control motion of the robotic arm. The feasibility is determined 
by the US image Jacobian which relates differential changes in image features to 
differential changes in the end effector location.  Thus, controling the motion of the US 
transducer to the center of the vessel is possible with this option and could be added in our 
new design. To improve these algorithms and control of the robotic arm as well as optimum 
settings of the US image, image servoing with RF images could also be used.  
Nevertheless, other sources of errors and artefacts may still occur in 3D-US imaging 
regardless of the image processing techniques applied [231]. 3D spatial compounding of 
US scans is an approach that could be used to improve the quality of US images. This 
method constructs an improved image from the combination of several different angles 
from the same cross-sectional plane. The acoustic shadows caused by calcified arteries and 
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speckle noise therefore could be reduced in the US images. This procedure has already 
shown potential with an articulated scan arm and a freehand system [165, 232]. Thus, our 
new robot architecture could incorporate this process by having multiple scans of the artery 
of interest viewed at different angles. Another strategy would be to use RF data with 
hardware and software developments in our new robot design that support this mode.  This 
would allow direct processing of the US images from its raw data and extract precise 
information without image artifacts. 
6.2.3 Clinical benefits 
Many clinical benefits could be gained from a 3D-US robotic imaging system to 
detect stenoses located in lower limb vessel arteries and to provide the clinician with an 
arterial or venous mapping without ionizing radiation or the use of expensive technologies 
such as MRI. After this technology has been completely validated and optimized, it can 
also qualify for image-guided therapy applications such as vessel puncture, guidance of 
angioplasty or stenting procedure [233]. After peripheral revascularization or bypass 
surgery, repetitive imaging follow-up is necessary to evaluate the remodeling of vein grafts 
and the effectiveness of balloon angioplasty and stents on patients over several years [52, 
103, 190, 195]. For these situations mentioned, 2D US imaging is cumbersome and too 
operator dependent, thus a 3D US B-mode and Doppler mapping can be a good alternative 
for these patients. Other benefits of this technology could be to quantify plaque and stenosis 
in lower limb vessel arteries in order to monitor the disease progression in patients under 
medical treatment [89, 90, 92, 220]. Computational flow models could also be achieved in 
lower limb vessels to assess the wall shear stress and localize the development of 
atherosclerotic plaques [98, 198]. Another approach with the new robotic system could be 
to study elastrography of the arteries by applying compressions to vessel and measure their 
rigidity. This method of analysis has already proven great potential for the carotid artery 
and the deep venous thrombosis detection [168, 169]. Evaluating stenosis in Doppler mode 
with spatially-registered spectral waveform in 3D is also another possibility with our 
system. Sample volumes of Doppler waveform registered in 3D space with a surface 
reconstruction of the lumen vessel in color Doppler are possible [101, 104]. Finally, with 
all the benefits available with the system, the best option would be to perform a clinical 
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study with a large patient data base to locate and quantify arterial stenoses in lower limb 
vessels and compare them to CTA or MRA for evaluating the impact of this approach on 
patient management.  
6.3 Conclusion 
This study confirmed that our new prototype medical 3D-US imaging robotic 
system technology is able to locate and quantify lower limb arterial stenoses for diagnosis, 
therapy planning and monitoring. Principally, this new technology can provide an accurate 
3D model of a lower limb artery, with a potential for accurate mapping and quantification 
of arterial stenoses in vitro but a need for improvement in vivo. Its evaluation with CTA has 
shown that this approach is feasible and has a potential to give high diagnostic accuracy in 
a clinical setting if several improvements are made on robotic interface and image 
processing. In regards to the clinical application, 3D reformation of the vessel where 
stenoses can be located and quantified accurately in any projection was generated at low-
cost and non-invasively. Finally, this study has provided the proof of concept that 3D-US 
imaging robotic system can manage optimally lower limb stenoses.  
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APPENDIX I 
US image characteristics 
US images (B-mode) are characterized by the frequency of the US wave formed by 
the transducers, beam focusing and lense shape. The resolution of the US image and the 
attenuation of the US beam depend on these elements. As a general rule, a high-frequency 
US beam provides a better image resolution than a low-frequency beam. Conversely, the 
depth of beam penetration is better at lower US frequency. In large anatomical regions such 
as the abdomen, a lower frequency US wave ranging from 3.5-5 MHz is used to image 
structures at significant depth [30]. A higher US frequency is employed within the range of 
7.5-10 MHz to image details situated at the skin periphery [30]. 
An US image is also dependant on the propagation medium, where the speed of 
sound varies widely in different materials [30]. The US frequency itself is not affected by 
changes in the sound of speed as the acoustic beam propagates through various media, but 
its wavelength depends on the medium. Usually, medical US scanners assume a speed of 
sound of 1540 m/sec for soft tissues and US wave form interactions (i.e., absorption, 
reflection, refraction, scattering and attenuation) that are determined by the acoustic 
properties of matter (i.e. acoustic impedance) [30]. Acoustic images are formed by US 
pulses that are reflected back to the receiver, where changes in time delay causes a texture 
of gray scale in the US image. 
The US beam produced by the transducers propagates as a longitudinal wave into 
the medium and has characteristic properties that define the spatial resolution seen in US 
images [30]. The axial, lateral and elevational (slice thickness) dimensions define the 
minimal volume element in the US scan (see Fig. A.1). The axial resolution is described as 
the ability to discern closely spaced objects that lie in the direction of the beam, whereas 
the lateral resolution is depicted as the ability to distinguish small adjacent structures 
perpendicular to the beam’s direction. The slice thickness is a measure of the beam 
dimension in the elevational direction (i.e., perpendicular to the image plane). 
Line density, focus of the beam and artefacts are other factors that influence greatly 
the image quality of an US image [30]. Line density represents the spatial sampling of the 
 xxvi 
US beam that decreases with depth in sector and phase arrays but remains constant with 
depth for linear arrays. Generally, a large number of lines will provide a higher US image 
quality but compromises the frame rate. The line density can be increased in a selected 
region of an image with a ‘write’ zoom feature that can rescan details with better resolution 
[30]. In addition, the US beam exhibits a distinct shape pattern of a converging beam out to 
a distance specified by the geometry and frequency of the transducer (the near field) and a 
diverging beam beyond that point (the far field) (see Fig. A.1b). In a focused beam, the 
narrowest beam width (i.e., lateral resolution) lies at the focus depth in the scan plane and 
the focal zone is defined as the region over which the width of the beam is less than two 
times the width at the focal distance (see Fig. A.1b). Transmit focusing, where the US beam 
is focused at multiple depths can improve the lateral resolution in a larger region of the 
image because the number of focal zone is increased [30]. However, an improvement in the 
lateral resolution or focusing at a certain range is always accompanied by a loss of 
resolution in the region beyond the focal zone. Incorrect display of anatomy or noise during 
imaging can also degrade the diagnostic value of the US image. Different speed of sound at 
the boundary of two tissues can produce artefacts in the US image. They appear as 
misallocated or missing anatomy, high intensity changes and multiple equally spaced 
boundaries (i.e., reverberation) with decreasing amplitude along a straight line caused by 
refraction. Principally, these characteristics represent the most limitations to expect with 
2D-US image. 
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Figure A.1 a) Resolution of the US beam in 3D space. b) The US beam pattern: focused 
and unfocused.31 
                                               
31
 Source: a)http://www.escardio.org/communities/EAE/3d-echo-box/3d-echo-atlas/technical-
hints/PublishingImages/Technical-factors/Axial-lateral-elevation.gif (Accessed: 10/03/2010). 
b) http://www.sprawls.org/ppmi2/USPRO/25USPROD08.png (Accessed: 10/03/2010). 
a) b) 
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